<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">65228</article-id><article-id pub-id-type="doi">10.7554/eLife.65228</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Egr2 induction in spiny projection neurons of the ventrolateral striatum contributes to cocaine place preference in mice</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-97699"><name><surname>Mukherjee</surname><given-names>Diptendu</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9752-1026</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund15"/><xref ref-type="other" rid="fund16"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-105568"><name><surname>Gonzales</surname><given-names>Ben Jerry</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7011-4631</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-217506"><name><surname>Ashwal-Fluss</surname><given-names>Reut</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-97703"><name><surname>Turm</surname><given-names>Hagit</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-217507"><name><surname>Groysman</surname><given-names>Maya</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-88875"><name><surname>Citri</surname><given-names>Ami</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9914-0278</contrib-id><email>ami.citri@mail.huji.ac.il</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund9"/><xref ref-type="other" rid="fund10"/><xref ref-type="other" rid="fund11"/><xref ref-type="other" rid="fund12"/><xref ref-type="other" rid="fund13"/><xref ref-type="other" rid="fund14"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>The Edmond and Lily Safra Center for Brain Sciences</institution><addr-line><named-content content-type="city">Jerusalem</named-content></addr-line><country>Israel</country></aff><aff id="aff2"><label>2</label><institution>Institute of Life Sciences, The Hebrew University of Jerusalem</institution><addr-line><named-content content-type="city">Jerusalem</named-content></addr-line><country>Israel</country></aff><aff id="aff3"><label>3</label><institution>Program in Child and Brain Development, Canadian Institute for Advanced Research, MaRS Centre</institution><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Day</surname><given-names>Jeremy J</given-names></name><role>Reviewing Editor</role><aff><institution>University of Alabama at Birmingham</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Wassum</surname><given-names>Kate M</given-names></name><role>Senior Editor</role><aff><institution>University of California, Los Angeles</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>16</day><month>03</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e65228</elocation-id><history><date date-type="received" iso-8601-date="2020-11-26"><day>26</day><month>11</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2021-03-15"><day>15</day><month>03</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Mukherjee et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Mukherjee et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-65228-v2.pdf"/><abstract><p>Drug addiction develops due to brain-wide plasticity within neuronal ensembles, mediated by dynamic gene expression. Though the most common approach to identify such ensembles relies on immediate early gene expression, little is known of how the activity of these genes is linked to modified behavior observed following repeated drug exposure. To address this gap, we present a broad-to-specific approach, beginning with a comprehensive investigation of brain-wide cocaine-driven gene expression, through the description of dynamic spatial patterns of gene induction in subregions of the striatum, and finally address functionality of region-specific gene induction in the development of cocaine preference. Our findings reveal differential cell-type specific dynamic transcriptional recruitment patterns within two subdomains of the dorsal striatum following repeated cocaine exposure. Furthermore, we demonstrate that induction of the IEG <italic>Egr2</italic> in the ventrolateral striatum, as well as the cells within which it is expressed, are required for the development of cocaine seeking.</p></abstract><abstract abstract-type="executive-summary"><title>eLife digest</title><p>The human brain is ever changing, constantly rewiring itself in response to new experiences, knowledge or information from the environment. Addictive drugs such as cocaine can hijack the genetic mechanisms responsible for this plasticity, creating dangerous, obsessive drug-seeking and consuming behaviors.</p><p>Cocaine-induced plasticity is difficult to apprehend, however, as brain regions or even cell populations can react differently to the compound. For instance, sub-regions in the striatum – the brain area that responds to rewards and helps to plan movement – show distinct responses during progressive exposure to cocaine. And while researchers know that the drug immediately changes how neurons switch certain genes on and off, it is still unclear how these genetic modifications later affect behavior.</p><p>Mukherjee, Gonzales et al. explored these questions at different scales, first focusing on how progressive cocaine exposure changed the way various gene programs were activated across the entire brain. This revealed that programs in the striatum were the most affected by the drug.</p><p>Examining this region more closely showed that cocaine switches on genes in specific ‘spiny projection’ neuron populations, depending on where these cells are located and the drug history of the mouse. Finally, Mukherjee, Gonzales et al. used genetically modified mice to piece together cocaine exposure, genetic changes and modifications in behavior. These experiments revealed that the drive to seek cocaine depended on activation of the <italic>Egr2</italic> gene in populations of spiny projection neurons in a specific sub-region of the striatum. The gene, which codes for a protein that regulates how genes are switched on and off, was itself strongly activated by cocaine intake.</p><p>Cocaine addiction can have devastating consequences for individuals. Grasping how this drug alters the brain could pave the way for new treatments, while also providing information on the basic mechanisms underlying brain plasticity.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>striatum</kwd><kwd>cocaine</kwd><kwd>reward</kwd><kwd>ensembles</kwd><kwd>IEG</kwd><kwd>transcriptomics</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003977</institution-id><institution>Israel Science Foundation</institution></institution-wrap></funding-source><award-id>1062/18</award-id><principal-award-recipient><name><surname>Citri</surname><given-names>Ami</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000781</institution-id><institution>European Research Council</institution></institution-wrap></funding-source><award-id>ERC 770951</award-id><principal-award-recipient><name><surname>Citri</surname><given-names>Ami</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003977</institution-id><institution>Israel Science Foundation</institution></institution-wrap></funding-source><award-id>393/12</award-id><principal-award-recipient><name><surname>Citri</surname><given-names>Ami</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003977</institution-id><institution>Israel Science Foundation</institution></institution-wrap></funding-source><award-id>1796/12</award-id><principal-award-recipient><name><surname>Citri</surname><given-names>Ami</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003977</institution-id><institution>Israel Science Foundation</institution></institution-wrap></funding-source><award-id>2341/15</award-id><principal-award-recipient><name><surname>Citri</surname><given-names>Ami</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution>The Israel Anti-Drug Administration</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Citri</surname><given-names>Ami</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution>EU Marie Curie</institution></institution-wrap></funding-source><award-id>PCIG13-GA-2013-618201</award-id><principal-award-recipient><name><surname>Citri</surname><given-names>Ami</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001739</institution-id><institution>National Institute for Psychobiology in Israel, Hebrew University of Jerusalem</institution></institution-wrap></funding-source><award-id>109-15-16</award-id><principal-award-recipient><name><surname>Citri</surname><given-names>Ami</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution>Adelis Award for Advances in Neuroscience</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Citri</surname><given-names>Ami</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000874</institution-id><institution>Brain and Behavior Research Foundation</institution></institution-wrap></funding-source><award-id>18795</award-id><principal-award-recipient><name><surname>Citri</surname><given-names>Ami</given-names></name></principal-award-recipient></award-group><award-group id="fund11"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001736</institution-id><institution>German-Israeli Foundation for Scientific Research and Development</institution></institution-wrap></funding-source><award-id>2299-2291.1/2011</award-id><principal-award-recipient><name><surname>Citri</surname><given-names>Ami</given-names></name></principal-award-recipient></award-group><award-group id="fund12"><funding-source><institution-wrap><institution>US-Isral Binational Science Foundation</institution></institution-wrap></funding-source><award-id>2011266</award-id><principal-award-recipient><name><surname>Citri</surname><given-names>Ami</given-names></name></principal-award-recipient></award-group><award-group id="fund13"><funding-source><institution-wrap><institution>The Milton Rosenbaum Endowment Fund for Research in Psychiatry</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Citri</surname><given-names>Ami</given-names></name></principal-award-recipient></award-group><award-group id="fund14"><funding-source><institution-wrap><institution>Prusiner-Abramsky Research Award in Clinical and Basic Neuroscience</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Citri</surname><given-names>Ami</given-names></name></principal-award-recipient></award-group><award-group id="fund15"><funding-source><institution-wrap><institution>Jerusalem Brain Community</institution></institution-wrap></funding-source><award-id>JBC Gold PhD Scholarship</award-id><principal-award-recipient><name><surname>Mukherjee</surname><given-names>Diptendu</given-names></name></principal-award-recipient></award-group><award-group id="fund16"><funding-source><institution-wrap><institution>Jerusalem Brain Community</institution></institution-wrap></funding-source><award-id>JBC Bridging Postdoctoral Scholarship</award-id><principal-award-recipient><name><surname>Mukherjee</surname><given-names>Diptendu</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The ventrolateral striatum is found to be recruited during the encoding of cocaine preference, within which Egr2-expressing ensembles are functionally important, as is the expression of Egr2 within them.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Psychostimulant addiction is characterized by life-long behavioral abnormalities, driven by circuit-specific modulation of gene expression (<xref ref-type="bibr" rid="bib88">Nestler, 2014</xref>; <xref ref-type="bibr" rid="bib90">Nestler and Lüscher, 2019</xref>; <xref ref-type="bibr" rid="bib104">Salery et al., 2020</xref>; <xref ref-type="bibr" rid="bib109">Steiner, 2016</xref>). Induction of immediate-early gene (IEG) transcription in the nucleus accumbens (NAc) and dorsal striatum (DS) are hallmarks of psychostimulant exposure (<xref ref-type="bibr" rid="bib12">Berke et al., 1998</xref>; <xref ref-type="bibr" rid="bib16">Caprioli et al., 2017</xref>; <xref ref-type="bibr" rid="bib19">Chandra and Lobo, 2017</xref>; <xref ref-type="bibr" rid="bib36">Gao et al., 2017b</xref>; <xref ref-type="bibr" rid="bib39">Gerfen, 2000</xref>; <xref ref-type="bibr" rid="bib41">Gonzales et al., 2020</xref>; <xref ref-type="bibr" rid="bib44">Guez-Barber et al., 2011</xref>; <xref ref-type="bibr" rid="bib47">Hope et al., 1994</xref>; <xref ref-type="bibr" rid="bib78">Moratalla et al., 1996</xref>; <xref ref-type="bibr" rid="bib80">Mukherjee et al., 2018</xref>; <xref ref-type="bibr" rid="bib84">Nestler et al., 1993</xref>; <xref ref-type="bibr" rid="bib85">Nestler, 2001</xref>; <xref ref-type="bibr" rid="bib89">Nestler and Aghajanian, 1997</xref>; <xref ref-type="bibr" rid="bib95">Piechota et al., 2010</xref>; <xref ref-type="bibr" rid="bib115">Turm et al., 2014</xref>). As such, IEG induction has been utilized to support the identification of functional neuronal assemblies mediating the development of cocaine-elicited behaviors (‘cocaine ensembles’; <xref ref-type="bibr" rid="bib13">Bobadilla et al., 2020</xref>; <xref ref-type="bibr" rid="bib25">Cruz et al., 2013</xref>). Within these striatal structures, the principal neuronal type is the spiny projection neuron (SPN), which is comprised of two competing subtypes, defined by their differential expression of dopamine receptors. Expression of the D1R dopamine receptor is found on direct-pathway neurons, responsible for action selection by promoting behavioral responses, while D2R-expressing indirect pathway neurons are responsible for action selection through behavioral inhibition (<xref ref-type="bibr" rid="bib62">Kreitzer and Malenka, 2008</xref>; <xref ref-type="bibr" rid="bib68">Lipton et al., 2019</xref>). In the striatum, the cellular composition of cocaine ensembles varies by domain: Fos-expressing cocaine ensembles in the NAc are enriched for D1R expression (<xref ref-type="bibr" rid="bib60">Koya et al., 2009</xref>), while in the DS, IEG expression and psychostimulant-responsive ensembles are spatially segregated to the medial striatum (MS) and ventrolateral striatum (VLS), encompassing both D1R<sup>+</sup> and D2R<sup>+</sup> neurons in the MS, and enriched for D1R expression in the VLS (<xref ref-type="bibr" rid="bib16">Caprioli et al., 2017</xref>; <xref ref-type="bibr" rid="bib27">Cruz et al., 2015</xref>; <xref ref-type="bibr" rid="bib41">Gonzales et al., 2020</xref>; <xref ref-type="bibr" rid="bib66">Li et al., 2015</xref>; <xref ref-type="bibr" rid="bib101">Rubio et al., 2015</xref>; <xref ref-type="bibr" rid="bib110">Steiner and Gerfen, 1993</xref>). The VLS subregion partially overlaps with a lateral striatum segment enriched for <italic>Gpr155</italic> expression, defined in recent molecular striatal subdivisions (<xref ref-type="bibr" rid="bib73">Märtin et al., 2019</xref>; <xref ref-type="bibr" rid="bib93">Ortiz et al., 2020</xref>).</p><p>Depending on the history of prior cocaine exposure, a unique pattern of IEG induction is observed across brain structures (<xref ref-type="bibr" rid="bib80">Mukherjee et al., 2018</xref>). This transcriptional code was characterized addressing a handful of transcripts within bulk tissue, warranting a comprehensive study of the induced gene expression programs across key structures of the reward circuitry. Here we comprehensively describe gene programs in progressive stages of cocaine experience across multiple brain structures, analyze the spatial and cell-type-specific patterns of IEG expression within prominently recruited brain regions, and functionally link induced gene expression to the development of cocaine preference.</p><p>Taking an unbiased approach to the identification of the cellular and molecular modifications underlying the development of cocaine-elicited behaviors, we analyzed dynamics of cocaine-induced transcription across five structures of the reward circuitry. Of these, the most prominently induced gene programs were in the DS. Addressing the spatial segregation of these transcriptional programs within the DS (studying 759,551 individual cells by multiplexed single-molecule fluorescence in-situ hybridization), we investigated the dynamics of cell-specific recruitment within the two striatal subdomains engaged by cocaine, the MS and VLS. While both D1R<sup>+</sup> and D2R<sup>+</sup> neurons in the MS were engaged transcriptionally throughout the development of cocaine sensitization, the recruitment of D1R<sup>+</sup> neurons in the VLS fluctuated depending on the history of cocaine exposure. The IEG <italic>Egr2</italic>, which we find to be the most robustly induced following cocaine experience, serves as a prominent marker for these VLS ensembles. We therefore addressed the function of VLS Egr2<sup>+</sup> ensembles, as well the role of VLS expressed Egr2-transcriptional complexes, in the development of cocaine seeking. Our results identify the VLS as a hub of dynamic transcriptional recruitment by cocaine and define a role for Egr2-dependent transcriptional regulation in VLS D1R<sup>+</sup> neurons in the development of cocaine seeking.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Characterization of transcriptional dynamics in the reward circuitry during the development of behavioral sensitization to cocaine</title><p>In order to characterize brain-wide gene expression programs corresponding to the development of psychostimulant sensitization, we exposed mice to cocaine (20 mg/kg, i.p.) acutely, or repeatedly (five daily exposures), as well as to a cocaine challenge (acute exposure following 21 days of abstinence from repeated exposure to cocaine) (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). We then profiled transcription (applying 3′-RNA-seq) within key brain structures of the reward circuitry (limbic cortex = LCtx, nucleus accumbens = NAc, dorsal striatum = DS, amygdala = Amy, lateral hypothalamus = LH; see <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref> for the delineation of brain tissue dissected; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref> and <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref> for a description of the samples sequenced) at 0 (not exposed to cocaine on day of sample collection), 1, 2 or 4 hr post-cocaine exposure (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Mice exhibited increased locomotion upon acute exposure to cocaine, further increasing following repeated exposure and maintained after abstinence and challenge re-exposure, typical of locomotor sensitization to this intermediate cocaine dose (<xref ref-type="fig" rid="fig1">Figure 1B</xref>, F<sub>8,312</sub> = 178.9, p&lt;0.0001, ANOVA).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Transcriptional profiling resolves the dynamics of cocaine-induced gene expression within major nodes of the reward circuitry.</title><p>(<bold>A</bold>) Scheme describing the cocaine sensitization paradigm and time points (0, 1, 2, 4 hr) at which samples were obtained for analysis of gene expression following acute (0 = cocaine naïve); repeated (fifth exposure to cocaine; 0 = 24 hr following fourth exposure); and challenge exposures (acute exposure following 21 days of abstinence from repeated exposure; 0 = abstinent mice). (<bold>B</bold>) Locomotor sensitization to cocaine (20 mg/kg i.p.; days 1–3 n = 58; days 4 n = 51; day 8 n = 30; day 29 n = 15) of mice included in this study. (<bold>C</bold>) Baseline shifts in expression of genes associated with categories of neuroplasticity following repeated cocaine exposure and abstinence (see <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplements 1</xref> and <xref ref-type="fig" rid="fig1s2">2</xref> for description of sectioned regions and RNA-seq QC). Heatmap depicting fold change of differentially expressed genes (normalized to cocaine naive samples and Z-scored per gene), with rows corresponding to individual genes, clustered according to annotation of biological function on Gene Ontology (p&lt;0.05 FDR corrected). Columns correspond to individual mice – naïve (=azure); repeated (=blue); challenge (=navy) cocaine; n = 6–8 samples in each group across brain structures (LCtx = limbic cortex, NAc = nucleus accumbens, DS = dorsal striatum, Amy = amygdala and LH = lateral hypothalamus). Genes were selected from analysis of a subset of samples which were sequenced together (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3A</xref>) and plotted here across all available samples (for gene identity, see <xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4</xref>). (<bold>D</bold>) Heatmaps depicting expression of inducible genes. Data was normalized to 0 hr of relevant cocaine experience, log-transformed, and clustered by peak expression (selected by FC &gt; 1.2 and FDR corrected p&lt;0.05, linear model followed by LRT, see Materials and methods). Columns correspond to individual mice (0, 1, 2, 4 hr following acute, repeated vs challenge cocaine; see adjacent key for color coding) across LCtx, NAc, DS and Amy. n = 2–4 samples for individual time points of a cocaine experience within a brain nucleus. (<bold>E</bold>) Dot plots represent the peak induction magnitude of genes induced in the LCtx, NAc, DS, and Amy following acute, repeated, and challenge cocaine. (<bold>F</bold>) Heatmap addressing the conservation of gene identity and peak induction time. Induced genes are color coded by their time point of peak induction (NI = not induced). (<bold>G</bold>) Venn diagrams represent overlap of the genes induced in each brain nuclei following different cocaine experiences (all: 1 and 2 and 4 hr; early: 1 hr; late: 2 hr and 4 hr time points). (<bold>H</bold>) DEGs induced within the DS are enriched for GO terms associated with signaling and transcription at 1 hr, diversifying to regulators of cellular function and plasticity at later times. Heatmap represents significantly enriched GO terms (p &lt; 0.05, Bonferoni corrected), graded according to p-value.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65228-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Boundaries of dissected brain structures.</title><p>Illustration of the brain tissue collected for RNA extraction and sequencing analysis. Red shaded boxes represent the area dissected from 400-micron coronal sections at specific rostral (+) or caudal (−) distances from Bregma (marked by the number). Left to right, brain regions include limbic cortex (medial prefrontal and cingulate cortex), nucleus accumbens, dorsal striatum, amygdala, and lateral hypothalamus.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65228-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Quality control analysis of RNA-seq experiments.</title><p>(<bold>A</bold>) Histograms of mean usable read depth of 3′-RNA-seq libraries. n = 194 libraries. (<bold>B</bold>) Principal component analysis (PCA) demonstrates clustering of RNA-seq libraries according to brain region, consistent with brain nuclei expressing distinct transcriptional profiles (<xref ref-type="bibr" rid="bib46">Hawrylycz et al., 2012</xref>; <xref ref-type="bibr" rid="bib55">Kang et al., 2011</xref>; <xref ref-type="bibr" rid="bib93">Ortiz et al., 2020</xref>). Each dot represents individual libraries color coded by brain structure. n = 194 samples. (<bold>C</bold>) PCA of genes differentially expressed in the DS following acute, repeated, and challenge cocaine reveals clustering according to the time point of gene expression. Libraries of 1 hr time point are most distinct from the relevant control (0 hr) groups. Each dot represents a sample color coded according to its time point. n = 16 samples for each cocaine experience. These analyses indicate the robustness of transcriptional dynamics induced by cocaine and also provide an indication for the reproducibility of the experimental samples and the quality of the sequencing.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65228-fig1-figsupp2-v2.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title>Repeated cocaine administration and abstinence induce baseline shifts in gene transcription.</title><p>(<bold>A</bold>) Gene expression profiles of repeated cocaine treated and abstinent mice within different brain regions. Heatmaps reflect log2 (fold change) of genes demonstrating differential expression between 0 hr of acute (cocaine naïve), repeated, and challenge cocaine in different brain regions. Columns represent individual samples sorted by the cocaine experience and brain nuclei. Expression is graded according to the color bar. Differentially expressed genes (DEGs) were assayed from samples that were included in the same sequencing run in order to avoid the introduction of batch effects. n = 2 samples in each condition. (FC &gt;1.2; FDR corrected p&lt;0.05 in at least one of the conditions, Wald test – see Materials and methods) (<bold>B</bold>) Dot plots demonstrate the magnitude and direction of DEG expression shifts in different brain nuclei. Each dot represents a DEG. LCtx: limbic cortex, NAc: nucleus accumbens, DS: dorsal striatum, Amy: amygdala, LH: lateral hypothalamus. (<bold>C</bold>) The number of genes that exhibit shift in their baseline expression following repeated cocaine and abstinence. Bar graphs color coded by brain structure depict the number of DEGs in each structure. (<bold>D</bold>) KEGG pathway annotation of gene clusters whose expression is modulated by repeated drug exposure and abstinence. Heat map showing enriched pathways consisting of at least 6 DEGs in different brain nuclei. Color represents p-value.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65228-fig1-figsupp3-v2.tif"/></fig><fig id="fig1s4" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 4.</label><caption><title>Repeated cocaine exposure and abstinence alters the expression of gene clusters related to neuroplasticity.</title><p>Heatmaps depict the expression levels of genes which are modulated between naïve mice and mice following repeated cocaine or abstinence in different brain regions clustered according to GO terms related to neuroplasticity (from <xref ref-type="fig" rid="fig1">Figure 1C</xref>). Columns represent individual mice. Expression is graded according to the color bar (Z-scored per gene). Cocaine experiences are color coded according to the key. LCtx = limbic cortex, NAc = nucleus accumbens, DS = dorsal striatum, Amy = amygdala, LH = lateral hypothalamus.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65228-fig1-figsupp4-v2.tif"/></fig></fig-group></sec><sec id="s2-2"><title>Repeated cocaine administration and abstinence induce prominent transcriptional shifts across multiple brain regions</title><p>Experience impacts gene transcription at multiple timescales (<xref ref-type="bibr" rid="bib21">Clayton et al., 2020</xref>; <xref ref-type="bibr" rid="bib80">Mukherjee et al., 2018</xref>; <xref ref-type="bibr" rid="bib90">Nestler and Lüscher, 2019</xref>; <xref ref-type="bibr" rid="bib99">Rittschof and Hughes, 2018</xref>; <xref ref-type="bibr" rid="bib108">Sinha et al., 2020</xref>; <xref ref-type="bibr" rid="bib130">Yap and Greenberg, 2018</xref>). Whereas the expression of inducible genes peak and decay on a time scale of minutes-to-hours following stimulation, baseline shifts in brain-wide gene expression programs are also observed following more prolonged periods (days to weeks) (<xref ref-type="bibr" rid="bib21">Clayton et al., 2020</xref>), presumably implementing, supporting, and maintaining the modified behavioral output (<xref ref-type="bibr" rid="bib108">Sinha et al., 2020</xref>). We initially focused on baseline shifts in gene expression, comparing naïve mice (never exposed to cocaine) to mice exposed repeatedly to cocaine, as well as to mice following 21 days of abstinence from repeated cocaine exposure (<xref ref-type="fig" rid="fig1">Figure 1C</xref>; <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3A</xref>; refer to <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref> for list of differentially expressed genes and normalized counts). Differentially expressed genes (DEGs) included both upregulated and downregulated genes across all brain regions analyzed, with prolonged abstinence driving the most extreme shifts in expression (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3B,C</xref>). While gene-expression shifts following repeated exposure to cocaine were prominent in the DS, abstinence-induced changes were more prominent in the NAc and LCtx (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3C</xref>). KEGG analysis demonstrated that DEGs were enriched for synaptic genes and disease pathways (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3D</xref>). To provide insight into the cellular mechanisms affected by repeated drug exposure and abstinence, we implemented Gene Ontology (GO term) enrichment analysis (<xref ref-type="fig" rid="fig1">Figure 1C</xref>, <xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4</xref>, see <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref> for definition of clusters and DEGs included within them). Gene clusters associated with synaptic plasticity, myelin, and proteostasis demonstrated shifts in expression across multiple brain structures, whereas a cluster of genes associated with structural plasticity appeared more specific to striatal structures (DS and NAc). Noteworthy gene clusters that displayed modified expression were involved in cell–cell communication; glutamate-induced plasticity; synaptic vesicle formation, transport, and fusion; actin filament components; and projection morphogenesis. Notably, the expression of protein folding genes was coordinately upregulated across structures, while myelin components were coordinately downregulated (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4</xref>). These results exemplify the dramatic shifts of transcription occurring in the brain in response to repeated cocaine exposure, potentially supporting maladaptive neuroplasticity driving drug addiction (<xref ref-type="bibr" rid="bib10">Bannon et al., 2014</xref>; <xref ref-type="bibr" rid="bib70">Lull et al., 2008</xref>).</p></sec><sec id="s2-3"><title>Transcriptional profiling illustrates dynamic recruitment of the striatum during the development of behavioral sensitization to cocaine</title><p>Inducible transcription supports the development of plastic changes following psychostimulant experience (<xref ref-type="bibr" rid="bib1">Alberini, 2009</xref>; <xref ref-type="bibr" rid="bib45">Han et al., 2019</xref>; <xref ref-type="bibr" rid="bib75">McClung and Nestler, 2008</xref>; <xref ref-type="bibr" rid="bib90">Nestler and Lüscher, 2019</xref>). We therefore assessed the inducible transcription response at 1, 2, or 4 hr following acute, repeated, or challenge cocaine exposure, observing robust IEG induction across all brain structures studied (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). The largest number of induced genes, as well as the highest fold induction levels, were found in the DS (<xref ref-type="fig" rid="fig1">Figure 1D,E</xref>; refer to <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref> for the identities of genes induced in each structure and cocaine condition).</p><p>To what extent do the transcription programs induced in the different structures share common attributes? To query the overlap in the identity of genes induced and their temporal induction patterns following the different schedules of cocaine exposure, we graphed the induced genes, color coding them according to their time of peak induction (1, 2, or 4 hr following cocaine) (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). Thus, for example, if a gene was commonly induced across structures with a peak at 1 hr across cocaine regimens, this would be evident as a contiguous vertical green line. This graph reveals aspects of the logic of these inducible transcription programs, whereby (1) genes induced following the different cocaine schedules largely maintain the same temporal structure, i.e., if the peak induction of a given gene was observed at a defined time point in one program, its peak induction time was maintained across other programs; (2) following repeated cocaine exposure, we observe a substantial dampening of the transcriptional response in the DS, which recovers following cocaine challenge, recapitulating a significant proportion of the acute cocaine gene program; (3) all gene programs largely represent subcomponents of the program induced by acute cocaine in the DS. We further visualized the overlap in the identity of genes induced in the different structures using Venn diagrams (<xref ref-type="fig" rid="fig1">Figure 1G</xref>), illustrating that the overlap stems principally from the immediate component of the transcriptional program (peaking at 1 hr following cocaine), while transcripts induced at 2 or 4 hr following cocaine diverged between structures. Focusing on the most robust programs, induced in the DS, we found that gene clusters enriched at the 1 hr time points are related primarily to transcriptional regulation and synapse-to-nucleus signal transduction, while clusters related to modification of neural morphology and function were enriched at later time points (<xref ref-type="fig" rid="fig1">Figure 1H</xref>; refer to <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>). Taken together, these results highlight robust transcriptional adaptations in the DS, positioning it as a major hub of cocaine-induced plasticity. Furthermore, our results illustrate the utilization of a conserved set of genes during the early wave of transcription following experience, followed by divergence of subsequent transcription, possibly to support region-specific mechanisms of plasticity (<xref ref-type="bibr" rid="bib48">Hrvatin et al., 2018</xref>; <xref ref-type="bibr" rid="bib122">Walker et al., 2018</xref>).</p></sec><sec id="s2-4"><title>IEG induction in subdomains of the DS is influenced by the history of cocaine exposure</title><p>Our observation of dynamic transcriptional responses to repeated cocaine exposure in the DS (<xref ref-type="fig" rid="fig1">Figure 1</xref>) motivated us to address the cellular and spatial distribution of this transcriptional plasticity. Recently, using single-molecule fluorescence in-situ hybridization (smFISH), we reported region-specific rules governing the recruitment of striatal assemblies following a single acute exposure to cocaine (<xref ref-type="bibr" rid="bib41">Gonzales et al., 2020</xref>). We now revisited this spatial analysis, applying smFISH to expand the investigation of the striatal distribution of the IEGs <italic>Arc</italic>, <italic>Egr2</italic>, <italic>Fos</italic>, and <italic>Nr4a1</italic> throughout the development of cocaine sensitization (<xref ref-type="fig" rid="fig2">Figure 2</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplements 1</xref> and <xref ref-type="fig" rid="fig2s2">2</xref>; results from <xref ref-type="bibr" rid="bib41">Gonzales et al., 2020</xref> serve as a reference for the effects of acute cocaine exposure).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Dynamic IEG induction in subregions of the striatum accompany the development of cocaine sensitization.</title><p>(<bold>A</bold>) Scheme of a coronal section of the dorsal striatum (DS) (+0.52 ± 0.1 mm from Bregma) corresponding to the region assayed by multicolor smFISH for cocaine-induced IEG expression. (<bold>B</bold>) Representative images of multicolor smFISH analysis of <italic>Arc</italic>, <italic>Egr2</italic>, <italic>Nr4a1</italic>, and <italic>Fos</italic> expression following acute, repeated and challenge cocaine exposures (40× magnification). (<bold>C</bold>) Spatial IEG expression patterns in the DS. Representative images of multicolor smFISH analysis of <italic>Arc</italic>, <italic>Egr2</italic>, <italic>Nr4a1</italic>, and <italic>Fos</italic> expression. (<bold>D</bold>) Cocaine experiences induce distinct spatial patterns of IEG expression. Two-dimensional kernel density estimation was used to demarcate the regions with maximal density of high expressing cells for each IEG. Color code for probes: <italic>Arc –</italic> yellow, <italic>Egr2 – </italic>red, <italic>Nr4a1 – </italic>green, <italic>Fos –</italic> blue. The opacity of the demarcated areas corresponds to the mean puncta/cell expression. (<bold>E, F</bold>) Dot plots depicting the proportion of cells suprathreshold for <italic>Egr2</italic><sup>+</sup> and <italic>Fos</italic><sup>+</sup> (fraction; <bold>E</bold>), as well as cellular expression (puncta/cell; <bold>F</bold>) of <italic>Egr2</italic><sup>+</sup> and <italic>Fos</italic><sup>+</sup> in the ventrolateral (VLS) and medial (MS) striatum following acute, repeated, and challenge cocaine. *p&lt;0.05, **p&lt;0.005, ***p&lt;0.0001, two-way ANOVA with post hoc Tukey’s test. Refer to <xref ref-type="supplementary-material" rid="supp7">Supplementary file 7</xref> for cell numbers. See <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref> for corresponding analysis of <italic>Arc</italic> and <italic>Nr4a1</italic>. See <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref> for correlation in expression of <italic>Egr2</italic>, <italic>Arc</italic>, and <italic>Nr4a1</italic>, as well as <italic>Egr2</italic> and <italic>Fos</italic>. Images relating to acute cocaine (in <bold>B</bold>, <bold>C</bold>, and <bold>D</bold>) were replicated from <xref ref-type="bibr" rid="bib41">Gonzales et al., 2020</xref>, with permission.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65228-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Cocaine dynamically modulates cellular IEG expression in the VLS and MS.</title><p>(<bold>A</bold>) Dot plot of the fraction of cells positive for expression of <italic>Arc</italic> and <italic>Nr4a1</italic> in the VLS and MS (threshold: <italic>Arc</italic> = 11, <italic>Nr4a1</italic> = 12 puncta/cell) following acute, repeated, and challenge cocaine exposures. n = 3 sections from three mice (8823–12,246 cells). ANOVA with post hoc Tukey; *p&lt;0.05, **p&lt;0.005. (<bold>B</bold>) Dot plot of the puncta/cell for <italic>Arc</italic> and <italic>Nr4a1</italic> following acute, repeated, and challenge cocaine exposures. n = 3 sections from three mice (8823–12,246 cells). ANOVA with post hoc Tukey; *p&lt;0.05, **p&lt;0.005, ***p<italic>&lt;</italic>0.005.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65228-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Coherence of cocaine-induced IEG expression.</title><p>(<bold>A</bold>) <italic>Arc</italic>, <italic>Egr2</italic>, and <italic>Nr4a1</italic> are coherently induced in cells of the VLS and MS. Coherence refers to the correlated co-expression of multiple IEGs within individual cells. Each dot depicts the expression [log2 (puncta per cell + 1)] of <italic>Arc</italic>, <italic>Egr2</italic>, and <italic>Nr4a1</italic> within a single cell. The plots are color coded by <italic>Egr2</italic> expression according to the color bar. Data summarized from n = 3 animals in each condition. Analysis using a linear model with <italic>Egr2</italic> expression as the dependent variable and <italic>Arc</italic> and <italic>Nr4a1</italic> expression as the independent variables demonstrated significant correlation between the genes (p&lt;0.0001 for all conditions; 6850–16,952 cells). (<bold>B</bold>) <italic>Egr2</italic> and <italic>Fos</italic> expression are strongly and positively correlated in the VLS and MS. Individual dots depict pairwise correlations of <italic>Egr2</italic> and <italic>Fos</italic> within single cells. n = 6 sections from three mice in each condition (Pearson correlation, p&lt;0.0001 for all conditions; 17,734–33,195 cells).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65228-fig2-figsupp2-v2.tif"/></fig></fig-group><p>Addressing an overview of induced expression of these IEGs, we observed robust induction of <italic>Arc</italic>, <italic>Egr2</italic>, <italic>Nr4a1</italic>, and <italic>Fos</italic> following acute cocaine exposure, which was dampened following repeated exposure to cocaine and reinstated following a challenge dose of cocaine, in-line with the results described in <xref ref-type="fig" rid="fig1">Figure 1</xref> (<xref ref-type="fig" rid="fig2">Figure 2A–C</xref>). To visualize the subdomains defined by IEG expressing cells, we applied 2D kernel density estimation on striatal sections following repeated and challenge cocaine and compared resulting patterns to those previously described following acute cocaine exposure (<xref ref-type="bibr" rid="bib41">Gonzales et al., 2020</xref>). The prominent recruitment of IEG expression in the VLS observed following acute cocaine exposure was dampened drastically after repeated cocaine exposure, and re-emerged upon cocaine challenge. In contrast to the findings in the VLS, dampening of IEG induction in the MS, while evident, was more modest (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). These results are quantified in <xref ref-type="fig" rid="fig2">Figure 2E,F</xref>. In the VLS, the fraction of robustly expressing cells of <italic>Egr2</italic> increased to 46 ± 10% after acute cocaine, decreased to 21 ± 4% following repeated cocaine, and subsequently increased to 40 ± 11% upon cocaine challenge. Similar dynamics were observed for <italic>Fos</italic>, where the fractions of suprathreshold cells were observed to be 37 ± 10%, 21 ± 4%, and 34 ± 7% following acute, repeated, and challenge cocaine, respectively. In contrast, in the MS, the fraction of cells expressing <italic>Egr2</italic> and <italic>Fos</italic> increased to 42 ± 8% and 40 ± 7% after acute cocaine, modestly decreased to 33 ± 3% and 35 ± 3% after repeated cocaine, and regained elevated induction of 43 ± 4% and 40 ± 4% following challenge cocaine (<xref ref-type="fig" rid="fig2">Figure 2E</xref> [mean ± SD]; <italic>Egr2</italic> VLS F<sub>2,66</sub> = 21.4, p&lt;0.0001; <italic>Fos</italic> VLS F<sub>2,30</sub> = 4.9964, p=0.01; <italic>Egr2</italic> MS F<sub>2,66</sub> = 6.4, p=0.002; <italic>Fos</italic> MS F<sub>2,30</sub> = 3.1, p=0.06; ANOVA followed by Tukey’s test; for detailed statistics refer to <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>). With reference to expression levels, acute, repeated, and challenge cocaine-mediated puncta/cell expression in the VLS was observed to be 11.9 ± 3.8, 3.9 ± 0.8, 9.5 ± 3.4 for <italic>Egr2</italic> and 6.8 ± 2.3, 3.5 ± 0.5, 5.9 ± 1.6 for <italic>Fos</italic>, respectively. Comparing these to the MS, the expression levels were observed to be 9.2 ± 2.2, 6.5 ± 1.0, and 9.5 ± 1.2 for <italic>Egr2</italic> and 7.4 ± 1.5, 6 ± 0.8, and 7.5 ± 1.3 for <italic>Fos</italic> after acute, repeated, and challenge, respectively (<xref ref-type="fig" rid="fig2">Figure 2F</xref>) (mean ± SD; <italic>Egr2</italic> VLS F<sub>2,66</sub> = 21.7, p&lt;0.0001; <italic>Fos</italic> VLS F<sub>2,30</sub> = 4.9, p=0.01; <italic>Egr2</italic> MS F<sub>2,66</sub> = 9.01, p=0.0003; <italic>Fos</italic> MS F<sub>2,30</sub> = 3.4, p=0.04; ANOVA followed by Tukey’s test; for detailed statistics refer to <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>). A similar trend was evident for the expression of <italic>Arc</italic> and <italic>Nr4a1</italic> in the VLS vs. the MS (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A,B</xref>). Notably, the expression of different IEGs was highly correlated within individual cells, defining overlapping populations of neurons responsive to the cocaine experiences studied. Once recruited by cocaine, neurons committed to co-expression of multiple IEGs to virtually identical levels (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>; for detailed statistics, see <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>). These data demonstrate the coherent co-expression of multiple IEGs within striatal assemblies during the development of behavioral sensitization to cocaine, likely to support mechanisms of long-term plasticity within these ensembles. In sum, the history of cocaine experience is reflected in the differential transcriptional recruitment of striatal subdomains, dampening drastically in the VLS following repeated exposure.</p></sec><sec id="s2-5"><title>The IEG response is selectively dampened in VLS <italic>Drd1</italic><sup>+</sup> SPNs following repeated cocaine</title><p>Striatal <italic>Drd1</italic><sup>+</sup>-neurons are implicated in promoting actions, while <italic>Drd2</italic><sup>+</sup>-neurons are implicated in the tempering and refinement of action selection (<xref ref-type="bibr" rid="bib11">Bariselli et al., 2019</xref>). Differential IEG induction in <italic>Drd1</italic><sup>+</sup> vs <italic>Drd2</italic><sup>+</sup> expressing SPN ensembles is expected to shed light on the relative contribution of plasticity within each cell type to the development of cocaine behaviors. We have previously reported that acute exposure to cocaine induces <italic>Egr2</italic> expression in both <italic>Drd1</italic><sup>+</sup> and <italic>Drd2</italic><sup>+</sup> neurons in the MS, while more selectively inducing <italic>Egr2</italic> expression in <italic>Drd1</italic><sup>+</sup>-neurons in the VLS (<xref ref-type="bibr" rid="bib41">Gonzales et al., 2020</xref>). Extending this analysis to repeated and challenge cocaine exposures and with additional IEGs, we observed robust dampening of the induction of <italic>Egr2</italic> and <italic>Fos</italic> in VLS <italic>Drd1</italic><sup>+</sup> neurons following repeated exposure to cocaine, while upon cocaine challenge, prominent induction was again evident, especially in <italic>Drd1</italic> SPNs. (<xref ref-type="fig" rid="fig3">Figure 3A–C</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). In contrast, in the MS, subtle dampening was observed and <italic>Egr2</italic> and <italic>Fos</italic> expression maintained consistent correlation to <italic>Drd1</italic> and <italic>Drd2</italic> expression throughout acute, repeated, and challenge cocaine exposures (<xref ref-type="fig" rid="fig3">Figure 3C</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>; for reference of <italic>Drd1</italic> and <italic>Drd2</italic> levels in MS and VLS, see <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>, <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref> for statistics). Thus, the observed attenuated transcriptional recruitment in the DS can be attributed to selective dampening of IEG induction, primarily within VLS <italic>Drd1</italic><sup>+</sup> neurons. This specialization in transcriptional plasticity likely underlies differential roles of the striatal subregions and cells within them in supporting behavioral modification induced by cocaine experience.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Induction of <italic>Egr2</italic> in VLS neurons contributes to the acquisition of cocaine reward.</title><p>(<bold>A</bold>) Representative 40× images showing <italic>Egr2</italic> expression within <italic>Drd1<sup>+</sup></italic> and <italic>Drd2<sup>+</sup></italic> SPNs in the VLS (left) and MS (right) following acute, repeated, and challenge cocaine exposures compared to controls. (<bold>B, C</bold>) The <italic>Drd1</italic><sup>+</sup> enriched IEG response in the VLS is dampened following repeated exposure to cocaine. (<bold>B</bold>) Scatter plots show cellular <italic>Egr2</italic> expression with <italic>Drd1</italic> or <italic>Drd2</italic> expression (puncta/cell) within individual cells. n = 6 sections from three mice for each condition (gray – 0 hr for either <italic>Drd1</italic> or <italic>Drd2</italic> combination, and blue or red – for <italic>Drd1</italic> or <italic>Drd2</italic> combination, respectively, 1 hr following cocaine experience). (<italic>Drd1-Egr2</italic>: acute control, slope = 0.028, r<sup>2</sup> = 0.038; acute cocaine, slope = 0.65, r<sup>2</sup> = 0.50; repeated control, slope = 0.019, r<sup>2</sup> = 0.02; repeated cocaine, slope = 0.11, r<sup>2</sup> = 0.1; challenge control, slope = 0.048, r<sup>2</sup> = 0.05; challenge cocaine, slope = 0.51, r<sup>2</sup> = 0.4. <italic>Drd2-Egr2</italic>: acute control, slope = 0.029, r<sup>2</sup> = 0.040; acute cocaine, slope = −0.036, r<sup>2</sup> = 0.0017; repeated control, slope = 0.03, r<sup>2</sup> = 0.069; repeated cocaine, slope = 0.06, r<sup>2</sup> = 0.03; challenge control, slope = 0.07, r<sup>2</sup> = 0.1; challenge cocaine, slope = −0.048, r<sup>2</sup> = 0.004. Pearson correlation, p&lt;0.0001 for all conditions; refer to <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref> for detailed statistics). (<bold>C</bold>) Spearman correlation plots showing acute induction of <italic>Egr2</italic> is correlated with <italic>Drd1</italic> expression in the VLS, dampened following repeated exposure and re-emerges following challenge exposure. In the MS, <italic>Egr2</italic> expression is consistently correlated to both <italic>Drd1</italic> and <italic>Drd2</italic> expression following acute, repeated, and challenge exposures. Refer to <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref> for additional correlations and <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref> for reference to <italic>Drd1</italic> and <italic>Drd2</italic> expression levels throughout the study. (<bold>D</bold>) Scheme of experimental paradigms for testing conditioned-place preference (CPP) for cocaine. Mice were tested (cyan) for initial preference (‘Tini’) followed by either three interleaved pairs of conditioning (yellow) – test days (‘Design 1’, relevant for panel E) – or three consecutive conditioning days and then a final preference test (‘Design 2’, relevant for <bold>F–I</bold>). (<bold>E</bold>) Chemogenetic inhibition of VLS-Egr2 expressing neurons impairs cocaine CPP. Egr2-CRE animals were transduced with AAV-DIO-hM4Di-mCherry and, following 3 weeks of recovery, subjected to a paradigm of cocaine CPP in which the preference of mice was tested repeatedly following individual training days (‘Design 1’; conditioning – days 2, 4, 6; tests – days 1, 3, 4, 7). The control group of mice was exposed to saline while experimental mice received CNO (5 mg/kg) 30 min prior to cocaine conditioning. Left – Line graphs representing % time spent on the cocaine paired side in individual preference test session (T<sub>1</sub>, T<sub>2</sub>, T<sub>3</sub>) compared to the initial preference (initial preference test; T<sub>ini</sub>). n = 6 mice in each group. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.005; paired t-test. Right – Bar graphs displaying the mean preference score (time spent on the drug paired side for relevant test session – initial test day). Significant difference in preference score is observed after three rounds of conditioning with cocaine n = 6 mice in each group. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.005; paired t-test. Data represented as mean ± sem. (<bold>F</bold>) Summary of expression domains of AAV-DIO-h4MDi in Egr2-CRE mice. (<bold>G</bold>) Chemogenetic inhibition of VLS-Egr2 expressing neurons during conditioning attenuates the development of cocaine CPP. Egr2-CRE animals were stereotactically transduced with AAV-DIO-mCherry (VLS-Egr2<sup>mCherry</sup>) or AAV-DIO-hM4Di-mCherry (VLS-Egr2<sup>hM4Di</sup>), and following recovery, all mice were subjected to cocaine CPP conditioning 30 min following exposure to CNO (10 mg/kg). Left panel represents change in % time spent on the cocaine paired side before and after conditioning for individual animals and the mean (paired t-test), while right panel (bar graphs) displays the mean preference score (time spent on the drug paired side of the final – first test day; unpaired t-test). Both groups developed CPP (paired t-test), while VLS-Egr2<sup>hM4Di</sup> mice displayed a lower preference score compared to VLS-Egr2<sup>mCherry</sup> controls (unpaired t-test). n = 7 mice in each group. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.005. For further documentation of expression domains and locomotion, see <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3</xref>. (<bold>H</bold>) Summary of expression domains of AAV-DN-Egr2. (<bold>I</bold>) Disruption of Egr2 function in the VLS inhibits the development of cocaine place preference. Left panel represents change in % time spent on the cocaine paired side before and after conditioning for individual animals and the mean, while bar graphs (right panel) display the mean preference score. Both groups developed CPP (paired t-test), while mice expressing AAV-DNEgr2 displayed a lower preference score compared to AAV-GFP controls (unpaired t-test). n = 8 mice in each group. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.005. For further documentation of expression domains, locomotion, and gene expression, see <xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4</xref>. Images relating to acute cocaine (in <bold>A</bold>) were replicated from <xref ref-type="bibr" rid="bib41">Gonzales et al., 2020</xref>, with permission.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65228-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Induced IEGs are correlated to <italic>Drd1</italic> expression in the VLS and to both <italic>Drd1</italic> and <italic>Drd2</italic> expressions in the MS.</title><p>(<bold>A</bold>) <italic>Egr2</italic> induction in the MS does not exhibit prominent cell-type bias and is modestly affected by the history of cocaine experience. Scatter plots show cellular <italic>Egr2</italic> expression with <italic>Drd1</italic> or <italic>Drd2</italic> expression (puncta/cell) within individual cells. n = 6 sections from three mice for each condition (gray dots represent cells from 0 hr for either <italic>Drd1</italic> or <italic>Drd2</italic> combination, and blue or red dots for <italic>Drd1</italic> or <italic>Drd2</italic> combination, respectively, 1 hr following cocaine experience). <italic>Egr2-D1</italic>: acute control, slope = 0.09, r<sup>2</sup> = 0.069; acute cocaine, slope = 0.41, r<sup>2</sup> = 0.24; repeated control, slope = 0.04, r<sup>2</sup> = 0.03; repeated cocaine, slope = 0.19, r<sup>2</sup> = 0.1; hallenge control, slope = 0.05, r<sup>2</sup> = 0.045; hallenge cocaine, slope = 0.42, r<sup>2</sup> = 0.2. <italic>Egr2-D2</italic>: acute control, slope = 0.08, r<sup>2</sup> = 0.05; acute cocaine, slope = 0.19, r<sup>2</sup> = 0.052; repeated control, slope = 0.06, r<sup>2</sup> = 0.09; repeated cocaine, slope = 0.19, r<sup>2</sup> = 0.10; challenge control, slope = 0.07, r<sup>2</sup> = 0.076; challenge cocaine, slope = 0.18, r<sup>2</sup> = 0.046. Linear model, p&lt;0.0001 for conditions, refer to <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref> for detailed statistics. (<bold>B</bold>) Scatter plots of cellular expression (puncta/cell) of <italic>Fos</italic> with <italic>Drd1</italic> or <italic>Drd2</italic> in the VLS and MS. VLS-Fos induction following acute and challenge cocaine is biased to Drd1<sup>+</sup> neurons. In the MS, irrespective of the cocaine experience, <italic>Fos</italic> induction is correlated with a similar degree with both Drd1<sup>+</sup> and Drd2<sup>+</sup>. Each dot represents a cell color coded similar to (<bold>A</bold>). n = 6 sections from three mice for each condition. <italic>Fos-D1</italic> in VLS: acute control, slope = 0.03, r<sup>2</sup> = 0.02; acute cocaine, slope = 0.33, r<sup>2</sup> = 0.32; repeated control, slope = 0.02, r<sup>2</sup> = 0.03; repeated cocaine, slope = 0.09, r<sup>2</sup> = 0.06; challenge control, slope = 0.05, r<sup>2</sup> = 0.07; challenge cocaine, slope = 0.42, r<sup>2</sup> = 0.2. <italic>Fos-D2</italic> in the VLS: acute control, slope = 0.03, r<sup>2</sup> = 0.02; acute cocaine, slope = −0.03, r<sup>2</sup> = 0; repeated control, slope = 0.02, r<sup>2</sup> = 0.02; repeated cocaine, slope = 0.02, r<sup>2</sup> = 0; challenge control, slope = 0.03, r<sup>2</sup> = 0.05; challenge cocaine, slope = −0.03, r<sup>2</sup> = 0. <italic>Fos-D1</italic> in the MS: acute control, slope = 0.09, r<sup>2</sup> = 0.03; acute cocaine, slope = 0.23, r<sup>2</sup> = 0.11; repeated control, slope = 0.03, r<sup>2</sup> = 0.02; repeated cocaine, slope = 0.16, r<sup>2</sup> = 0.08; challenge control, slope = 0.04, r<sup>2</sup> = 0.03; challenge cocaine, slope = 0.26, r<sup>2</sup> = 0.13. <italic>Fos-D2</italic> in the MS: acute control, slope = 0.08, r<sup>2</sup> = 0.03; acute cocaine, slope = 0.12, r<sup>2</sup> = 0.03; repeated control, slope = 0.04, r<sup>2</sup> = 0.04; repeated cocaine, slope = 0.09, r<sup>2</sup> = 0.03; challenge control, slope = 0.04, r<sup>2</sup> = 0.04; challenge cocaine, slope = 0.12, r<sup>2</sup> = 0.03. Linear model, p&lt;0.0001 for conditions, refer to <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref> for detailed statistics. (<bold>C</bold>) Line graphs depicting spearman correlation show specific and dramatic improvement of <italic>Fos</italic> correlation with <italic>Drd1</italic> and not <italic>Drd2</italic> expression upon acute cocaine exposure in the VLS, dampened following repeated exposure and re-emerging upon cocaine challenge. In the MS, <italic>Fos</italic> expression is consistently correlated to both <italic>Drd1</italic> and <italic>Drd2</italic> expression irrespective of the cocaine experience, with a modest bias towards <italic>Drd1</italic><sup>+</sup> neurons. (<bold>D</bold>) Cumulative bar graphs illustrating the % of <italic>Drd1<sup>+</sup></italic>/Drd2<sup>+</sup>/<italic>Drd1<sup>+</sup>Drd2</italic><sup>+</sup> neurons expressing <italic>Egr2<sup>+</sup></italic> at different time points during the development of behavioral sensitization to cocaine.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65228-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title><italic>Drd1</italic> and <italic>Drd2</italic> receptor expression in the VLS and MS.</title><p>(<bold>A</bold>) Dot plots depicting the fraction of <italic>Drd1</italic> vs <italic>Drd2</italic> expressing cells in the VLS and MS in control (gray) and cocaine (red) conditions following distinct cocaine experiences. n = 6 sections from three mice in each condition. (<bold>B</bold>) Dot plots depicting puncta/cell expression of <italic>Drd1</italic> and <italic>Drd2</italic> following distinct cocaine experiences. Color code as in (<bold>A</bold>). n = 6 sections from three mice in each condition.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65228-fig3-figsupp2-v2.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title>DREADD inhibition of VLS Egr2<sup>+</sup> cells does not affect locomotion.</title><p>(<bold>A, B</bold>) Verification of AAV transduction in the VLS of transgenic Egr2-CRE mice tested in experiment depicted in <xref ref-type="fig" rid="fig3">Figure 3F-G</xref>. Example of AAV-DIO-hM4Di-mcherry infections in the VLS (<bold>A</bold>) and summary of AAV-DIO-mCherry and AAV-DIO-hM4Di-mcherry infections (<bold>B</bold>). Span of viral transduction in individual mice was manually overlaid on corresponding coronal sections from the mouse brain atlas. n = 7 mice in each group. (<bold>C</bold>) Expression of AAV-DIO-hM4Di does not affect locomotor behavior (p=0.93, ANOVA for interaction day with group, see <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref> for stats). Bar graphs compare the locomotion of VLS-Egr2<sup>mCherry</sup> and VLS-Egr2<sup>hM4Di</sup> mice in the CPP chambers on pre-test, conditioning session with cocaine, and post-test days. CNO (10 mg/kg, i.p.) was administered to both groups 30 min prior to cocaine conditioning. n = 7 mice in each group. Data represented as mean ± sem.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65228-fig3-figsupp3-v2.tif"/></fig><fig id="fig3s4" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 4.</label><caption><title>Disruption of Egr2 function in the VLS does not affect locomotor behavior or IEG expression outside of VLS.</title><p>(<bold>A, B</bold>) Verification of AAV-GFP and AAV-DNEgr2 infection in the VLS. Example of AAV-DNEgr2 infection in the VLS (<bold>A</bold>). (<bold>B</bold>) Summary of infection from individual mice of VLS<sup>DNEgr2</sup> and VLS<sup>GFP</sup> groups manually overlaid onto corresponding coronal sections from the mouse brain atlas. n = 8 mice in each group. (<bold>C</bold>) DN-Egr2 expression does not affect locomotor behavior (p=0.7, ANOVA for interaction day with group, see <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>). Bar graphs compare the average locomotion of VLS<sup>GFP</sup> and VLS<sup>DNEgr2</sup> mice in the CPP chambers on pretest, conditioning session with cocaine, and post-test days. n = 8 mice in each group. Data represented as mean ± sem. (D-G) Comparison of gene expression in mice injected with AAV-GFP (gray) or AAV-DN-Egr2 (orange) 24 hr after the final CPP test. (<bold>D, E</bold>) AAV-DN-Egr2 inhibits <italic>Nr4a1</italic> and <italic>Arc</italic> expression in the VLS (<bold>D</bold>), but not in the MS (<bold>E</bold>). (<bold>F, G</bold>) Viral transduction of AAV-DNEgr2 in the VLS does not impact gene transcription in LCtx (<bold>F</bold>) and NAc (<bold>G</bold>). Bar graphs represent expression of <italic>Arc</italic>, <italic>Nr4a1</italic>, and <italic>Egr2</italic> in LCtx and NAc of VLS<sup>GFP</sup> (gray) and VLS<sup>DNEgr2</sup> (orange) mice. n = 3 mice in each group. Data represented as mean ± sem. *p&lt;0.05, **p&lt;0.005 unpaired t-test, n = 3 mice in each group.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65228-fig3-figsupp4-v2.tif"/></fig></fig-group></sec><sec id="s2-6"><title>Implication of VLS <italic>Egr2</italic> transcriptional activity in the development of cocaine-seeking behavior</title><p>The greater enrichment of <italic>Egr2</italic> induction within VLS neurons suggests a causal role for this neuronal population in supporting cocaine conditioned behaviors. To address the role of VLS <italic>Egr2</italic><sup>+</sup> neurons in cocaine seeking, we bilaterally injected Cre-dependent inhibitory hM4Di DREADD (VLS-Egr2<sup>hM4Di</sup>), targeting the VLS of Egr2-Cre knock-in mice. In these mice, an <italic>Egr2</italic> allele is substituted for <italic>Cre</italic> (<xref ref-type="bibr" rid="bib119">Voiculescu et al., 2000</xref>), supporting the expression of Cre recombinase in neurons expressing <italic>Egr2</italic>. DREADD hM4Di-mediated selective inhibition of the VLS <italic>Egr2</italic>-expressing neuronal ensembles was achieved by administration of clozapine-N-oxide (CNO) (<xref ref-type="bibr" rid="bib5">Atlan et al., 2018</xref>; <xref ref-type="bibr" rid="bib113">Terem et al., 2020</xref>). Control mice were either transduced with viruses expressing hM4Di, similar to the experimental group, and exposed to saline (<xref ref-type="fig" rid="fig3">Figure 3E</xref>) or transduced with viruses conditionally expressing mCherry and exposed to CNO (<xref ref-type="fig" rid="fig3">Figure 3G</xref>, for expression domains, see <xref ref-type="fig" rid="fig3">Figure 3F</xref>, <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3A,B</xref>).</p><p>In an initial experiment, we transduced two groups of mice with AAV-DIO-hM4Di to the VLS. Three weeks later, we ran a cocaine conditioned-place preference (CPP) experiment, in which mice were conditioned over three alternate days to a cocaine-associated context, while on the day following each conditioning session their side preference was tested (conditioning – days 2, 4, 6; tests – days 1, 3, 5, 7; <xref ref-type="fig" rid="fig3">Figure 3D</xref>, ‘Design 1’). In control mice expressing hM4Di and exposed to saline prior to cocaine conditioning sessions, CPP developed following a single conditioning session and was reinforced following additional conditioning sessions (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). The experimental group, which was exposed to CNO (5 mg/kg; i.p.) 30 min prior to cocaine conditioning, also displayed CPP following the initial exposure; however, in this group, the preference decayed with additional conditioning, such that following the third conditioning session, CPP in this group was significantly different from the control group (preference score saline vs. CNO Test3: p&lt;0.05, t = 2, df = 8.6; one-tailed t-test; <xref ref-type="fig" rid="fig3">Figure 3E</xref>). We interpret these results as suggesting that the first cocaine conditioning session induced expression of Cre within VLS <italic>Egr2</italic><sup>+</sup> neurons, supporting the accumulation of functional hM4Di within these neurons to a CNO-responsive complement by the third conditioning session, resulting in diminished conditioned-place preference.</p><p>In a subsequent experiment, we implemented conditioning to the cocaine-associated context for three consecutive days prior to performing a preference test and exposed both experimental (hM4Di-expressing) and control (mCherry-expressing) groups to CNO (10 mg/kg; i.p.) prior to cocaine conditioning session (<xref ref-type="fig" rid="fig3">Figure 3D</xref>, ‘Design 2’). We found that both groups demonstrated CPP (<xref ref-type="fig" rid="fig3">Figure 3G</xref>; paired t-test on % time spent on drug paired side; p<sub>VLS-Egr2mCherry</sub> &lt; 0.00001, t = −11.362, df = 6; p<sub>VLS-Egr2hM4Di</sub> &lt; 0.003, t = −4.1232, df = 6). However, mice in which VLS <italic>Egr2</italic><sup>+</sup> neurons were inhibited (VLS-Egr2<sup>hM4Di</sup>) displayed lower preference for the drug paired context (preference score) compared to control mice (VLS-Egr2<sup>mCherry</sup>) (<xref ref-type="fig" rid="fig3">Figure 3G</xref>; p&lt;0.05, t = 1.95, df = 9.4, one-tailed t-test). Importantly, no differences in locomotion were observed between groups on conditioning or test days (p=0.93, F<sub>4,48</sub> = 0.19, ANOVA; <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3C</xref>). We therefore conclude that VLS <italic>Egr2</italic><sup>+</sup>-expressing neurons contribute to the development of cocaine-seeking behavior, with no obvious impact on locomotor aspects of cocaine-driven behavior.</p><p>Salient experiences in general, and specifically exposure to cocaine, are thought to modify future behavior through induced gene expression responses, leading to stable changes in cell and circuit function (<xref ref-type="bibr" rid="bib90">Nestler and Lüscher, 2019</xref>; <xref ref-type="bibr" rid="bib100">Robison and Nestler, 2011</xref>). We hypothesized that the induction of <italic>Egr2</italic> by cocaine within VLS neurons may play a causal role in cocaine-induced modification of behavior. To assess a potential link between the expression of <italic>Egr2</italic> and cellular plasticity responsible for such behavioral modification, we ran an additional CPP experiment, following bilateral viral transduction of the VLS neurons with AAV-eGFP (VLS<sup>GFP</sup>), or a dominant-negative (S382R, D383Y) isoform of <italic>Egr2</italic> (VLS<sup>DNEgr2</sup>; <xref ref-type="fig" rid="fig3">Figure 3H</xref>, <xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4A,B</xref>). The dominant-negative mutation disrupts the DNA-binding activity of Egr2, while not interfering with the capacity of the protein to form heteromeric complexes with its natural binding partners, effectively inhibiting transcriptional activation of downstream genes regulated by Egr2 (<xref ref-type="bibr" rid="bib64">LeBlanc et al., 2007</xref>; <xref ref-type="bibr" rid="bib82">Nagarajan et al., 2001</xref>). Comparing the development of cocaine CPP, we found that both groups of mice developed CPP (<xref ref-type="fig" rid="fig3">Figure 3I</xref>, paired t-test on % time spent on drug paired side; p<sub>VLS-GFP</sub> &lt;0.001, t = −4.9782, df = 7; p<sub>VLS-DNEgr2</sub> &lt;0.05, t = −2.2199, df = 7). However, VLS<sup>DNEgr2</sup> developed lower CPP than VLS<sup>GFP</sup> mice (<xref ref-type="fig" rid="fig3">Figure 3I</xref>, p&lt;0.05, t = 2.36, df = 14, unpaired t-test). No differences in locomotion were observed between the groups of mice (p=0.7, F<sub>4,56</sub> = 0.54, ANOVA; <xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4C</xref>). These results assign a functional role to <italic>Egr2</italic> induction, primarily within VLS <italic>Drd1</italic><sup>+</sup> neurons, in the development of conditioned-place preference to cocaine. To test the effect of disrupting Egr2 complexes may have on transcription, we analyzed the expression of <italic>Arc</italic>, <italic>Egr2</italic>, and <italic>Nr4a1</italic> in the VLS, MS, NAc, and LCtx. In the VLS, we observed the anticipated overexpression of <italic>Egr2</italic> (<xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4D</xref>, p<sub>(Egr2)</sub>&lt;0.05, t = −5.3616, df = 2; two-tailed t-test, reflecting exogenous expression of the mutant gene), as well as blunted <italic>Arc</italic> and <italic>Nr4a1</italic> expression (<xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4D</xref>, p<sub>(Arc)</sub>&lt;0.01, t = 6, df = 2.8; p<sub>(Nr4a1)</sub>&lt;0.005, t = 6.2, df = 3.8; two-tailed t-test). We did not observe any clear differences in gene expression between groups within other structures, demonstrating the localized effect of our viral manipulation (<xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4E–G</xref>). These results demonstrate a role for cocaine-induced expression of <italic>Egr2</italic> in the VLS in supporting the development of cocaine-seeking and suggest that inducible transcriptional complexes involving Egr2 are functional in facilitating drug-induced maladaptive plasticity.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Drugs of abuse such as cocaine are known to act on key brain circuits, modifying and biasing the future behavior of an individual toward increased drug seeking. In this study, we develop a comprehensive compendium of the transcriptional dynamics induced within key brain regions during the development of cocaine sensitization. We highlight the striatum as a major hub of plasticity, within which we identify differential transcriptional recruitment of neuronal ensembles by cocaine, dependent on striatal subdomain, identity of projection neurons and the history of cocaine exposure. Finally, we focus on a prominent cocaine-sensitive IEG, <italic>Egr2</italic>, and show that <italic>Egr2</italic>-expressing SPNs in the VLS, and the expression of <italic>Egr2</italic> within them, support drug-seeking behavior.</p><p>Repeated exposure to cocaine, as well as abstinence, produces long-lasting functional changes in the reward circuit to drive the maladaptive modification of reinforced behavior (<xref ref-type="bibr" rid="bib30">Dong and Nestler, 2014</xref>; <xref ref-type="bibr" rid="bib32">Everitt, 2014</xref>; <xref ref-type="bibr" rid="bib43">Gremel and Lovinger, 2017</xref>; <xref ref-type="bibr" rid="bib51">Hyman et al., 2006</xref>; <xref ref-type="bibr" rid="bib57">Kelley, 2004</xref>; <xref ref-type="bibr" rid="bib71">Lüscher, 2016</xref>; <xref ref-type="bibr" rid="bib72">Lüscher and Malenka, 2011</xref>; <xref ref-type="bibr" rid="bib87">Nestler, 2013</xref>; <xref ref-type="bibr" rid="bib102">Russo and Nestler, 2013</xref>; <xref ref-type="bibr" rid="bib104">Salery et al., 2020</xref>; <xref ref-type="bibr" rid="bib121">Volkow and Morales, 2015</xref>; <xref ref-type="bibr" rid="bib127">Wolf, 2016</xref>; <xref ref-type="bibr" rid="bib132">Zahm et al., 2010</xref>). The imprinting of such potentially lifelong alterations in behavior driven by drug experience is supported by cocaine-induced modifications in gene expression (<xref ref-type="bibr" rid="bib75">McClung and Nestler, 2008</xref>; <xref ref-type="bibr" rid="bib86">Nestler, 2002</xref>; <xref ref-type="bibr" rid="bib90">Nestler and Lüscher, 2019</xref>; <xref ref-type="bibr" rid="bib104">Salery et al., 2020</xref>; <xref ref-type="bibr" rid="bib109">Steiner, 2016</xref>; <xref ref-type="bibr" rid="bib111">Steiner and Van Waes, 2013</xref>). In this study, using an unbiased approach to screen gene expression, we resolved the transcriptional landscapes of distinct cocaine experiences across multiple reward-related brain circuits with broad temporal resolution. Our approach allowed us to describe transcripts modulated at updated baselines (after a history of either repeated cocaine exposure or abstinence), as well as in the hours following exposure to distinct cocaine experiences.</p><p>Baseline transcriptional changes in cortical and basal ganglia structures following defined cocaine schedules have been described previously in both rodents and humans (<xref ref-type="bibr" rid="bib9">Bannon et al., 2005</xref>; <xref ref-type="bibr" rid="bib10">Bannon et al., 2014</xref>; <xref ref-type="bibr" rid="bib31">Eipper-Mains et al., 2013</xref>; <xref ref-type="bibr" rid="bib34">Freeman et al., 2010</xref>; <xref ref-type="bibr" rid="bib35">Gao et al., 2017a</xref>; <xref ref-type="bibr" rid="bib49">Hurd and Herkenham, 1993</xref>; <xref ref-type="bibr" rid="bib70">Lull et al., 2008</xref>; <xref ref-type="bibr" rid="bib98">Ribeiro et al., 2017</xref>; <xref ref-type="bibr" rid="bib122">Walker et al., 2018</xref>). Consistent with previous findings, we observed dynamic shifts in baseline gene expression in multiple categories potentially associated with neuronal plasticity (synaptic genes; genes associated with projection morphogenesis, actin filament regulation; proteostasis and myelin). Interestingly, genes associated with neuronal morphology and synaptic function demonstrated unique patterns of shifts within different brain structures. For example, expression of genes such as <italic>Vamp</italic>, <italic>Pkrcg</italic>, <italic>Ncdn</italic>, <italic>Camk2b, Shank3</italic>, and <italic>Syp</italic> were downregulated in the NAc following repeated cocaine exposure, while being upregulated in the DS. Such region-specific shifts in gene expression may support circuit-specific structural and functional modifications to cell assemblies (<xref ref-type="bibr" rid="bib21">Clayton et al., 2020</xref>; <xref ref-type="bibr" rid="bib63">Kyrke-Smith and Williams, 2018</xref>). Myelin genes (<italic>Plp1</italic>, <italic>Mobp</italic>, <italic>Mbp</italic>, <italic>Mal</italic>, <italic>Pllp</italic>) were downregulated across all structures studied (LCtx, Amy, NAc, DS, LH), initially following repeated cocaine exposure, and further following abstinence, across all experimental mice. Conversely, genes associated with proteostasis (e.g., chaperones such as members of the CCT, Hsp40, Hsp70, and Hsp90 complexes) were upregulated in concert across structures following cocaine abstinence. Notably, similar changes in myelin genes and genes associated with proteostasis have been described in both human and rodent studies (<xref ref-type="bibr" rid="bib3">Albertson et al., 2004</xref>; <xref ref-type="bibr" rid="bib10">Bannon et al., 2014</xref>; <xref ref-type="bibr" rid="bib37">García-Fuster et al., 2012</xref>; <xref ref-type="bibr" rid="bib54">Johnson et al., 2012</xref>; <xref ref-type="bibr" rid="bib59">Kovalevich et al., 2012</xref>; <xref ref-type="bibr" rid="bib70">Lull et al., 2008</xref>; <xref ref-type="bibr" rid="bib83">Narayana et al., 2014</xref>), but their functional implications remain unknown. Future investigation into the features of cocaine experience-related transcriptome is anticipated to provide targets for intervention, potentially supporting the reversal of brain function to a ‘cocaine-naive’ state.</p><p>IEG expression is well accepted to be the substrate for long-term modulations supporting memory formation (<xref ref-type="bibr" rid="bib1">Alberini, 2009</xref>; <xref ref-type="bibr" rid="bib2">Alberini and Kandel, 2015</xref>). Although cocaine-induced IEG expression has been extensively characterized in rodents (<xref ref-type="bibr" rid="bib12">Berke et al., 1998</xref>; <xref ref-type="bibr" rid="bib17">Caster and Kuhn, 2009</xref>; <xref ref-type="bibr" rid="bib35">Gao et al., 2017a</xref>; <xref ref-type="bibr" rid="bib44">Guez-Barber et al., 2011</xref>; <xref ref-type="bibr" rid="bib78">Moratalla et al., 1996</xref>; <xref ref-type="bibr" rid="bib95">Piechota et al., 2010</xref>; <xref ref-type="bibr" rid="bib100">Robison and Nestler, 2011</xref>; <xref ref-type="bibr" rid="bib105">Savell et al., 2020</xref>; <xref ref-type="bibr" rid="bib109">Steiner, 2016</xref>; <xref ref-type="bibr" rid="bib118">Valjent et al., 2006</xref>; <xref ref-type="bibr" rid="bib132">Zahm et al., 2010</xref>), these studies were mostly limited in the number of genes analyzed and restricted to isolated brain structures following specific drug regimens. Addressing the cocaine-induced transcriptome, we observed transcriptional recruitment of the LCtx, Amy, NAc, and DS, of which the DS was most prominent. Furthermore, the immediate-early transcriptional programs induced across other tissues largely consisted of subcomponents of DS programs. What does this imply? We propose thathe overlapping fraction of induced genes is representative of a ‘core transcriptome’ that is consistently induced across many structures or cell types and only varies in the magnitude of their expression (<xref ref-type="bibr" rid="bib48">Hrvatin et al., 2018</xref>; <xref ref-type="bibr" rid="bib105">Savell et al., 2020</xref>; <xref ref-type="bibr" rid="bib116">Tyssowski et al., 2018</xref>). This core component predominantly corresponds to signaling molecules and transcriptional regulators (the genes common across most programs are <italic>Arc, Arl4d, Btg2, Ddit4, Dusp1, Egr2, Egr4, Fos, Fosb, Junb, Nr4a1, Per1</italic>, and <italic>Tiparp</italic>), likely responsible for transforming inducing signals into instructions for implementation of appropriate synaptic, cellular, and circuit-specific plasticity mechanisms by ‘effector’ genes. These downstream effector genes are induced in a secondary wave of transcription, corresponding to the significantly diversified gene response at 2–4 hr following cocaine (<xref ref-type="bibr" rid="bib4">Amit et al., 2007</xref>; <xref ref-type="bibr" rid="bib21">Clayton et al., 2020</xref>; <xref ref-type="bibr" rid="bib42">Gray and Spiegel, 2019</xref>; <xref ref-type="bibr" rid="bib48">Hrvatin et al., 2018</xref>; <xref ref-type="bibr" rid="bib80">Mukherjee et al., 2018</xref>; <xref ref-type="bibr" rid="bib116">Tyssowski et al., 2018</xref>; <xref ref-type="bibr" rid="bib130">Yap and Greenberg, 2018</xref>). Interestingly, a recent landmark study (<xref ref-type="bibr" rid="bib105">Savell et al., 2020</xref>) utilized a multiplexed CRISPR strategy to drive co-expression of genes overlapping with many of the components of the putative ‘core transcriptome’ (<italic>Btg2</italic>, <italic>Egr2</italic>, <italic>Egr4</italic>, <italic>Fos</italic>, <italic>FosB</italic>, <italic>JunB</italic>, and <italic>Nr4a1</italic>) in the NAc and found that this manipulation increased SPN excitability and enhanced the development of cocaine sensitization.</p><p>What might be the role of the transcriptional induction in the DS and its subsequent dampening? It is becoming more broadly accepted that IEG induction serves to support long-term plasticity (<xref ref-type="bibr" rid="bib19">Chandra and Lobo, 2017</xref>; <xref ref-type="bibr" rid="bib20">Clayton, 2000</xref>; <xref ref-type="bibr" rid="bib21">Clayton et al., 2020</xref>; <xref ref-type="bibr" rid="bib80">Mukherjee et al., 2018</xref>; <xref ref-type="bibr" rid="bib117">Tyssowski and Gray, 2019</xref>). The MS is defined as the ‘associative striatum’ and is associated with goal-directed behaviors, as well as defining the vigor of locomotor actions (<xref ref-type="bibr" rid="bib7">Balleine and O'Doherty, 2010</xref>; <xref ref-type="bibr" rid="bib8">Balleine and Ostlund, 2007</xref>; <xref ref-type="bibr" rid="bib61">Kravitz et al., 2010</xref>; <xref ref-type="bibr" rid="bib68">Lipton et al., 2019</xref>; <xref ref-type="bibr" rid="bib91">Nonomura et al., 2018</xref>). We propose that the cocaine-driven locomotor sensitization may be mediated by the balanced and largely maintained transcriptional induction within Drd1/Drd2 SPNs in the MS. The lateral ‘sensori-motor’ striatum is strongly associated with habit formation and compulsive drug seeking (<xref ref-type="bibr" rid="bib68">Lipton et al., 2019</xref>; <xref ref-type="bibr" rid="bib131">Yin et al., 2004</xref>; <xref ref-type="bibr" rid="bib133">Zapata et al., 2010</xref>). Moreover, the VLS receives selective sensorimotor afferents mapped to upper limb and orofacial cortical regions. Interestingly, behavioral stereotypies, primarily upper limb and orofacial, arise upon high-dose psychostimulant exposure (<xref ref-type="bibr" rid="bib56">Karler et al., 1994</xref>; <xref ref-type="bibr" rid="bib81">Murray et al., 2015</xref>; <xref ref-type="bibr" rid="bib106">Schlussman et al., 2003</xref>), and orofacial stereotypies have been induced following selective infusion of psychostimulants to the VLS (<xref ref-type="bibr" rid="bib6">Baker et al., 1998</xref>; <xref ref-type="bibr" rid="bib29">Delfs and Kelley, 1990</xref>; <xref ref-type="bibr" rid="bib97">Rebec et al., 1997</xref>; <xref ref-type="bibr" rid="bib125">White et al., 1998</xref>). It is intriguing to consider the possibility that recruitment of plasticity mechanisms within VLS Drd1<sup>+</sup> neurons supports the increased propensity to engage in orofacial stereotypies, while the subsequent dampening of cocaine-induced transcription within these neurons may indicate the ‘canalization’ of this limited action repertoire, at the expense of a broader behavioral repertoire. This topic will form the basis for future investigation.</p><p>Infusion of psychostimulants into the VLS has also been shown to promote operant reinforcement and conditioned-place preference, implicating it in reward and reinforcement (<xref ref-type="bibr" rid="bib6">Baker et al., 1998</xref>; <xref ref-type="bibr" rid="bib58">Kelley and Delfs, 1991</xref>). In order to query the role of the VLS IEG-expressing ensembles in the development of cocaine context association, we inhibited the activity of VLS <italic>Egr2</italic><sup>+</sup> neurons by conditional expression of hM4Di DREADDs, which curbed CPP. To directly investigate a role for VLS IEG induction on CPP behavior, we expressed a dominant-negative isoform of Egr2 (in which the DNA-binding domain was inactivated) in the VLS and observed a similar impact. Thus, to our knowledge, we provide the first functional implication of the VLS in cocaine seeking. Furthermore, we describe cellular dynamics of transcriptional recruitment of VLS IEG<sup>+</sup> neurons (primarily <italic>Drd1</italic><sup>+</sup>) during the development of behavioral sensitization to cocaine. The development and execution of drug-seeking behavior is heavily context dependent (<xref ref-type="bibr" rid="bib15">Calipari et al., 2016</xref>; <xref ref-type="bibr" rid="bib22">Crombag et al., 2002</xref>; <xref ref-type="bibr" rid="bib23">Crombag et al., 2008</xref>; <xref ref-type="bibr" rid="bib24">Crombag and Shaham, 2002</xref>; <xref ref-type="bibr" rid="bib26">Cruz et al., 2014</xref>; <xref ref-type="bibr" rid="bib65">Lee et al., 2006</xref>; <xref ref-type="bibr" rid="bib101">Rubio et al., 2015</xref>). Potentially, the dampening of sensorimotor VLS IEG induction following repeated cocaine could serve to ‘cement’ the initial context association, limiting behavioral flexibility and the capacity to revert context association, exacerbating the impact of contextual cues on drug seeking behavior (<xref ref-type="bibr" rid="bib15">Calipari et al., 2016</xref>; <xref ref-type="bibr" rid="bib24">Crombag and Shaham, 2002</xref>; <xref ref-type="bibr" rid="bib40">Gipson et al., 2013</xref>; <xref ref-type="bibr" rid="bib50">Hyman, 2005</xref>; <xref ref-type="bibr" rid="bib94">Phillips et al., 2003</xref>; <xref ref-type="bibr" rid="bib107">Shaham et al., 2003</xref>; <xref ref-type="bibr" rid="bib120">Volkow et al., 2006</xref>).</p><p>Recently, we have shown that salient experiences are represented in the mouse brain by unique patterns of gene expression. Thus, the induction pattern of a handful of genes is sufficient to decode the recent experience of individual mice with almost absolute certainty. Of these, the IEG whose expression contributes most towards classification of the recent experience of individual mice is <italic>Egr2</italic> (<xref ref-type="bibr" rid="bib80">Mukherjee et al., 2018</xref>). <italic>Egr2</italic> is, furthermore, the gene most robustly induced by cocaine in the dorsal striatum (<xref ref-type="bibr" rid="bib41">Gonzales et al., 2020</xref>; <xref ref-type="bibr" rid="bib80">Mukherjee et al., 2018</xref>; <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>) and is a sensitive indicator of cocaine-engaged striatal cell assemblies (<xref ref-type="bibr" rid="bib41">Gonzales et al., 2020</xref>). In the current study, we initiated investigation into the role of <italic>Egr2</italic> in promoting drug seeking. Previous studies have shown that Egr2 is crucial for normal hindbrain development, peripheral myelination, and humoral immune response and is implicated in diseases such as congenital hypomyelinating neuropathy, Charcot–Marie-Tooth disease, Dejerine–Sottas syndrome, as well as schizophrenia (<xref ref-type="bibr" rid="bib14">Boerkoel et al., 2001</xref>; <xref ref-type="bibr" rid="bib28">De and Turman, 2005</xref>; <xref ref-type="bibr" rid="bib67">Li et al., 2019</xref>; <xref ref-type="bibr" rid="bib79">Morita et al., 2016</xref>; <xref ref-type="bibr" rid="bib92">Okamura et al., 2015</xref>; <xref ref-type="bibr" rid="bib112">Svaren and Meijer, 2008</xref>; <xref ref-type="bibr" rid="bib114">Topilko et al., 1994</xref>; <xref ref-type="bibr" rid="bib124">Warner et al., 1999</xref>; <xref ref-type="bibr" rid="bib123">Warner et al., 1998</xref>; <xref ref-type="bibr" rid="bib126">Wilkinson, 1995</xref>; <xref ref-type="bibr" rid="bib129">Yamada et al., 2007</xref>). In the central nervous system, <italic>Egr2</italic> has been shown to be induced by seizure activity, kainic acid injection, LTP-inducing stimuli in hippocampal neurons, as well as following administration of several groups of drugs such as methamphetamine, cocaine, heroin, and alcohol (<xref ref-type="bibr" rid="bib35">Gao et al., 2017a</xref>; <xref ref-type="bibr" rid="bib38">Gass et al., 1994</xref>; <xref ref-type="bibr" rid="bib52">Imperio et al., 2018</xref>; <xref ref-type="bibr" rid="bib69">López-López et al., 2017</xref>; <xref ref-type="bibr" rid="bib74">Mataga et al., 2001</xref>; <xref ref-type="bibr" rid="bib96">Rakhade et al., 2007</xref>; <xref ref-type="bibr" rid="bib103">Saint-Preux et al., 2013</xref>; <xref ref-type="bibr" rid="bib128">Worley et al., 1993</xref>). However, the role <italic>Egr2</italic> may play in encoding memory or drug-induced behavior remained unresolved. Our findings show that the activity of <italic>Egr2</italic> is required for the full development of cocaine place preference, and highlight an additional member of the Egr family, alongside <italic>Egr1</italic> and <italic>Egr3</italic>, in drug-induced plasticity (<xref ref-type="bibr" rid="bib10">Bannon et al., 2014</xref>; <xref ref-type="bibr" rid="bib18">Chandra et al., 2015</xref>; <xref ref-type="bibr" rid="bib77">Moratalla et al., 1992</xref>; <xref ref-type="bibr" rid="bib118">Valjent et al., 2006</xref>). <italic>Egr2</italic> has been implicated in the regulation of cell-specific gene expression in peripheral Schwann cells (<xref ref-type="bibr" rid="bib53">Jang et al., 2006</xref>) and fibroblasts (<xref ref-type="bibr" rid="bib33">Fang et al., 2011</xref>), and disruptions to Egr2 DNA binding have been implicated in diseases of myelination and brain development. However, we are not aware of any study identifying the targets of Egr2 in the mature brain. We report downregulated expression of <italic>Nr4a1</italic> and <italic>Arc</italic> following overexpression of dominant-negative Egr2 in the VLS. However, as we did not identify Egr2 binding sites within regulatory regions of <italic>Nr4a1</italic> or <italic>Arc</italic>, we hypothesize that the impact of DN-Egr2 expression on <italic>Nr4a1</italic> and <italic>Arc</italic> may be indirect, a point for future investigation.</p><p>In conclusion, our study provides (1) a comprehensive description of brain-wide transcriptional dynamics, as well as spatial dynamics of SPN-specific IEG recruitment during the development of cocaine sensitization and (2) a demonstration of the role of VLS <italic>Egr2</italic>-expressing ensembles, as well as VLS expression of <italic>Egr2</italic>, in the development of cocaine seeking. Future work will address the mechanisms supporting cell-type specificity of transcriptional induction, as well as the role of IEG-mediated plasticity mechanisms in VLS-dependent stereotypy and context association.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reagent type (species) or resource</th><th valign="top">Designation</th><th valign="top">Source or reference</th><th valign="top">Identifiers</th><th valign="top">Additional information</th></tr></thead><tbody><tr><td valign="top">Strain, strain background (<italic>Mus musculus</italic>)</td><td valign="top">Wild-type C57BL/6OLAHSD mice</td><td valign="top">The Harlan Laboratory</td><td valign="top">NA</td><td valign="top"/></tr><tr><td valign="top">Strain, strain background (<italic>Mus musculus</italic>)</td><td valign="top">Egr2-Cre knock in mice</td><td valign="top">The Jackson Laboratory</td><td valign="top">Cat# 025744 <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:025744">IMSR_JAX:025744</ext-link></td><td valign="top"/></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">AAV2-hSyn-DIO-hM4d(Gi)- mCherry</td><td valign="top">Addgene</td><td valign="top">Cat# 44362-AAV2 <break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_44362">Addgene_44362</ext-link></td><td valign="top">1.15 dilution</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">AAV2-hSyn-DIO-mCherry</td><td valign="top">UNC vector core facility</td><td valign="top">N/A</td><td valign="top">1.15 dilution</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">AAVdj-CMV-eGFP</td><td valign="top">ELSC vector core facility</td><td valign="top">N/A</td><td valign="top">1.15 dilution</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">AAVdj-CAG-DNEgr2-IRES-GFP</td><td valign="top">ELSC vector core facility</td><td valign="top">N/A</td><td valign="top">1.15 dilution</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">Plasmid with dominant negative mutant Egr2 (S382R,D383Y)</td><td valign="top">Jeffrey Milbrant, Washington University</td><td valign="top">N/A</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Clozapine-N-oxide (CNO)</td><td valign="top">Sigma–Aldrich</td><td valign="top">Cat # C0832-5MG</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Cocaine</td><td valign="top">Hadassah Hospital Pharmacy</td><td valign="top">N/A</td><td valign="top"/></tr><tr><td valign="top">Commercial assay, kit</td><td valign="top">Fluorescent Multiplex <break/>Reagent Kit</td><td valign="top">Advanced Cell Diagnostics RNAscope</td><td valign="top">Cat # 320850</td><td valign="top"/></tr><tr><td valign="top">Commercial assay, kit</td><td valign="top">NEBNext Ultra II Non-Directional RNA Second-Strand Synthesis Module</td><td valign="top">New England Biolabs</td><td valign="top">Cat # E6111L</td><td valign="top"/></tr><tr><td valign="top">Commercial assay, kit</td><td valign="top">KAPA Hifi Hotstart ReadyMix</td><td valign="top">Roche</td><td valign="top">Cat # KK-KK2601-2 07958927001</td><td valign="top"/></tr><tr><td valign="top">Commercial assay, kit</td><td valign="top">MinElute Gel Extraction Kit</td><td valign="top">Qiagen</td><td valign="top">Cat # 28604</td><td valign="top"/></tr><tr><td valign="top">Commercial assay, kit</td><td valign="top">NEBNext Library Quant Kit for Illumina</td><td valign="top">New England Biolabs</td><td valign="top">Cat # E7630L</td><td valign="top"/></tr><tr><td valign="top">Commercial assay, kit</td><td valign="top">High-sensitivity DNA kit</td><td valign="top">Agilent Technologies</td><td valign="top">Cat # 5067–4626</td><td valign="top"/></tr><tr><td valign="top">Commercial assay, kit</td><td valign="top">NextSeq 500 High Output V2 kits</td><td valign="top">Illumina</td><td valign="top">Cat # FC-404–2005</td><td valign="top"/></tr><tr><td valign="top">Commercial assay, kit</td><td valign="top">SMARTScribe Reverse Transcriptase</td><td valign="top">Takara</td><td valign="top">Cat # 639536</td><td valign="top"/></tr><tr><td valign="top">Sequence-based reagent (smFISH)</td><td valign="top">Probe-Mm-Drd1a-C2</td><td valign="top">Advanced Cell Diagnostics RNAscope</td><td valign="top">Cat # 406491-C2</td><td valign="top"/></tr><tr><td valign="top">Sequence-based reagent (smFISH)</td><td valign="top">Probe-Mm-Drd1a-C3</td><td valign="top">Advanced Cell Diagnostics RNAscope</td><td valign="top">Cat # 406491-C3</td><td valign="top"/></tr><tr><td valign="top">Sequence-based reagent (smFISH)</td><td valign="top">Probe-Mm-Drd2-C2</td><td valign="top">Advanced Cell Diagnostics RNAscope</td><td valign="top">Cat # 406501-C2</td><td valign="top"/></tr><tr><td valign="top">Sequence-based reagent (smFISH)</td><td valign="top">Probe-Mm-Egr2</td><td valign="top">Advanced Cell Diagnostics RNAscope</td><td valign="top">Cat # 407871</td><td valign="top"/></tr><tr><td valign="top">Sequence-based reagent (smFISH)</td><td valign="top">Probe-Mm-Fos-C3</td><td valign="top">Advanced Cell Diagnostics RNAscope</td><td valign="top">Cat # 316921-C3</td><td valign="top"/></tr><tr><td valign="top">Sequence-based reagent (smFISH)</td><td valign="top">Probe-Mm-Arc-C3</td><td valign="top">Advanced Cell Diagnostics RNAscope</td><td valign="top">Cat # 316911-C3</td><td valign="top"/></tr><tr><td valign="top">Sequence-based reagent (smFISH)</td><td valign="top">Probe-Mm-Nr4a1-C2</td><td valign="top">Advanced Cell Diagnostics RNAscope</td><td valign="top">Cat # 423341-C2</td><td valign="top"/></tr><tr><td valign="top">Sequence-based reagent <break/>(RNA-seq)</td><td valign="top">Primers for first-strand synthesis</td><td valign="top">This paper</td><td valign="top">N/A</td><td valign="top"><named-content content-type="sequence">CGATTGAGGCCGGTAATACGACTCACTATAGGGGCGACGTGTGCTCTTCCGATCTNNNNNNNNNNNNNNNTTTTTTTTTTTTTTTTTTTTN</named-content></td></tr><tr><td valign="top">Sequence-based reagent <break/>(RNA-seq)</td><td valign="top">Forward primer with P5-Read1 sequence</td><td valign="top">This paper</td><td valign="top">NA</td><td valign="top"><named-content content-type="sequence">AATGATACGGCGACCACCGAGATCTACACTAGATCGCTCGTCGGCAGCGTCAGATGTG</named-content></td></tr><tr><td valign="top">Sequence-based reagent <break/>(RNA-seq)</td><td valign="top">Reverse primer with P7-Read2 sequence</td><td valign="top">This paper</td><td valign="top">NA</td><td valign="top"><named-content content-type="sequence">CAAGCAGAAGACGGCATACGAGATGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT</named-content></td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">R</td><td valign="top">R studio</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://rstudio.com/products/rstudio/">https://rstudio.com/products/rstudio/</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">ImageJ</td><td valign="top">National Institutes of Health</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/ij/">https://imagej.nih.gov/ij/</ext-link> <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_003070">SCR_003070</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">CellProfiler</td><td valign="top">Broad Institute</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://cellprofiler.org/">https://cellprofiler.org/</ext-link> <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_007358">SCR_007358</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Prism7</td><td valign="top">GraphPad</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com">https://www.graphpad.com</ext-link> <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002798">SCR_002798</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Ethovision XT</td><td valign="top">Noldus</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://www.noldus.com/ethovision-xt">https://www.noldus.com/ethovision-xt</ext-link> RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_000441">SCR_000441</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Photoshop and Illustrator</td><td valign="top">Adobe</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://www.adobe.com/in/creativecloud/catalog/desktop.html?promoid=PTYTQ77P&amp;mv=other">https://www.adobe.com/in/creativecloud/catalog/desktop.html?promoid=PTYTQ77P&amp;mv=other</ext-link></td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">0.9% Nacl</td><td valign="top"/><td valign="top">Cat # 3642828</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">Isoflurane</td><td valign="top">Piramal Critical Care</td><td valign="top">Cat # AWN34014604</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">Microtome (7000 smz2)</td><td valign="top">Camden Instruments</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://www.emsdiasum.com/microscopy/products/equipment/vibrating_microtome.aspx">https://www.emsdiasum.com/microscopy/products/equipment/vibrating_microtome.aspx</ext-link></td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">Stereoscope</td><td valign="top">Olympus</td><td valign="top">Cat # N1197800</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">TissueLyser LT</td><td valign="top">Qiagen</td><td valign="top">Cat # 69980</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">Superfrost Plus slides</td><td valign="top">ThermoFisher Scientific</td><td valign="top">Cat # J1800AMNZ</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">Hermes high-definition cell-imaging system</td><td valign="top">Wiscan</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://idea-bio.com/products/wiscan-hermes/">https://idea-bio.com/products/wiscan-hermes/</ext-link></td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">SomnoSuite Low-Flow Anesthesia System</td><td valign="top">Kent Scientific <break/>Corporation</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://www.kentscientific.com/products/somnosuite/">https://www.kentscientific.com/products/somnosuite/</ext-link></td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">Fine drill burr</td><td valign="top">RWD Life Science</td><td valign="top">Cat # <sc>78001</sc></td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">Microsyringe (33G)</td><td valign="top">Hamilton</td><td valign="top">Cat # 65460–05</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">3M Vetbond tissue Adhesive</td><td valign="top">3M (Ebay)</td><td valign="top">Cat # 8017242664</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">Isoflurane</td><td valign="top">Piramal Critical Care</td><td valign="top">Cat # AWN34014604</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">Tri-Reagent</td><td valign="top">Sigma–Aldrich</td><td valign="top">Cat # T9424</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">OCT embedding medium</td><td valign="top">Scigen Scientific Gardena</td><td valign="top">Cat # 23-730-625</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">ACD RNAscope fresh frozen tissue pretreatment</td><td valign="top">Advanced Cell Diagnostics RNAscope</td><td valign="top">Cat # 320513</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">DAPI</td><td valign="top">Sigma–Aldrich</td><td valign="top">Cat # 10236276001</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">Lab Vision PermaFluor Aqueous Mounting Medium</td><td valign="top">ThermoFisher Scientific</td><td valign="top">Cat # TA-030-FM</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">dNTPs</td><td valign="top">New England Biolabs</td><td valign="top">Cat # N0447s</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">MnCl<sub>2</sub></td><td valign="top">Sigma–Aldrich</td><td valign="top">Cat # 244589–10G</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">SPRI magnetic beads</td><td valign="top">Beckman Coulter</td><td valign="top">Cat # A63881</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">1 M Tris–HCI, pH 8.0</td><td valign="top">ThermoFisher Scientific</td><td valign="top">Cat # 15568025</td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">SDS Solution (10%)</td><td valign="top">Biological Industries</td><td valign="top">Cat # 01-890-1B</td><td valign="top"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Lead contact and materials availability</title><p>Further information and requests for resources should be directed to and will be fulfilled by the Lead Contact, Ami Citri (ami.citri@mail.huji.ac.il). This study did not generate new unique reagents.</p><sec id="s4-1-1"><title>Experimental models and subject details</title><p>Male C57BL/6OLAHSD mice used for RNA-sequencing and single-molecule FISH analysis following cocaine sensitization were obtained from Harlan Laboratories, Jerusalem, Israel. Transgenic Egr2-Cre knock-in mice were obtained from Jackson Laboratories. All animals were bred at Hebrew University, Givat Ram campus, by crossing positive males with C57BL/6OLAHSD female mice obtained from Harlan Laboratories. All animals (wild types and transgenic littermates of same sex) were group housed both before and during the experiments. They were maintained under standard environmental conditions – temperature (20–22°C), humidity (55 ± 10%), and 12–12 hr light/dark cycle (7 am on and 7 pm off), with ad libitum access to water and food. Behavioral assays were performed during the light phase of the circadian cycle. All animal protocols (# NS-13-13660-3; NS-13-13895-3; NS-15-14326-3; NS-16-14644-2; NS-14667–3; NS-16-14856-3; NS-19-15753-3) were approved by the Institutional Animal Care and Use Committees at the Hebrew University of Jerusalem and were in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Animals were randomly assigned to individual experimental groups, with some exceptions, such as in case of conditioned-place preference experiments (elaborated later). Experimenters were blinded regarding experimental manipulations wherever possible. While all experiments were performed in male mice, we do not anticipate that the results would differ between males and females, as similar gene programs are recruited in both (<xref ref-type="bibr" rid="bib105">Savell et al., 2020</xref>).</p><p><table-wrap id="inlinetable1" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th>Animals</th><th>Sex</th><th>Age (weeks)</th></tr></thead><tbody><tr><td valign="top">Wild-type C57BL/6 mice</td><td valign="top">Male</td><td valign="top">6–7</td></tr><tr><td valign="top">Egr2-Cre knock in mice</td><td valign="top">Male</td><td valign="top">10–30</td></tr></tbody></table></table-wrap></p></sec></sec><sec id="s4-2"><title>Detailed methods</title><sec id="s4-2-1"><title>Behavioral assays</title><sec id="s4-2-1-1"><title>Cocaine sensitization</title><p>Six to seven week old C57BL/6OLAHSD mice, after arriving from Harlan Laboratories, were first allowed to acclimate to the SPF facility for a period of 5–7 days. Animals were then briefly handled once or twice daily for 2–3 days. During the handling sessions, animals were allowed to freely move around on the experimenter’s palm for 1–2 min either alone or in pairs. On the following three consecutive days, mice were subjected to once daily intraperitoneal (IP) saline injections (250 µl) and immediately transferred to a clear Plexiglas box (30 × 30 × 30 cm) within a sound- and light-attenuated chamber fitted with an overhead camera, for ~20 min, and then returned to their home cage. After this habituation phase, animals were subjected to one daily IP cocaine injection (20 mg/kg; Stock solution: 2 mg/ml dissolved in 0.9% saline and injected at 10 ml/kg volume), according to the following groups: (1) <italic>acute cocaine</italic> group received a single dose of IP cocaine, (2) <italic>repeated cocaine</italic> group was administered cocaine once daily for five consecutive days, and (3) <italic>challenge cocaine</italic> group of animals was treated similarly to the repeated cocaine group for the first 5 days, subjected to abstinence (no drug treatment) for 21 days, and then re-exposed to a single dose of cocaine. Animals sacrificed directly from the home cage without any treatment were regarded as controls in the experiment (0 hr) and interleaved with the other groups corresponding to the relevant cocaine regiment (acute, chronic, and challenge cocaine). Transcription was analyzed at 1, 2, and 4 hr following the cocaine injection for the RNA-seq experiments. In smFISH experiments, animals were sacrificed for brain collection 1 hr after the cocaine injection, while control animals were treated as described earlier. Locomotor activity was measured as distance traveled in the open field arena for a period of 15 min, following either saline/cocaine injections, on each day was quantified by Ethovision (Noldus) software.</p></sec><sec id="s4-2-1-2"><title>Conditioned-place preference</title><p>Conditioned-place preference was assessed in a custom-fitted arena (Plexiglass box [30 × 30 × 30 cm]) designed in-house and placed in individual light- and sound-attenuated chambers as in <xref ref-type="bibr" rid="bib113">Terem et al., 2020</xref>. On the preference test days, the arena was divided into two compartments of equal dimensions. One compartment was fitted with rough floor (‘crushed ice’ textured Plexiglas) and black (on white) dotted wallpaper, while the other was fitted with smooth floor with black (on white) striped wallpaper. On the conditioning days, animals were presented with only one context in each training session, such that the entire box had rough flooring and dotted wallpaper or smooth flooring with striped wallpaper. Animals were placed in the center of the arena, and free behavior was recorded for 20 min. General activity and position/location of the mice in the arena were monitored by video recording using an overhead camera. Baseline preference was measured using the Ethovision XT software by analyzing the time spent in each chamber during the 20 min session. Mice were randomly assigned a conditioning compartment in order to approximately balance any initial bias in preference toward a specific chamber. <italic>Procedure:</italic> All experiments were performed using an unbiased design and consisted of the following phases: Handling: Two to three days performed twice daily and involved free exploration on the palms of the experimenter for 2–3 min. Pre-test: Single 20 min session (performed around noon), during which animals explored the arena which was divided into two compartments. Conditioning: Three days of two counterbalanced 20 min sessions per day separated by at least 4 hr. Mice were randomly assigned to a context (combination of a single floor-type and wallpaper patterns, as described above), which was paired with IP injections of saline (250 µl), and a separate context, which was paired with IP cocaine (10 mg/kg; Stock solution: 1 mg/ml dissolved in 0.9% saline and injected at 10 ml/kg volume). Post-conditioning final preference test was performed as in the pre-test.</p><p>For chemogenetic experiments, CNO (10 mg dissolved in 500 μl DMSO and then mixed into 9.5 ml 0.9% saline, to a total of 10 ml CNO solution at a concentration of 1 mg/ml) was injected at a dose of 5 or 10 mg/kg 30 min before cocaine conditioning sessions.</p></sec><sec id="s4-2-1-3"><title>Tissue dissections and RNA extraction</title><p>Collection of tissue samples (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>) and RNA extraction were performed as described previously (<xref ref-type="bibr" rid="bib80">Mukherjee et al., 2018</xref>; <xref ref-type="bibr" rid="bib115">Turm et al., 2014</xref>), with few modifications. Briefly animals were anesthetized in isoflurane (Piramal Critical Care), euthanized by cervical dislocation, and the brains quickly transferred to ice-cold artificial cerebrospinal fluid (ACSF) solution. Coronal slices of 400 µm were subsequently made on a vibrating microtome (7000 smz2; Camden Instruments) and relevant brain areas dissected under a stereoscope (Olympus). Tissue pieces were collected in PBS, snap-frozen in dry-ice, and on the same day transferred to Tri-Reagent (Sigma–Aldrich). The tissue was stored at −80°C until being processed for RNA extraction. For RNA extraction, the stored tissue was thawed at 37°C using a drybath and then immediately homogenized using TissueLyser LT (Qiagen). RNA extraction was performed according to the manufacturer’s guidelines. All steps were performed in cold conditions.</p></sec><sec id="s4-2-1-4"><title>RNA-seq library preparation</title><p>One hundred nanogram of RNA was used for first-strand cDNA preparation as follows: The RNA was mixed with RT primers containing barcodes (seven bps) and unique molecular identifiers (UMIs; eight bps) for subsequent de-multiplexing and correction for amplification biases, respectively. The mixture was denatured in a Thermocycler (Bio-Rad) at 72°C for 3 min and transferred immediately to ice. An RT reaction cocktail containing 5× SmartScribe buffer, SmartScribe reverse transcriptase (Takara), 25 mM dNTP mix (NEB), and 100 mM MnCl<sub>2</sub> (Sigma) was added to the RNA and primer mix and incubated at 42°C for 1 hr followed by 70°C for 15 min. The cDNA from all samples were pooled, cleaned with 1.2× AMPURE magnetic beads (Beckman Coulter), and eluted with 10 mM Tris of pH 8 (ThermoFisher Scientific). The eluted cDNA was further processed for double-stranded DNA synthesis with the NEBNext Ultra II Non-Directional RNA Second-Strand Synthesis Module (NEB), followed by another round of clean-up with 1.4× SPRI magnetic beads. The resultant double-stranded cDNA was then incubated with Tn5 tagmentase enzyme and a 21 bp oligo (<named-content content-type="sequence">TCGTCGGCAGCGTCAGATGTG</named-content> sequence) at 55°C for 8 min. The reaction was stopped by denaturing the enzyme with 0.2% SDS (Biological Industries), followed by another round of cleaning with 2× SPRI magnetic beads. The elute was amplified using the KAPA Hifi Hotstart ReadyMix (Kapa Biosystems along with forward primer that contains Illumina P5-Read1 sequence) and reverse primer containing the P7-Read2 sequence. The resultant libraries were loaded on 4% agarose gel (Invitrogen) for size selection (250–700 bp) and cleaned with Mini Elute Gel Extraction kit (Qiagen). Library concentration and molecular size were determined with NEBNext Library Quant Kit for Illumina (NEB) according to manufacturer’s guidelines, as well as Bioanalyzer using High-Sensitivity DNA kit (Agilent Technologies). The libraries were run on the Illumina platform using NextSeq 500 High Output V2 kits (Illumina).</p></sec><sec id="s4-2-1-5"><title>Single-molecule fluorescence in-situ hybridization</title><p>A detailed protocol is available in <xref ref-type="bibr" rid="bib41">Gonzales et al., 2020</xref>. Briefly, smFISH protocol was performed on 14 µm tissue sections using the RNAscope Multiplex Fluorescent Reagent kit (Advanced Cell Diagnostics) according to the RNAscope Sample Preparation and Pretreatment Guide for Fresh Frozen Tissue and the RNAscope Fluorescent Multiplex Kit User Manual (Advanced Cell Diagnostics). Image acquisition was performed using a Hermes high-definition cell-imaging system with 10 × 0.4 NA and 40 × 0.75 NA objectives. Five Z-stack images were captured for each of four channels – 475/28 nm (FITC), 549/15 nm (TRITC), 648/20 nm (Cy5), and 390/18 nm (DAPI). Image processing was performed using ImageJ software. Maximum-intensity images for each channel were obtained using Maximum Intensity Z-projection. All channels were subsequently merged, and the dorsal striatum region was manually cropped from these merged images according to the Franklin and Paxinos Mouse brain atlas, Third edition. Quantification of RNA expression from images was done using the CellProfiler (<xref ref-type="bibr" rid="bib76">McQuin et al., 2018</xref>) speckle counting pipeline.</p></sec><sec id="s4-2-1-6"><title>Stereotactic surgeries</title><p>Induction and maintenance of anesthesia during surgery were achieved using SomnoSuite Low-Flow Anesthesia System (Kent Scientific Corporation). Following induction of anesthesia, animals were quickly secured to the stereotaxic apparatus (David KOPF instruments). The skin was cleaned with Betadine (Dr. Fischer Medical), and Lidocaine (Rafa Laboratories) was applied to minimize pain. An incision was made to expose the skull, which was immediately cleaned with hydrogen peroxide (GADOT), and a small hole was drilled using a fine drill burr (RWD Life Science). Using a microsyringe (33G; Hamilton) connected to an UltraMicroPump (World Precision Instruments), virus was subsequently injected at a flow rate of 100 nl/min. Upon completion of virus delivery, the microsyringe was left in the tissue for up to 5 min and then slowly withdrawn. The skin incision was closed using a Vetbond bioadhesive (3M), the animals were removed from the stereotaxic apparatus, injected with saline and pain-killer Rimadyl (Norbrook), and allowed to recover under gentle heating. Coordinates of the stereotactic injection were determined using the Paxinos and Franklin mouse brain atlas. Every virus used in the study was titrated appropriately to ensure localized infections. All injections were performed bilaterally and observed to be symmetric.</p></sec></sec><sec id="s4-2-2"><title>Coordinates of the stereotactic injection</title><table-wrap id="inlinetable2" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th valign="top">Experiment ID</th><th valign="top">Viruses</th><th valign="top">Coordinates</th><th valign="top">Strain</th><th valign="top">Virus expression time (days)</th></tr></thead><tbody><tr><td valign="top">Chemogenetic inhibition <break/>(<xref ref-type="fig" rid="fig3">Figure 3E</xref>)</td><td valign="top">AAV2-hSyn-DIO-hM4d(Gi)-mCherry (n = 6; received saline) AAV2-hSyn-DIO-hM4d(Gi)-mCherry <break/>(n = 6, received CNO at 5 mg/kg)</td><td valign="top">AP: 0.9; ML: ±2.6; DV: 3.6</td><td valign="top">Egr2-Cre</td><td valign="top">21</td></tr><tr><td valign="top">Chemogenetic inhibition <break/>(<xref ref-type="fig" rid="fig3">Figure 3F–G</xref>, <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3</xref>)</td><td valign="top">AAV2-hSyn-DIO-hM4d(Gi)-mCherry (n = 8; all received CNO at 10 mg/kg) AAV2-hSyn-DIO- mCherry (n = 8, all received CNO at 10 mg/kg)</td><td valign="top">AP: 0.9; ML: ±2.6; DV: 3.6</td><td valign="top">Egr2-Cre</td><td valign="top">21</td></tr><tr><td valign="top">DN-Egr2 (<xref ref-type="fig" rid="fig3">Figure 3H,I</xref>, <xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4</xref>)</td><td valign="top">AAVdj-CMV-eGFP (n = 8) <break/>AAVdj-CAG-DNEgr2-IRES-GFP (n = 8)</td><td valign="top">AP: 0.9; ML: ±2.65; DV: 3.6</td><td valign="top">WT</td><td valign="top">21</td></tr></tbody></table></table-wrap></sec></sec><sec id="s4-3"><title>Quantification and statistical analysis</title><sec id="s4-3-1"><title>Statistical analysis and data visualization</title><p>R version 3.4.4 was used for all statistical analysis and graphical representations. Venn diagrams were generated with ‘eulerr’ package. Three-dimensional plots were generated with ‘plot3D’ package. Heatmaps were generated with ‘Heatmap.2’ function form ‘gplots’ package. All other figures were generated using ‘ggplot2’. Details of the statistics applied in analysis of smFISH and behavioral experiments are summarized in <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>.</p></sec></sec><sec id="s4-4"><title>RNA-seq analysis</title><sec id="s4-4-1"><title>Alignment and QC</title><p>RNA-seq read quality was evaluated using FastQC. PCR duplicates were removed using unique molecular identifiers (UMIs), and polyA tail, if existing, was trimmed from the 3' end of the reads. Reads were aligned to the mouse genome (GRCm38) using STAR, and HTseq was used to count the number of reads for each gene. Samples with less than 1 million usable reads were removed from the analysis. Samples with more than 8 million reads were down-sampled to 50% (using R package ‘subSeq’). The list of the samples analyzed in this paper and the distribution of library size are presented in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref> and <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>. All raw sequencing data is available on NCBI GEO: GSE158588.</p></sec><sec id="s4-4-2"><title>Analysis of shifts in baseline transcription</title><p>In order to compare baseline shifts in gene expression following repeated cocaine administration, we compared gene expression within the samples obtained at time 0 (not exposed to cocaine on day of sample collection) in each one of the conditions – acute, repeated, and challenge cocaine (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3A</xref> – heatmap of all genes exhibiting change). This analysis was performed with ‘DEseq2’ package in R. We used the Wald test in the DEseq function and compared gene expression in cocaine naïve mice vs. mice exposed to repeated cocaine, as well as comparing to abstinent mice following repeated cocaine. List of detected genes, normalized counts, and p-values (FDR corrected) are presented in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>. We observed that in a few samples, an apparent sequencing batch effect was detected, likely related to the library preparation and/or to the association of samples with different sequencing runs. Therefore, we performed the final analysis on only a subset of the samples, which did not exhibit a batch effect. While gene selection was performed on the subset of samples, the data portrayed in <xref ref-type="fig" rid="fig1">Figure 1C</xref> depicts all samples from the relevant time points – demonstrating that the genes identified from the subset of samples are consistently modified across all samples. Therefore, our gene list likely provides a conservative estimate of the true magnitude of shifts in gene expression.</p></sec><sec id="s4-4-3"><title>Analysis of inducible transcription</title><p>Detection of the induced genes following cocaine administration was performed with the ‘DEseq2’ package in R. Each structure was analyzed separately. The model included time (0, 1, 2, 4 hr after cocaine administration) and the experiment (acute, repeated, and challenge), as well as the interaction time × experiment. We used a likelihood ratio test (LRT) and selected genes changing over time in at least one of the experiments (eliminating genes that are changing only between experiments, but not in time). Next, to evaluate the effect of time in each specific experiment, we used the selected gene list and fitted a generalized linear model with a negative binomial distribution followed by LRT for each experiment separately. Genes with p&lt;0.05 (corrected) and fold change &gt; 1.2 were considered significant. List of the detected genes, normalized counts, and p-values (FDR corrected) is presented in <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>.</p></sec><sec id="s4-4-4"><title>Gene annotation and functional analysis</title><p>KEGG pathway analysis was performed using the ‘SPIA’ package (Signaling Pathway Impact Analysis) in R. Pathways with p&lt;0.05 and at least eight differentially expressed genes were considered significant. GO term enrichment analysis was performed using the ‘clusterProfiler’ package in R. Molecular function (MF) sub-ontologies were included in the analysis. The results of the inducible transcription analysis (p&lt;0.05, FDR corrected) are included in <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref> (complete list of enriched GO terms and genes) and in <xref ref-type="fig" rid="fig1">Figure 1H</xref> (representative GO term list). In the analysis of baseline transcription, we perform a second step of clustering in order to remove redundancy and identify global patterns across structures. After selecting the significantly enriched GO terms (p&lt;0.05, FDR corrected), we grouped together all GO terms that shared at least 50% identity of the differentially expressed genes in any of the structures (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). As described in the Results section, few clusters were selected for presentation, and the expression levels of genes included in these clusters – across all time points and all structures – are presented as a heatmap in <xref ref-type="fig" rid="fig1">Figure 1C</xref>, <xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4</xref>.</p></sec><sec id="s4-4-5"><title>smFISH analysis</title><p>For the IEG probes, selection for ‘robust-expressing’ cells was done as follows: We used the cocaine-naïve control data and after removing the non-expressing cells (cells expressing 0–1 puncta), the remaining cells were binned equally into three groups based on the per-cell expression levels, and the top 33% cells were defined ‘robust expressors’ or ‘suprathreshold cells’. Thus, cells qualified as ‘robust expressors’ for a given IEG if they expressed at least the following number of puncta per cell: <italic>Arc</italic> – 11, <italic>Egr2</italic> – 6, <italic>Nr4a1 –</italic> 12, <italic>Fos</italic> – 5. For <italic>Drd1</italic> and <italic>Drd2</italic> expression, a threshold of 8 puncta/cell was implemented (<xref ref-type="bibr" rid="bib41">Gonzales et al., 2020</xref>).</p><p>In order to identify the area with the highest density of IEG expressing cells in the striatum, we performed two-dimensional kernel density estimation using the function ‘geom_density_2d’ in R as in <xref ref-type="bibr" rid="bib41">Gonzales et al., 2020</xref>. This function estimates two-dimensional kernel density with an axis-aligned bivariate normal kernel, evaluated on a square grid, while displaying the result with contours. The regions of highest density, within which at least 20% of the cells are found, were selected. This process was performed independently for each one of the replicas and the selected contours plotted. A list of the samples and number of cells included in the analysis is found in <xref ref-type="supplementary-material" rid="supp7">Supplementary file 7</xref>. Details of statistical analysis and results for smFISH data are summarized in <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>. Raw data (puncta per cell) is available on Mendeley Data (<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.17632/p5tsv2wpmg.1">http://dx.doi.org/10.17632/p5tsv2wpmg.1</ext-link>).</p></sec><sec id="s4-4-6"><title>Re-used data</title><p>Image reproduction: In the current study, we perform a comparison of the expression patterns and spatial distribution of IEGs following behavioral sensitization to cocaine. To this end, we compare the response to repeated and challenge cocaine exposures (novel data) to the response to acute cocaine, which was previously published (<xref ref-type="bibr" rid="bib41">Gonzales et al., 2020</xref>). The reproduced images are the panels labeled ‘acute’ in <xref ref-type="fig" rid="fig2">Figures 2B–D</xref> and <xref ref-type="fig" rid="fig3">3A–C</xref>.</p><p>Data re-analysis: smFISH data presented in the manuscript relating to acute cocaine were previously published (<xref ref-type="bibr" rid="bib41">Gonzales et al., 2020</xref>) and are included in the current manuscript for the sake of comparison to repeated and challenge cocaine (relevant to <xref ref-type="fig" rid="fig2">Figures 2</xref> and <xref ref-type="fig" rid="fig3">3</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 2–S1, S2</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). The reproduction of the data was approved by the editorial office of PNAS.</p><p>The locomotor sensitization data presented in <xref ref-type="fig" rid="fig1">Figure 1B</xref> is a summed representation of all mice collected for RNA-seq and smFISH analysis. Samples included in the RNA-seq analysis (n = 48) are derived from a subset of the mice (n = 71) analyzed by qPCR in <xref ref-type="bibr" rid="bib80">Mukherjee et al., 2018</xref><sc>, DOI:</sc> <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7554/eLife.31220">10.7554/eLife.31220</ext-link>, while brain sections utilized for smFISH analysis were from mice that were also used for smFISH analysis in <xref ref-type="bibr" rid="bib41">Gonzales et al., 2020</xref>; <xref ref-type="bibr" rid="bib113">Terem et al., 2020</xref>.</p></sec></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>The authors appreciate the helpful critical comments of members of the Citri lab and Prof. Inbal Goshen on data, writing, and presentation. Prof. Ido Amit generously provided instruction and guidance on RNA-seq library preparation. Work in the Citri laboratory is funded by the European Research Council (ERC 770951), The Israel Science Foundation (1062/18, 393/12, 1796/12, and 2341/15), The Israel Anti-Drug Administration, EU Marie Curie (PCIG13-GA-2013–618201), the National Institute for Psychobiology in Israel, Hebrew University of Jerusalem Israel founded by the Charles E Smith family (109-15-16), an Adelis Award for Advances in Neuroscience, the Brain and Behavior Foundation (NARSAD 18795), German–Israel Foundation (2299–2291.1/2011), and Binational Israel–United States Foundation (2011266), the Milton Rosenbaum Endowment Fund for Research in Psychiatry, a seed grant from the Eric Roland Fund for interdisciplinary research administered by the ELSC, contributions from anonymous philanthropists in Los Angeles and Mexico City, as well as research support from the Safra Center for Brain Sciences (ELSC) and the Canadian Institute for Advanced Research (CIFAR). DM was funded by a ‘Golden Opportunity Doctoral fellowship’, as well as a ‘Bridging’ Post-Doctoral Fellowship from the Jerusalem Brain Community.</p> </ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Formal analysis, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Data curation, Software, Formal analysis, Investigation, Visualization, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Investigation, Methodology, Project administration</p></fn><fn fn-type="con" id="con5"><p>Resources</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Resources, Supervision, Funding acquisition, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal protocols (# NS-13-13660-3; NS-13-13895-3; NS-15-14326-3; NS-16-14644-2; NS-14667-3; NS-16-14856-3; NS-19-15753-3) were approved by the Institutional Animal Care and Use Committees at the Hebrew University of Jerusalem and were in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Distribution of sequencing libraries analyzed in this study.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65228-supp1-v2.xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Normalized reads of baseline shifted genes (tabs corresponding to individual structures).</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65228-supp2-v2.xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Clusters of Gene Ontology (GO) analysis and corresponding genes.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65228-supp3-v2.xlsx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>Normalized reads of induced genes (tabs correspond to structures).</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65228-supp4-v2.xlsx"/></supplementary-material><supplementary-material id="supp5"><label>Supplementary file 5.</label><caption><title>Gene Ontology annotation of cocaine-induced genes in the dorsal striatum.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65228-supp5-v2.xlsx"/></supplementary-material><supplementary-material id="supp6"><label>Supplementary file 6.</label><caption><title>Statistical analysis.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65228-supp6-v2.xlsx"/></supplementary-material><supplementary-material id="supp7"><label>Supplementary file 7.</label><caption><title>Distribution of cell numbers among replicates in smFISH analysis.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-65228-supp7-v2.xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-65228-transrepform-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Source data file for RNA-seq and smFISH experiments are available at NCBI GEO: GSE158588, and <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.17632/p5tsv2wpmg.1">https://doi.org/10.17632/p5tsv2wpmg.1</ext-link>.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Mukherjee</surname><given-names>D</given-names></name><name><surname>Gonzales</surname><given-names>BJ</given-names></name><name><surname>Ashwal-Fluss</surname><given-names>R</given-names></name><name><surname>Turm</surname><given-names>H</given-names></name><name><surname>Groysman</surname><given-names>M</given-names></name><name><surname>Citri</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>RNA-seq of five brain structures after repeated exposure to cocaine</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE158588">GSE158588</pub-id></element-citation></p><p><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Mukherjee</surname><given-names>D</given-names></name><name><surname>Gonzales</surname><given-names>BJ</given-names></name><name><surname>Ashwal-Fluss</surname><given-names>R</given-names></name><name><surname>Turm</surname><given-names>H</given-names></name><name><surname>Groysman</surname><given-names>M</given-names></name><name><surname>Citri</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>smFISH data of IEG expression in the dorsal striatum after acute, repeated, and challenge cocaine exposures</data-title><source>Mendeley Data</source><pub-id assigning-authority="other" pub-id-type="doi">10.17632/p5tsv2wpmg.1</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alberini</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Transcription factors in long-term memory and synaptic plasticity</article-title><source>Physiological Reviews</source><volume>89</volume><fpage>121</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1152/physrev.00017.2008</pub-id><pub-id pub-id-type="pmid">19126756</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alberini</surname> <given-names>CM</given-names></name><name><surname>Kandel</surname> <given-names>ER</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The regulation of transcription in memory consolidation</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>7</volume><elocation-id>a021741</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a021741</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albertson</surname> <given-names>DN</given-names></name><name><surname>Pruetz</surname> <given-names>B</given-names></name><name><surname>Schmidt</surname> <given-names>CJ</given-names></name><name><surname>Kuhn</surname> <given-names>DM</given-names></name><name><surname>Kapatos</surname> <given-names>G</given-names></name><name><surname>Bannon</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Gene expression profile of the nucleus accumbens of human cocaine abusers: evidence for dysregulation of myelin</article-title><source>Journal of Neurochemistry</source><volume>88</volume><fpage>1211</fpage><lpage>1219</lpage><pub-id pub-id-type="doi">10.1046/j.1471-4159.2003.02247.x</pub-id><pub-id pub-id-type="pmid">15009677</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amit</surname> <given-names>I</given-names></name><name><surname>Citri</surname> <given-names>A</given-names></name><name><surname>Shay</surname> <given-names>T</given-names></name><name><surname>Lu</surname> <given-names>Y</given-names></name><name><surname>Katz</surname> <given-names>M</given-names></name><name><surname>Zhang</surname> <given-names>F</given-names></name><name><surname>Tarcic</surname> <given-names>G</given-names></name><name><surname>Siwak</surname> <given-names>D</given-names></name><name><surname>Lahad</surname> <given-names>J</given-names></name><name><surname>Jacob-Hirsch</surname> <given-names>J</given-names></name><name><surname>Amariglio</surname> <given-names>N</given-names></name><name><surname>Vaisman</surname> <given-names>N</given-names></name><name><surname>Segal</surname> <given-names>E</given-names></name><name><surname>Rechavi</surname> <given-names>G</given-names></name><name><surname>Alon</surname> <given-names>U</given-names></name><name><surname>Mills</surname> <given-names>GB</given-names></name><name><surname>Domany</surname> <given-names>E</given-names></name><name><surname>Yarden</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>A module of negative feedback regulators defines growth factor signaling</article-title><source>Nature Genetics</source><volume>39</volume><fpage>503</fpage><lpage>512</lpage><pub-id pub-id-type="doi">10.1038/ng1987</pub-id><pub-id pub-id-type="pmid">17322878</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atlan</surname> <given-names>G</given-names></name><name><surname>Terem</surname> <given-names>A</given-names></name><name><surname>Peretz-Rivlin</surname> <given-names>N</given-names></name><name><surname>Sehrawat</surname> <given-names>K</given-names></name><name><surname>Gonzales</surname> <given-names>BJ</given-names></name><name><surname>Pozner</surname> <given-names>G</given-names></name><name><surname>Tasaka</surname> <given-names>GI</given-names></name><name><surname>Goll</surname> <given-names>Y</given-names></name><name><surname>Refaeli</surname> <given-names>R</given-names></name><name><surname>Zviran</surname> <given-names>O</given-names></name><name><surname>Lim</surname> <given-names>BK</given-names></name><name><surname>Groysman</surname> <given-names>M</given-names></name><name><surname>Goshen</surname> <given-names>I</given-names></name><name><surname>Mizrahi</surname> <given-names>A</given-names></name><name><surname>Nelken</surname> <given-names>I</given-names></name><name><surname>Citri</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The claustrum supports resilience to distraction</article-title><source>Current Biology</source><volume>28</volume><fpage>2752</fpage><lpage>2762</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2018.06.068</pub-id><pub-id pub-id-type="pmid">30122531</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname> <given-names>DA</given-names></name><name><surname>Specio</surname> <given-names>SE</given-names></name><name><surname>Tran-Nguyen</surname> <given-names>LT</given-names></name><name><surname>Neisewander</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Amphetamine infused into the ventrolateral striatum produces oral stereotypies and conditioned place preference</article-title><source>Pharmacology Biochemistry and Behavior</source><volume>61</volume><fpage>107</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1016/S0091-3057(98)00070-7</pub-id><pub-id pub-id-type="pmid">9715812</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balleine</surname> <given-names>BW</given-names></name><name><surname>O'Doherty</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Human and rodent homologies in action control: corticostriatal determinants of goal-directed and habitual action</article-title><source>Neuropsychopharmacology</source><volume>35</volume><fpage>48</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1038/npp.2009.131</pub-id><pub-id pub-id-type="pmid">19776734</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balleine</surname> <given-names>BW</given-names></name><name><surname>Ostlund</surname> <given-names>SB</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Still at the choice-point: action selection and initiation in instrumental conditioning</article-title><source>Annals of the New York Academy of Sciences</source><volume>1104</volume><fpage>147</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1196/annals.1390.006</pub-id><pub-id pub-id-type="pmid">17360797</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bannon</surname> <given-names>M</given-names></name><name><surname>Kapatos</surname> <given-names>G</given-names></name><name><surname>Albertson</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Gene expression profiling in the brains of human cocaine abusers</article-title><source>Addiction Biology</source><volume>10</volume><fpage>119</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1080/13556210412331308921</pub-id><pub-id pub-id-type="pmid">15849025</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bannon</surname> <given-names>MJ</given-names></name><name><surname>Johnson</surname> <given-names>MM</given-names></name><name><surname>Michelhaugh</surname> <given-names>SK</given-names></name><name><surname>Hartley</surname> <given-names>ZJ</given-names></name><name><surname>Halter</surname> <given-names>SD</given-names></name><name><surname>David</surname> <given-names>JA</given-names></name><name><surname>Kapatos</surname> <given-names>G</given-names></name><name><surname>Schmidt</surname> <given-names>CJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A molecular profile of cocaine abuse includes the differential expression of genes that regulate transcription, Chromatin, and dopamine cell phenotype</article-title><source>Neuropsychopharmacology</source><volume>39</volume><fpage>2191</fpage><lpage>2199</lpage><pub-id pub-id-type="doi">10.1038/npp.2014.70</pub-id><pub-id pub-id-type="pmid">24642598</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bariselli</surname> <given-names>S</given-names></name><name><surname>Fobbs</surname> <given-names>WC</given-names></name><name><surname>Creed</surname> <given-names>MC</given-names></name><name><surname>Kravitz</surname> <given-names>AV</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A competitive model for striatal action selection</article-title><source>Brain Research</source><volume>1713</volume><fpage>70</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2018.10.009</pub-id><pub-id pub-id-type="pmid">30300636</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berke</surname> <given-names>JD</given-names></name><name><surname>Paletzki</surname> <given-names>RF</given-names></name><name><surname>Aronson</surname> <given-names>GJ</given-names></name><name><surname>Hyman</surname> <given-names>SE</given-names></name><name><surname>Gerfen</surname> <given-names>CR</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>A complex program of striatal gene expression induced by dopaminergic stimulation</article-title><source>The Journal of Neuroscience</source><volume>18</volume><fpage>5301</fpage><lpage>5310</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.18-14-05301.1998</pub-id><pub-id pub-id-type="pmid">9651213</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bobadilla</surname> <given-names>AC</given-names></name><name><surname>Dereschewitz</surname> <given-names>E</given-names></name><name><surname>Vaccaro</surname> <given-names>L</given-names></name><name><surname>Heinsbroek</surname> <given-names>JA</given-names></name><name><surname>Scofield</surname> <given-names>MD</given-names></name><name><surname>Kalivas</surname> <given-names>PW</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cocaine and sucrose rewards recruit different seeking ensembles in the nucleus accumbens core</article-title><source>Molecular Psychiatry</source><volume>25</volume><fpage>3150</fpage><lpage>3163</lpage><pub-id pub-id-type="doi">10.1038/s41380-020-00888-z</pub-id><pub-id pub-id-type="pmid">32985600</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boerkoel</surname> <given-names>CF</given-names></name><name><surname>Takashima</surname> <given-names>H</given-names></name><name><surname>Bacino</surname> <given-names>CA</given-names></name><name><surname>Daentl</surname> <given-names>D</given-names></name><name><surname>Lupski</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>EGR2 mutation R359W causes a spectrum of Dejerine-Sottas neuropathy</article-title><source>Neurogenetics</source><volume>3</volume><fpage>153</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1007/s100480100107</pub-id><pub-id pub-id-type="pmid">11523566</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calipari</surname> <given-names>ES</given-names></name><name><surname>Bagot</surname> <given-names>RC</given-names></name><name><surname>Purushothaman</surname> <given-names>I</given-names></name><name><surname>Davidson</surname> <given-names>TJ</given-names></name><name><surname>Yorgason</surname> <given-names>JT</given-names></name><name><surname>Peña</surname> <given-names>CJ</given-names></name><name><surname>Walker</surname> <given-names>DM</given-names></name><name><surname>Pirpinias</surname> <given-names>ST</given-names></name><name><surname>Guise</surname> <given-names>KG</given-names></name><name><surname>Ramakrishnan</surname> <given-names>C</given-names></name><name><surname>Deisseroth</surname> <given-names>K</given-names></name><name><surname>Nestler</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>In vivo imaging identifies temporal signature of D1 and D2 medium spiny neurons in cocaine reward</article-title><source>PNAS</source><volume>113</volume><fpage>2726</fpage><lpage>2731</lpage><pub-id pub-id-type="doi">10.1073/pnas.1521238113</pub-id><pub-id pub-id-type="pmid">26831103</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caprioli</surname> <given-names>D</given-names></name><name><surname>Venniro</surname> <given-names>M</given-names></name><name><surname>Zhang</surname> <given-names>M</given-names></name><name><surname>Bossert</surname> <given-names>JM</given-names></name><name><surname>Warren</surname> <given-names>BL</given-names></name><name><surname>Hope</surname> <given-names>BT</given-names></name><name><surname>Shaham</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Role of dorsomedial striatum neuronal ensembles in incubation of methamphetamine craving after voluntary abstinence</article-title><source>The Journal of Neuroscience</source><volume>37</volume><fpage>1014</fpage><lpage>1027</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3091-16.2016</pub-id><pub-id pub-id-type="pmid">28123032</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caster</surname> <given-names>JM</given-names></name><name><surname>Kuhn</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Maturation of coordinated immediate early gene expression by cocaine during adolescence</article-title><source>Neuroscience</source><volume>160</volume><fpage>13</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2009.01.001</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandra</surname> <given-names>R</given-names></name><name><surname>Francis</surname> <given-names>TC</given-names></name><name><surname>Konkalmatt</surname> <given-names>P</given-names></name><name><surname>Amgalan</surname> <given-names>A</given-names></name><name><surname>Gancarz</surname> <given-names>AM</given-names></name><name><surname>Dietz</surname> <given-names>DM</given-names></name><name><surname>Lobo</surname> <given-names>MK</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Opposing role for Egr3 in nucleus accumbens cell subtypes in cocaine action</article-title><source>Journal of Neuroscience</source><volume>35</volume><fpage>7927</fpage><lpage>7937</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0548-15.2015</pub-id><pub-id pub-id-type="pmid">25995477</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandra</surname> <given-names>R</given-names></name><name><surname>Lobo</surname> <given-names>MK</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Beyond neuronal activity markers: select immediate early genes in striatal neuron subtypes functionally mediate psychostimulant addiction</article-title><source>Frontiers in Behavioral Neuroscience</source><volume>11</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.3389/fnbeh.2017.00112</pub-id><pub-id pub-id-type="pmid">28642692</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clayton</surname> <given-names>DF</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The genomic action potential</article-title><source>Neurobiology of Learning and Memory</source><volume>74</volume><fpage>185</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1006/nlme.2000.3967</pub-id><pub-id pub-id-type="pmid">11031127</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clayton</surname> <given-names>DF</given-names></name><name><surname>Anreiter</surname> <given-names>I</given-names></name><name><surname>Aristizabal</surname> <given-names>M</given-names></name><name><surname>Frankland</surname> <given-names>PW</given-names></name><name><surname>Binder</surname> <given-names>EB</given-names></name><name><surname>Citri</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The role of the genome in experience-dependent plasticity: extending the analogy of the genomic action potential</article-title><source>PNAS</source><volume>117</volume><fpage>23252</fpage><lpage>23260</lpage><pub-id pub-id-type="doi">10.1073/pnas.1820837116</pub-id><pub-id pub-id-type="pmid">31127037</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crombag</surname> <given-names>HS</given-names></name><name><surname>Grimm</surname> <given-names>JW</given-names></name><name><surname>Shaham</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Effect of dopamine receptor antagonists on renewal of cocaine seeking by reexposure to drug-associated contextual cues</article-title><source>Neuropsychopharmacology</source><volume>27</volume><fpage>1006</fpage><lpage>1015</lpage><pub-id pub-id-type="doi">10.1016/S0893-133X(02)00356-1</pub-id><pub-id pub-id-type="pmid">12464457</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crombag</surname> <given-names>HS</given-names></name><name><surname>Bossert</surname> <given-names>JM</given-names></name><name><surname>Koya</surname> <given-names>E</given-names></name><name><surname>Shaham</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Context-induced relapse to drug seeking: a review</article-title><source>Philosophical Transactions of the Royal Society B: Biological Sciences</source><volume>363</volume><fpage>3233</fpage><lpage>3243</lpage><pub-id pub-id-type="doi">10.1098/rstb.2008.0090</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crombag</surname> <given-names>HS</given-names></name><name><surname>Shaham</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Renewal of drug seeking by contextual cues after prolonged extinction in rats</article-title><source>Behavioral Neuroscience</source><volume>116</volume><fpage>169</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1037/0735-7044.116.1.169</pub-id><pub-id pub-id-type="pmid">11895178</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cruz</surname> <given-names>FC</given-names></name><name><surname>Koya</surname> <given-names>E</given-names></name><name><surname>Guez-Barber</surname> <given-names>DH</given-names></name><name><surname>Bossert</surname> <given-names>JM</given-names></name><name><surname>Lupica</surname> <given-names>CR</given-names></name><name><surname>Shaham</surname> <given-names>Y</given-names></name><name><surname>Hope</surname> <given-names>BT</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>New technologies for examining the role of neuronal ensembles in drug addiction and fear</article-title><source>Nature Reviews Neuroscience</source><volume>14</volume><fpage>743</fpage><lpage>754</lpage><pub-id pub-id-type="doi">10.1038/nrn3597</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cruz</surname> <given-names>FC</given-names></name><name><surname>Babin</surname> <given-names>KR</given-names></name><name><surname>Leao</surname> <given-names>RM</given-names></name><name><surname>Goldart</surname> <given-names>EM</given-names></name><name><surname>Bossert</surname> <given-names>JM</given-names></name><name><surname>Shaham</surname> <given-names>Y</given-names></name><name><surname>Hope</surname> <given-names>BT</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Role of nucleus accumbens shell neuronal ensembles in context-induced reinstatement of cocaine-seeking</article-title><source>Journal of Neuroscience</source><volume>34</volume><fpage>7437</fpage><lpage>7446</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0238-14.2014</pub-id><pub-id pub-id-type="pmid">24872549</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cruz</surname> <given-names>FC</given-names></name><name><surname>Javier Rubio</surname> <given-names>F</given-names></name><name><surname>Hope</surname> <given-names>BT</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Using c-fos to study neuronal ensembles in corticostriatal circuitry of addiction</article-title><source>Brain Research</source><volume>1628</volume><fpage>157</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2014.11.005</pub-id><pub-id pub-id-type="pmid">25446457</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De</surname> <given-names>S</given-names></name><name><surname>Turman</surname> <given-names>JE</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Krox-20 gene expression: influencing hindbrain-craniofacial developmental interactions</article-title><source>Archives of Histology and Cytology</source><volume>68</volume><fpage>227</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1679/aohc.68.227</pub-id><pub-id pub-id-type="pmid">16477142</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delfs</surname> <given-names>JM</given-names></name><name><surname>Kelley</surname> <given-names>AE</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum</article-title><source>Neuroscience</source><volume>39</volume><fpage>59</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/0306-4522(90)90221-O</pub-id><pub-id pub-id-type="pmid">1982467</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname> <given-names>Y</given-names></name><name><surname>Nestler</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The neural rejuvenation hypothesis of cocaine addiction</article-title><source>Trends in Pharmacological Sciences</source><volume>35</volume><fpage>374</fpage><lpage>383</lpage><pub-id pub-id-type="doi">10.1016/j.tips.2014.05.005</pub-id><pub-id pub-id-type="pmid">24958329</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eipper-Mains</surname> <given-names>JE</given-names></name><name><surname>Kiraly</surname> <given-names>DD</given-names></name><name><surname>Duff</surname> <given-names>MO</given-names></name><name><surname>Horowitz</surname> <given-names>MJ</given-names></name><name><surname>McManus</surname> <given-names>CJ</given-names></name><name><surname>Eipper</surname> <given-names>BA</given-names></name><name><surname>Graveley</surname> <given-names>BR</given-names></name><name><surname>Mains</surname> <given-names>RE</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Effects of cocaine and withdrawal on the mouse nucleus accumbens transcriptome</article-title><source>Genes, Brain and Behavior</source><volume>12</volume><fpage>21</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1111/j.1601-183X.2012.00873.x</pub-id><pub-id pub-id-type="pmid">23094851</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Everitt</surname> <given-names>BJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Neural and psychological mechanisms underlying compulsive drug seeking habits and drug memories – indications for novel treatments of addiction</article-title><source>European Journal of Neuroscience</source><volume>40</volume><fpage>2163</fpage><lpage>2182</lpage><pub-id pub-id-type="doi">10.1111/ejn.12644</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname> <given-names>F</given-names></name><name><surname>Ooka</surname> <given-names>K</given-names></name><name><surname>Bhattacharyya</surname> <given-names>S</given-names></name><name><surname>Bhattachyya</surname> <given-names>S</given-names></name><name><surname>Wei</surname> <given-names>J</given-names></name><name><surname>Wu</surname> <given-names>M</given-names></name><name><surname>Du</surname> <given-names>P</given-names></name><name><surname>Lin</surname> <given-names>S</given-names></name><name><surname>Del Galdo</surname> <given-names>F</given-names></name><name><surname>Feghali-Bostwick</surname> <given-names>CA</given-names></name><name><surname>Varga</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The early growth response gene Egr2 (Alias Krox20) is a novel transcriptional target of transforming growth factor-β that is up-regulated in systemic sclerosis and mediates profibrotic responses</article-title><source>The American Journal of Pathology</source><volume>178</volume><fpage>2077</fpage><lpage>2090</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2011.01.035</pub-id><pub-id pub-id-type="pmid">21514423</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freeman</surname> <given-names>WM</given-names></name><name><surname>Lull</surname> <given-names>ME</given-names></name><name><surname>Patel</surname> <given-names>KM</given-names></name><name><surname>Brucklacher</surname> <given-names>RM</given-names></name><name><surname>Morgan</surname> <given-names>D</given-names></name><name><surname>Roberts</surname> <given-names>DC</given-names></name><name><surname>Vrana</surname> <given-names>KE</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Gene expression changes in the medial prefrontal cortex and nucleus accumbens following abstinence from cocaine self-administration</article-title><source>BMC Neuroscience</source><volume>11</volume><elocation-id>29</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2202-11-29</pub-id><pub-id pub-id-type="pmid">20187946</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname> <given-names>P</given-names></name><name><surname>de Munck</surname> <given-names>JC</given-names></name><name><surname>Limpens</surname> <given-names>JHW</given-names></name><name><surname>Vanderschuren</surname> <given-names>L</given-names></name><name><surname>Voorn</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017a</year><article-title>A neuronal activation correlate in striatum and prefrontal cortex of prolonged cocaine intake</article-title><source>Brain Structure and Function</source><volume>222</volume><fpage>3453</fpage><lpage>3475</lpage><pub-id pub-id-type="doi">10.1007/s00429-017-1412-4</pub-id><pub-id pub-id-type="pmid">28393262</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname> <given-names>P</given-names></name><name><surname>Limpens</surname> <given-names>JH</given-names></name><name><surname>Spijker</surname> <given-names>S</given-names></name><name><surname>Vanderschuren</surname> <given-names>LJ</given-names></name><name><surname>Voorn</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017b</year><article-title>Stable immediate early gene expression patterns in medial prefrontal cortex and striatum after long-term cocaine self-administration</article-title><source>Addiction Biology</source><volume>22</volume><fpage>354</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1111/adb.12330</pub-id><pub-id pub-id-type="pmid">26598422</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>García-Fuster</surname> <given-names>MJ</given-names></name><name><surname>Flagel</surname> <given-names>SB</given-names></name><name><surname>Mahmood</surname> <given-names>ST</given-names></name><name><surname>Watson</surname> <given-names>SJ</given-names></name><name><surname>Akil</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Cocaine withdrawal causes delayed dysregulation of stress genes in the Hippocampus</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e42092</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0042092</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gass</surname> <given-names>P</given-names></name><name><surname>Herdegen</surname> <given-names>T</given-names></name><name><surname>Bravo</surname> <given-names>R</given-names></name><name><surname>Kiessling</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>High induction threshold for transcription factor KROX-20 in the rat brain: partial co-expression with heat shock protein 70 following limbic seizures</article-title><source>Molecular Brain Research</source><volume>23</volume><fpage>292</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1016/0169-328X(94)90238-0</pub-id><pub-id pub-id-type="pmid">8090069</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerfen</surname> <given-names>CR</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Molecular effects of dopamine on striatal-projection pathways</article-title><source>Trends in Neurosciences</source><volume>23</volume><fpage>S64</fpage><lpage>S70</lpage><pub-id pub-id-type="doi">10.1016/S1471-1931(00)00019-7</pub-id><pub-id pub-id-type="pmid">11052222</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gipson</surname> <given-names>CD</given-names></name><name><surname>Kupchik</surname> <given-names>YM</given-names></name><name><surname>Shen</surname> <given-names>H</given-names></name><name><surname>Reissner</surname> <given-names>KJ</given-names></name><name><surname>Thomas</surname> <given-names>CA</given-names></name><name><surname>Kalivas</surname> <given-names>PW</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Relapse induced by cues predicting cocaine depends on rapid, transient synaptic potentiation</article-title><source>Neuron</source><volume>77</volume><fpage>867</fpage><lpage>872</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2013.01.005</pub-id><pub-id pub-id-type="pmid">23473317</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzales</surname> <given-names>BJ</given-names></name><name><surname>Mukherjee</surname> <given-names>D</given-names></name><name><surname>Ashwal-Fluss</surname> <given-names>R</given-names></name><name><surname>Loewenstein</surname> <given-names>Y</given-names></name><name><surname>Citri</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Subregion-specific rules govern the distribution of neuronal immediate-early gene induction</article-title><source>PNAS</source><volume>117</volume><fpage>23304</fpage><lpage>23310</lpage><pub-id pub-id-type="doi">10.1073/pnas.1913658116</pub-id><pub-id pub-id-type="pmid">31636216</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gray</surname> <given-names>JM</given-names></name><name><surname>Spiegel</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cell-type-specific programs for activity-regulated gene expression</article-title><source>Current Opinion in Neurobiology</source><volume>56</volume><fpage>33</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2018.11.001</pub-id><pub-id pub-id-type="pmid">30529822</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gremel</surname> <given-names>CM</given-names></name><name><surname>Lovinger</surname> <given-names>DM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Associative and sensorimotor cortico-basal ganglia circuit roles in effects of abused drugs</article-title><source>Genes, Brain and Behavior</source><volume>16</volume><fpage>71</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1111/gbb.12309</pub-id><pub-id pub-id-type="pmid">27457495</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guez-Barber</surname> <given-names>D</given-names></name><name><surname>Fanous</surname> <given-names>S</given-names></name><name><surname>Golden</surname> <given-names>SA</given-names></name><name><surname>Schrama</surname> <given-names>R</given-names></name><name><surname>Koya</surname> <given-names>E</given-names></name><name><surname>Stern</surname> <given-names>AL</given-names></name><name><surname>Bossert</surname> <given-names>JM</given-names></name><name><surname>Harvey</surname> <given-names>BK</given-names></name><name><surname>Picciotto</surname> <given-names>MR</given-names></name><name><surname>Hope</surname> <given-names>BT</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>FACS identifies unique cocaine-induced gene regulation in selectively activated adult striatal neurons</article-title><source>Journal of Neuroscience</source><volume>31</volume><fpage>4251</fpage><lpage>4259</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.6195-10.2011</pub-id><pub-id pub-id-type="pmid">21411666</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Han</surname> <given-names>M-H</given-names></name><name><surname>Russo</surname> <given-names>SJ</given-names></name><name><surname>Nestler</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><chapter-title>Molecular, cellular, and circuit basis of depression susceptibility and resilience</chapter-title><person-group person-group-type="editor"><name><surname>Han</surname> <given-names>M. -H</given-names></name></person-group><source>Neurobiology of Depression</source><publisher-loc>Amsterdam, Netherlands</publisher-loc><publisher-name>Elsevier</publisher-name><fpage>123</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1038/s41380-019-0415-3</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawrylycz</surname> <given-names>MJ</given-names></name><name><surname>Lein</surname> <given-names>ES</given-names></name><name><surname>Guillozet-Bongaarts</surname> <given-names>AL</given-names></name><name><surname>Shen</surname> <given-names>EH</given-names></name><name><surname>Ng</surname> <given-names>L</given-names></name><name><surname>Miller</surname> <given-names>JA</given-names></name><name><surname>van de Lagemaat</surname> <given-names>LN</given-names></name><name><surname>Smith</surname> <given-names>KA</given-names></name><name><surname>Ebbert</surname> <given-names>A</given-names></name><name><surname>Riley</surname> <given-names>ZL</given-names></name><name><surname>Abajian</surname> <given-names>C</given-names></name><name><surname>Beckmann</surname> <given-names>CF</given-names></name><name><surname>Bernard</surname> <given-names>A</given-names></name><name><surname>Bertagnolli</surname> <given-names>D</given-names></name><name><surname>Boe</surname> <given-names>AF</given-names></name><name><surname>Cartagena</surname> <given-names>PM</given-names></name><name><surname>Chakravarty</surname> <given-names>MM</given-names></name><name><surname>Chapin</surname> <given-names>M</given-names></name><name><surname>Chong</surname> <given-names>J</given-names></name><name><surname>Dalley</surname> <given-names>RA</given-names></name><name><surname>David Daly</surname> <given-names>B</given-names></name><name><surname>Dang</surname> <given-names>C</given-names></name><name><surname>Datta</surname> <given-names>S</given-names></name><name><surname>Dee</surname> <given-names>N</given-names></name><name><surname>Dolbeare</surname> <given-names>TA</given-names></name><name><surname>Faber</surname> <given-names>V</given-names></name><name><surname>Feng</surname> <given-names>D</given-names></name><name><surname>Fowler</surname> <given-names>DR</given-names></name><name><surname>Goldy</surname> <given-names>J</given-names></name><name><surname>Gregor</surname> <given-names>BW</given-names></name><name><surname>Haradon</surname> <given-names>Z</given-names></name><name><surname>Haynor</surname> <given-names>DR</given-names></name><name><surname>Hohmann</surname> <given-names>JG</given-names></name><name><surname>Horvath</surname> <given-names>S</given-names></name><name><surname>Howard</surname> <given-names>RE</given-names></name><name><surname>Jeromin</surname> <given-names>A</given-names></name><name><surname>Jochim</surname> <given-names>JM</given-names></name><name><surname>Kinnunen</surname> <given-names>M</given-names></name><name><surname>Lau</surname> <given-names>C</given-names></name><name><surname>Lazarz</surname> <given-names>ET</given-names></name><name><surname>Lee</surname> <given-names>C</given-names></name><name><surname>Lemon</surname> <given-names>TA</given-names></name><name><surname>Li</surname> <given-names>L</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Morris</surname> <given-names>JA</given-names></name><name><surname>Overly</surname> <given-names>CC</given-names></name><name><surname>Parker</surname> <given-names>PD</given-names></name><name><surname>Parry</surname> <given-names>SE</given-names></name><name><surname>Reding</surname> <given-names>M</given-names></name><name><surname>Royall</surname> <given-names>JJ</given-names></name><name><surname>Schulkin</surname> <given-names>J</given-names></name><name><surname>Sequeira</surname> <given-names>PA</given-names></name><name><surname>Slaughterbeck</surname> <given-names>CR</given-names></name><name><surname>Smith</surname> <given-names>SC</given-names></name><name><surname>Sodt</surname> <given-names>AJ</given-names></name><name><surname>Sunkin</surname> <given-names>SM</given-names></name><name><surname>Swanson</surname> <given-names>BE</given-names></name><name><surname>Vawter</surname> <given-names>MP</given-names></name><name><surname>Williams</surname> <given-names>D</given-names></name><name><surname>Wohnoutka</surname> <given-names>P</given-names></name><name><surname>Zielke</surname> <given-names>HR</given-names></name><name><surname>Geschwind</surname> <given-names>DH</given-names></name><name><surname>Hof</surname> <given-names>PR</given-names></name><name><surname>Smith</surname> <given-names>SM</given-names></name><name><surname>Koch</surname> <given-names>C</given-names></name><name><surname>Grant</surname> <given-names>SGN</given-names></name><name><surname>Jones</surname> <given-names>AR</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>An anatomically comprehensive atlas of the adult human brain transcriptome</article-title><source>Nature</source><volume>489</volume><fpage>391</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1038/nature11405</pub-id><pub-id pub-id-type="pmid">22996553</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hope</surname> <given-names>BT</given-names></name><name><surname>Nye</surname> <given-names>HE</given-names></name><name><surname>Kelz</surname> <given-names>MB</given-names></name><name><surname>Self</surname> <given-names>DW</given-names></name><name><surname>Iadarola</surname> <given-names>MJ</given-names></name><name><surname>Nakabeppu</surname> <given-names>Y</given-names></name><name><surname>Duman</surname> <given-names>RS</given-names></name><name><surname>Nestler</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments</article-title><source>Neuron</source><volume>13</volume><fpage>1235</fpage><lpage>1244</lpage><pub-id pub-id-type="doi">10.1016/0896-6273(94)90061-2</pub-id><pub-id pub-id-type="pmid">7946359</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hrvatin</surname> <given-names>S</given-names></name><name><surname>Hochbaum</surname> <given-names>DR</given-names></name><name><surname>Nagy</surname> <given-names>MA</given-names></name><name><surname>Cicconet</surname> <given-names>M</given-names></name><name><surname>Robertson</surname> <given-names>K</given-names></name><name><surname>Cheadle</surname> <given-names>L</given-names></name><name><surname>Zilionis</surname> <given-names>R</given-names></name><name><surname>Ratner</surname> <given-names>A</given-names></name><name><surname>Borges-Monroy</surname> <given-names>R</given-names></name><name><surname>Klein</surname> <given-names>AM</given-names></name><name><surname>Sabatini</surname> <given-names>BL</given-names></name><name><surname>Greenberg</surname> <given-names>ME</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Single-cell analysis of experience-dependent transcriptomic states in the mouse visual cortex</article-title><source>Nature Neuroscience</source><volume>21</volume><fpage>120</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1038/s41593-017-0029-5</pub-id><pub-id pub-id-type="pmid">29230054</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hurd</surname> <given-names>YL</given-names></name><name><surname>Herkenham</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Molecular alterations in the neostriatum of human cocaine addicts</article-title><source>Synapse</source><volume>13</volume><fpage>357</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1002/syn.890130408</pub-id><pub-id pub-id-type="pmid">7683144</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hyman</surname> <given-names>SE</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Addiction: a disease of learning and memory</article-title><source>American Journal of Psychiatry</source><volume>162</volume><fpage>1414</fpage><lpage>1422</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.162.8.1414</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hyman</surname> <given-names>SE</given-names></name><name><surname>Malenka</surname> <given-names>RC</given-names></name><name><surname>Nestler</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Neural mechanisms of addiction: the role of reward-related learning and memory</article-title><source>Annual Review of Neuroscience</source><volume>29</volume><fpage>565</fpage><lpage>598</lpage><pub-id pub-id-type="doi">10.1146/annurev.neuro.29.051605.113009</pub-id><pub-id pub-id-type="pmid">16776597</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imperio</surname> <given-names>CG</given-names></name><name><surname>McFalls</surname> <given-names>AJ</given-names></name><name><surname>Hadad</surname> <given-names>N</given-names></name><name><surname>Blanco-Berdugo</surname> <given-names>L</given-names></name><name><surname>Masser</surname> <given-names>DR</given-names></name><name><surname>Colechio</surname> <given-names>EM</given-names></name><name><surname>Coffey</surname> <given-names>AA</given-names></name><name><surname>Bixler</surname> <given-names>GV</given-names></name><name><surname>Stanford</surname> <given-names>DR</given-names></name><name><surname>Vrana</surname> <given-names>KE</given-names></name><name><surname>Grigson</surname> <given-names>PS</given-names></name><name><surname>Freeman</surname> <given-names>WM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Exposure to environmental enrichment attenuates addiction-like behavior and alters molecular effects of heroin self-administration in rats</article-title><source>Neuropharmacology</source><volume>139</volume><fpage>26</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1016/j.neuropharm.2018.06.037</pub-id><pub-id pub-id-type="pmid">29964093</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname> <given-names>SW</given-names></name><name><surname>LeBlanc</surname> <given-names>SE</given-names></name><name><surname>Roopra</surname> <given-names>A</given-names></name><name><surname>Wrabetz</surname> <given-names>L</given-names></name><name><surname>Svaren</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>In vivo detection of Egr2 binding to target genes during peripheral nerve myelination</article-title><source>Journal of Neurochemistry</source><volume>98</volume><fpage>1678</fpage><lpage>1687</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2006.04069.x</pub-id><pub-id pub-id-type="pmid">16923174</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname> <given-names>MM</given-names></name><name><surname>David</surname> <given-names>JA</given-names></name><name><surname>Michelhaugh</surname> <given-names>SK</given-names></name><name><surname>Schmidt</surname> <given-names>CJ</given-names></name><name><surname>Bannon</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Increased heat shock protein 70 gene expression in the brains of cocaine-related fatalities may be reflective of postdrug survival and intervention rather than excited delirium</article-title><source>Journal of Forensic Sciences</source><volume>57</volume><fpage>1519</fpage><lpage>1523</lpage><pub-id pub-id-type="doi">10.1111/j.1556-4029.2012.02212.x</pub-id><pub-id pub-id-type="pmid">22803793</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname> <given-names>HJ</given-names></name><name><surname>Kawasawa</surname> <given-names>YI</given-names></name><name><surname>Cheng</surname> <given-names>F</given-names></name><name><surname>Zhu</surname> <given-names>Y</given-names></name><name><surname>Xu</surname> <given-names>X</given-names></name><name><surname>Li</surname> <given-names>M</given-names></name><name><surname>Sousa</surname> <given-names>AM</given-names></name><name><surname>Pletikos</surname> <given-names>M</given-names></name><name><surname>Meyer</surname> <given-names>KA</given-names></name><name><surname>Sedmak</surname> <given-names>G</given-names></name><name><surname>Guennel</surname> <given-names>T</given-names></name><name><surname>Shin</surname> <given-names>Y</given-names></name><name><surname>Johnson</surname> <given-names>MB</given-names></name><name><surname>Krsnik</surname> <given-names>Z</given-names></name><name><surname>Mayer</surname> <given-names>S</given-names></name><name><surname>Fertuzinhos</surname> <given-names>S</given-names></name><name><surname>Umlauf</surname> <given-names>S</given-names></name><name><surname>Lisgo</surname> <given-names>SN</given-names></name><name><surname>Vortmeyer</surname> <given-names>A</given-names></name><name><surname>Weinberger</surname> <given-names>DR</given-names></name><name><surname>Mane</surname> <given-names>S</given-names></name><name><surname>Hyde</surname> <given-names>TM</given-names></name><name><surname>Huttner</surname> <given-names>A</given-names></name><name><surname>Reimers</surname> <given-names>M</given-names></name><name><surname>Kleinman</surname> <given-names>JE</given-names></name><name><surname>Sestan</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Spatio-temporal transcriptome of the human brain</article-title><source>Nature</source><volume>478</volume><fpage>483</fpage><lpage>489</lpage><pub-id pub-id-type="doi">10.1038/nature10523</pub-id><pub-id pub-id-type="pmid">22031440</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karler</surname> <given-names>R</given-names></name><name><surname>Calder</surname> <given-names>LD</given-names></name><name><surname>Thai</surname> <given-names>LH</given-names></name><name><surname>Bedingfield</surname> <given-names>JB</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>A dopaminergic-glutamatergic basis for the action of amphetamine and cocaine</article-title><source>Brain Research</source><volume>658</volume><fpage>8</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/S0006-8993(09)90003-8</pub-id><pub-id pub-id-type="pmid">7834358</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelley</surname> <given-names>AE</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Memory and addiction</article-title><source>Neuron</source><volume>44</volume><fpage>161</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2004.09.016</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelley</surname> <given-names>AE</given-names></name><name><surname>Delfs</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Dopamine and conditioned reinforcement</article-title><source>Psychopharmacology</source><volume>103</volume><fpage>187</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1007/BF02244202</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovalevich</surname> <given-names>J</given-names></name><name><surname>Corley</surname> <given-names>G</given-names></name><name><surname>Yen</surname> <given-names>W</given-names></name><name><surname>Rawls</surname> <given-names>SM</given-names></name><name><surname>Langford</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Cocaine-induced loss of white matter proteins in the adult mouse nucleus accumbens is attenuated by administration of a β-lactam antibiotic during cocaine withdrawal</article-title><source>The American Journal of Pathology</source><volume>181</volume><fpage>1921</fpage><lpage>1927</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2012.08.013</pub-id><pub-id pub-id-type="pmid">23031254</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koya</surname> <given-names>E</given-names></name><name><surname>Golden</surname> <given-names>SA</given-names></name><name><surname>Harvey</surname> <given-names>BK</given-names></name><name><surname>Guez-Barber</surname> <given-names>DH</given-names></name><name><surname>Berkow</surname> <given-names>A</given-names></name><name><surname>Simmons</surname> <given-names>DE</given-names></name><name><surname>Bossert</surname> <given-names>JM</given-names></name><name><surname>Nair</surname> <given-names>SG</given-names></name><name><surname>Uejima</surname> <given-names>JL</given-names></name><name><surname>Marin</surname> <given-names>MT</given-names></name><name><surname>Mitchell</surname> <given-names>TB</given-names></name><name><surname>Farquhar</surname> <given-names>D</given-names></name><name><surname>Ghosh</surname> <given-names>SC</given-names></name><name><surname>Mattson</surname> <given-names>BJ</given-names></name><name><surname>Hope</surname> <given-names>BT</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Targeted disruption of cocaine-activated nucleus accumbens neurons prevents context-specific sensitization</article-title><source>Nature Neuroscience</source><volume>12</volume><fpage>1069</fpage><lpage>1073</lpage><pub-id pub-id-type="doi">10.1038/nn.2364</pub-id><pub-id pub-id-type="pmid">19620976</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kravitz</surname> <given-names>AV</given-names></name><name><surname>Freeze</surname> <given-names>BS</given-names></name><name><surname>Parker</surname> <given-names>PR</given-names></name><name><surname>Kay</surname> <given-names>K</given-names></name><name><surname>Thwin</surname> <given-names>MT</given-names></name><name><surname>Deisseroth</surname> <given-names>K</given-names></name><name><surname>Kreitzer</surname> <given-names>AC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry</article-title><source>Nature</source><volume>466</volume><fpage>622</fpage><lpage>626</lpage><pub-id pub-id-type="doi">10.1038/nature09159</pub-id><pub-id pub-id-type="pmid">20613723</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreitzer</surname> <given-names>AC</given-names></name><name><surname>Malenka</surname> <given-names>RC</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Striatal plasticity and basal ganglia circuit function</article-title><source>Neuron</source><volume>60</volume><fpage>543</fpage><lpage>554</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2008.11.005</pub-id><pub-id pub-id-type="pmid">19038213</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kyrke-Smith</surname> <given-names>M</given-names></name><name><surname>Williams</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Bridging synaptic and epigenetic maintenance mechanisms of the engram</article-title><source>Frontiers in Molecular Neuroscience</source><volume>11</volume><elocation-id>369</elocation-id><pub-id pub-id-type="doi">10.3389/fnmol.2018.00369</pub-id><pub-id pub-id-type="pmid">30344478</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LeBlanc</surname> <given-names>SE</given-names></name><name><surname>Ward</surname> <given-names>RM</given-names></name><name><surname>Svaren</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Neuropathy-associated Egr2 mutants disrupt cooperative activation of myelin protein zero by Egr2 and Sox10</article-title><source>Molecular and Cellular Biology</source><volume>27</volume><fpage>3521</fpage><lpage>3529</lpage><pub-id pub-id-type="doi">10.1128/MCB.01689-06</pub-id><pub-id pub-id-type="pmid">17325040</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>JL</given-names></name><name><surname>Milton</surname> <given-names>AL</given-names></name><name><surname>Everitt</surname> <given-names>BJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Cue-induced cocaine seeking and relapse are reduced by disruption of drug memory reconsolidation</article-title><source>Journal of Neuroscience</source><volume>26</volume><fpage>5881</fpage><lpage>5887</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0323-06.2006</pub-id><pub-id pub-id-type="pmid">16738229</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Rubio</surname> <given-names>FJ</given-names></name><name><surname>Zeric</surname> <given-names>T</given-names></name><name><surname>Bossert</surname> <given-names>JM</given-names></name><name><surname>Kambhampati</surname> <given-names>S</given-names></name><name><surname>Cates</surname> <given-names>HM</given-names></name><name><surname>Kennedy</surname> <given-names>PJ</given-names></name><name><surname>Liu</surname> <given-names>QR</given-names></name><name><surname>Cimbro</surname> <given-names>R</given-names></name><name><surname>Hope</surname> <given-names>BT</given-names></name><name><surname>Nestler</surname> <given-names>EJ</given-names></name><name><surname>Shaham</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Incubation of methamphetamine craving is associated with selective increases in expression of bdnf and trkb, glutamate receptors, and epigenetic enzymes in cue-activated fos-expressing dorsal striatal neurons</article-title><source>Journal of Neuroscience</source><volume>35</volume><fpage>8232</fpage><lpage>8244</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1022-15.2015</pub-id><pub-id pub-id-type="pmid">26019338</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>K</given-names></name><name><surname>Wu</surname> <given-names>Y</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Yu</surname> <given-names>Q</given-names></name><name><surname>Tian</surname> <given-names>Z</given-names></name><name><surname>Wei</surname> <given-names>H</given-names></name><name><surname>Qu</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Landscape and dynamics of the transcriptional regulatory network during natural killer cell differentiation</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/572768</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipton</surname> <given-names>DM</given-names></name><name><surname>Gonzales</surname> <given-names>BJ</given-names></name><name><surname>Citri</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Dorsal striatal circuits for habits, compulsions and addictions</article-title><source>Frontiers in Systems Neuroscience</source><volume>13</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.3389/fnsys.2019.00028</pub-id><pub-id pub-id-type="pmid">31379523</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>López-López</surname> <given-names>D</given-names></name><name><surname>Gómez-Nieto</surname> <given-names>R</given-names></name><name><surname>Herrero-Turrión</surname> <given-names>MJ</given-names></name><name><surname>García-Cairasco</surname> <given-names>N</given-names></name><name><surname>Sánchez-Benito</surname> <given-names>D</given-names></name><name><surname>Ludeña</surname> <given-names>MD</given-names></name><name><surname>López</surname> <given-names>DE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Overexpression of the immediate-early genes Egr1, Egr2, and Egr3 in two strains of rodents susceptible to audiogenic seizures</article-title><source>Epilepsy &amp; Behavior</source><volume>71</volume><fpage>226</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1016/j.yebeh.2015.12.020</pub-id><pub-id pub-id-type="pmid">26775236</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lull</surname> <given-names>ME</given-names></name><name><surname>Freeman</surname> <given-names>WM</given-names></name><name><surname>Vrana</surname> <given-names>KE</given-names></name><name><surname>Mash</surname> <given-names>DC</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Correlating human and animal studies of cocaine abuse and gene expression</article-title><source>Annals of the New York Academy of Sciences</source><volume>1141</volume><fpage>58</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1196/annals.1441.013</pub-id><pub-id pub-id-type="pmid">18991951</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lüscher</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The emergence of a circuit model for addiction</article-title><source>Annual Review of Neuroscience</source><volume>39</volume><fpage>257</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1146/annurev-neuro-070815-013920</pub-id><pub-id pub-id-type="pmid">27145911</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lüscher</surname> <given-names>C</given-names></name><name><surname>Malenka</surname> <given-names>RC</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling</article-title><source>Neuron</source><volume>69</volume><fpage>650</fpage><lpage>663</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.01.017</pub-id><pub-id pub-id-type="pmid">21338877</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Märtin</surname> <given-names>A</given-names></name><name><surname>Calvigioni</surname> <given-names>D</given-names></name><name><surname>Tzortzi</surname> <given-names>O</given-names></name><name><surname>Fuzik</surname> <given-names>J</given-names></name><name><surname>Wärnberg</surname> <given-names>E</given-names></name><name><surname>Meletis</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A Spatiomolecular Map of the Striatum</article-title><source>Cell Reports</source><volume>29</volume><fpage>4320</fpage><lpage>4333</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.11.096</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mataga</surname> <given-names>N</given-names></name><name><surname>Fujishima</surname> <given-names>S</given-names></name><name><surname>Condie</surname> <given-names>BG</given-names></name><name><surname>Hensch</surname> <given-names>TK</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Experience-dependent plasticity of mouse visual cortex in the absence of the neuronal activity-dependent marker <italic>egr1/zif268</italic></article-title><source>The Journal of Neuroscience</source><volume>21</volume><fpage>9724</fpage><lpage>9732</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-24-09724.2001</pub-id><pub-id pub-id-type="pmid">11739581</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McClung</surname> <given-names>CA</given-names></name><name><surname>Nestler</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Neuroplasticity mediated by altered gene expression</article-title><source>Neuropsychopharmacology</source><volume>33</volume><fpage>3</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1038/sj.npp.1301544</pub-id><pub-id pub-id-type="pmid">17728700</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McQuin</surname> <given-names>C</given-names></name><name><surname>Goodman</surname> <given-names>A</given-names></name><name><surname>Chernyshev</surname> <given-names>V</given-names></name><name><surname>Kamentsky</surname> <given-names>L</given-names></name><name><surname>Cimini</surname> <given-names>BA</given-names></name><name><surname>Karhohs</surname> <given-names>KW</given-names></name><name><surname>Doan</surname> <given-names>M</given-names></name><name><surname>Ding</surname> <given-names>L</given-names></name><name><surname>Rafelski</surname> <given-names>SM</given-names></name><name><surname>Thirstrup</surname> <given-names>D</given-names></name><name><surname>Wiegraebe</surname> <given-names>W</given-names></name><name><surname>Singh</surname> <given-names>S</given-names></name><name><surname>Becker</surname> <given-names>T</given-names></name><name><surname>Caicedo</surname> <given-names>JC</given-names></name><name><surname>Carpenter</surname> <given-names>AE</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>CellProfiler 3.0: next-generation image processing for biology</article-title><source>PLOS Biology</source><volume>16</volume><elocation-id>e2005970</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.2005970</pub-id><pub-id pub-id-type="pmid">29969450</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moratalla</surname> <given-names>R</given-names></name><name><surname>Robertson</surname> <given-names>HA</given-names></name><name><surname>Graybiel</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Dynamic regulation of NGFI-A (zif268, egr1) gene expression in the striatum</article-title><source>The Journal of Neuroscience</source><volume>12</volume><fpage>2609</fpage><lpage>2622</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.12-07-02609.1992</pub-id><pub-id pub-id-type="pmid">1613551</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moratalla</surname> <given-names>R</given-names></name><name><surname>Elibol</surname> <given-names>B</given-names></name><name><surname>Vallejo</surname> <given-names>M</given-names></name><name><surname>Graybiel</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Network-level changes in expression of inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal</article-title><source>Neuron</source><volume>17</volume><fpage>147</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(00)80288-3</pub-id><pub-id pub-id-type="pmid">8755486</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morita</surname> <given-names>K</given-names></name><name><surname>Okamura</surname> <given-names>T</given-names></name><name><surname>Inoue</surname> <given-names>M</given-names></name><name><surname>Komai</surname> <given-names>T</given-names></name><name><surname>Teruya</surname> <given-names>S</given-names></name><name><surname>Iwasaki</surname> <given-names>Y</given-names></name><name><surname>Sumitomo</surname> <given-names>S</given-names></name><name><surname>Shoda</surname> <given-names>H</given-names></name><name><surname>Yamamoto</surname> <given-names>K</given-names></name><name><surname>Fujio</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Egr2 and Egr3 in regulatory T cells cooperatively control systemic autoimmunity through Ltbp3-mediated TGF-β3 production</article-title><source>PNAS</source><volume>113</volume><fpage>E8131</fpage><lpage>E8140</lpage><pub-id pub-id-type="doi">10.1073/pnas.1611286114</pub-id><pub-id pub-id-type="pmid">27911796</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukherjee</surname> <given-names>D</given-names></name><name><surname>Ignatowska-Jankowska</surname> <given-names>BM</given-names></name><name><surname>Itskovits</surname> <given-names>E</given-names></name><name><surname>Gonzales</surname> <given-names>BJ</given-names></name><name><surname>Turm</surname> <given-names>H</given-names></name><name><surname>Izakson</surname> <given-names>L</given-names></name><name><surname>Haritan</surname> <given-names>D</given-names></name><name><surname>Bleistein</surname> <given-names>N</given-names></name><name><surname>Cohen</surname> <given-names>C</given-names></name><name><surname>Amit</surname> <given-names>I</given-names></name><name><surname>Shay</surname> <given-names>T</given-names></name><name><surname>Grueter</surname> <given-names>B</given-names></name><name><surname>Zaslaver</surname> <given-names>A</given-names></name><name><surname>Citri</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Salient experiences are represented by unique transcriptional signatures in the mouse brain</article-title><source>eLife</source><volume>7</volume><elocation-id>e31220</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.31220</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname> <given-names>RC</given-names></name><name><surname>Logan</surname> <given-names>MC</given-names></name><name><surname>Horner</surname> <given-names>KA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Striatal patch compartment lesions reduce stereotypy following repeated cocaine administration</article-title><source>Brain Research</source><volume>1618</volume><fpage>286</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2015.06.012</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagarajan</surname> <given-names>R</given-names></name><name><surname>Svaren</surname> <given-names>J</given-names></name><name><surname>Le</surname> <given-names>N</given-names></name><name><surname>Araki</surname> <given-names>T</given-names></name><name><surname>Watson</surname> <given-names>M</given-names></name><name><surname>Milbrandt</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>EGR2 Mutations in Inherited Neuropathies Dominant-Negatively Inhibit Myelin Gene Expression</article-title><source>Neuron</source><volume>30</volume><fpage>355</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(01)00282-3</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narayana</surname> <given-names>PA</given-names></name><name><surname>Herrera</surname> <given-names>JJ</given-names></name><name><surname>Bockhorst</surname> <given-names>KH</given-names></name><name><surname>Esparza-Coss</surname> <given-names>E</given-names></name><name><surname>Xia</surname> <given-names>Y</given-names></name><name><surname>Steinberg</surname> <given-names>JL</given-names></name><name><surname>Moeller</surname> <given-names>FG</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Chronic cocaine administration causes extensive white matter damage in brain: Diffusion tensor imaging and immunohistochemistry studies</article-title><source>Psychiatry Research: Neuroimaging</source><volume>221</volume><fpage>220</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.1016/j.pscychresns.2014.01.005</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nestler</surname> <given-names>EJ</given-names></name><name><surname>Hope</surname> <given-names>BT</given-names></name><name><surname>Widnell</surname> <given-names>KL</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Drug addiction: A model for the molecular basis of neural plasticity</article-title><source>Neuron</source><volume>11</volume><fpage>995</fpage><lpage>1006</lpage><pub-id pub-id-type="doi">10.1016/0896-6273(93)90213-B</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nestler</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Molecular basis of long-term plasticity underlying addiction</article-title><source>Nature Reviews Neuroscience</source><volume>2</volume><fpage>119</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1038/35053570</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nestler</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Common Molecular and Cellular Substrates of Addiction and Memory</article-title><source>Neurobiology of Learning and Memory</source><volume>78</volume><fpage>637</fpage><lpage>647</lpage><pub-id pub-id-type="doi">10.1006/nlme.2002.4084</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nestler</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Cellular basis of memory for addiction</article-title><source>Dialogues in Clinical Neuroscience</source><volume>15</volume><fpage>431</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.31887/DCNS.2013.15.4/enestler</pub-id><pub-id pub-id-type="pmid">24459410</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nestler</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Epigenetic mechanisms of drug addiction</article-title><source>Neuropharmacology</source><volume>76</volume><fpage>259</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1016/j.neuropharm.2013.04.004</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nestler</surname> <given-names>EJ</given-names></name><name><surname>Aghajanian</surname> <given-names>GK</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Molecular and Cellular Basis of Addiction</article-title><source>Science</source><volume>278</volume><fpage>58</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1126/science.278.5335.58</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nestler</surname> <given-names>EJ</given-names></name><name><surname>Lüscher</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The molecular basis of drug addiction: linking epigenetic to synaptic and circuit mechanisms</article-title><source>Neuron</source><volume>102</volume><fpage>48</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2019.01.016</pub-id><pub-id pub-id-type="pmid">30946825</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nonomura</surname> <given-names>S</given-names></name><name><surname>Nishizawa</surname> <given-names>K</given-names></name><name><surname>Sakai</surname> <given-names>Y</given-names></name><name><surname>Kawaguchi</surname> <given-names>Y</given-names></name><name><surname>Kato</surname> <given-names>S</given-names></name><name><surname>Uchigashima</surname> <given-names>M</given-names></name><name><surname>Watanabe</surname> <given-names>M</given-names></name><name><surname>Yamanaka</surname> <given-names>K</given-names></name><name><surname>Enomoto</surname> <given-names>K</given-names></name><name><surname>Chiken</surname> <given-names>S</given-names></name><name><surname>Sano</surname> <given-names>H</given-names></name><name><surname>Soma</surname> <given-names>S</given-names></name><name><surname>Yoshida</surname> <given-names>J</given-names></name><name><surname>Samejima</surname> <given-names>K</given-names></name><name><surname>Ogawa</surname> <given-names>M</given-names></name><name><surname>Kobayashi</surname> <given-names>K</given-names></name><name><surname>Nambu</surname> <given-names>A</given-names></name><name><surname>Isomura</surname> <given-names>Y</given-names></name><name><surname>Kimura</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Monitoring and updating of action selection for Goal-Directed behavior through the striatal direct and indirect pathways</article-title><source>Neuron</source><volume>99</volume><fpage>1302</fpage><lpage>1314</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2018.08.002</pub-id><pub-id pub-id-type="pmid">30146299</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okamura</surname> <given-names>T</given-names></name><name><surname>Sumitomo</surname> <given-names>S</given-names></name><name><surname>Morita</surname> <given-names>K</given-names></name><name><surname>Iwasaki</surname> <given-names>Y</given-names></name><name><surname>Inoue</surname> <given-names>M</given-names></name><name><surname>Nakachi</surname> <given-names>S</given-names></name><name><surname>Komai</surname> <given-names>T</given-names></name><name><surname>Shoda</surname> <given-names>H</given-names></name><name><surname>Miyazaki</surname> <given-names>J</given-names></name><name><surname>Fujio</surname> <given-names>K</given-names></name><name><surname>Yamamoto</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>TGF-β3-expressing CD4+CD25(-)LAG3+ regulatory T cells control humoral immune responses</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>6329</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms7329</pub-id><pub-id pub-id-type="pmid">25695838</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortiz</surname> <given-names>C</given-names></name><name><surname>Navarro</surname> <given-names>JF</given-names></name><name><surname>Jurek</surname> <given-names>A</given-names></name><name><surname>Märtin</surname> <given-names>A</given-names></name><name><surname>Lundeberg</surname> <given-names>J</given-names></name><name><surname>Meletis</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Molecular atlas of the adult mouse brain</article-title><source>Science Advances</source><volume>6</volume><elocation-id>eabb3446</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.abb3446</pub-id><pub-id pub-id-type="pmid">32637622</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname> <given-names>PE</given-names></name><name><surname>Stuber</surname> <given-names>GD</given-names></name><name><surname>Heien</surname> <given-names>ML</given-names></name><name><surname>Wightman</surname> <given-names>RM</given-names></name><name><surname>Carelli</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Subsecond dopamine release promotes cocaine seeking</article-title><source>Nature</source><volume>422</volume><fpage>614</fpage><lpage>618</lpage><pub-id pub-id-type="doi">10.1038/nature01476</pub-id><pub-id pub-id-type="pmid">12687000</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piechota</surname> <given-names>M</given-names></name><name><surname>Korostynski</surname> <given-names>M</given-names></name><name><surname>Solecki</surname> <given-names>W</given-names></name><name><surname>Gieryk</surname> <given-names>A</given-names></name><name><surname>Slezak</surname> <given-names>M</given-names></name><name><surname>Bilecki</surname> <given-names>W</given-names></name><name><surname>Ziolkowska</surname> <given-names>B</given-names></name><name><surname>Kostrzewa</surname> <given-names>E</given-names></name><name><surname>Cymerman</surname> <given-names>I</given-names></name><name><surname>Swiech</surname> <given-names>L</given-names></name><name><surname>Jaworski</surname> <given-names>J</given-names></name><name><surname>Przewlocki</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The dissection of transcriptional modules regulated by various drugs of abuse in the mouse striatum</article-title><source>Genome Biology</source><volume>11</volume><elocation-id>R48</elocation-id><pub-id pub-id-type="doi">10.1186/gb-2010-11-5-r48</pub-id><pub-id pub-id-type="pmid">20459597</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rakhade</surname> <given-names>SN</given-names></name><name><surname>Shah</surname> <given-names>AK</given-names></name><name><surname>Agarwal</surname> <given-names>R</given-names></name><name><surname>Yao</surname> <given-names>B</given-names></name><name><surname>Asano</surname> <given-names>E</given-names></name><name><surname>Loeb</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Activity-dependent gene expression correlates with interictal spiking in human neocortical epilepsy</article-title><source>Epilepsia</source><volume>48</volume><fpage>86</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1111/j.1528-1167.2007.01294.x</pub-id><pub-id pub-id-type="pmid">17910586</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rebec</surname> <given-names>GV</given-names></name><name><surname>White</surname> <given-names>IM</given-names></name><name><surname>Puotz</surname> <given-names>JK</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Responses of neurons in dorsal striatum during amphetamine-induced focused stereotypy</article-title><source>Psychopharmacology</source><volume>130</volume><fpage>343</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1007/s002130050249</pub-id><pub-id pub-id-type="pmid">9160850</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro</surname> <given-names>EA</given-names></name><name><surname>Scarpa</surname> <given-names>JR</given-names></name><name><surname>Garamszegi</surname> <given-names>SP</given-names></name><name><surname>Kasarskis</surname> <given-names>A</given-names></name><name><surname>Mash</surname> <given-names>DC</given-names></name><name><surname>Nestler</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Gene network dysregulation in dorsolateral prefrontal cortex neurons of humans with cocaine use disorder</article-title><source>Scientific Reports</source><volume>7</volume><elocation-id>5412</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-017-05720-3</pub-id><pub-id pub-id-type="pmid">28710498</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rittschof</surname> <given-names>CC</given-names></name><name><surname>Hughes</surname> <given-names>KA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Advancing behavioural genomics by considering timescale</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>489</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-02971-0</pub-id><pub-id pub-id-type="pmid">29434301</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robison</surname> <given-names>AJ</given-names></name><name><surname>Nestler</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Transcriptional and epigenetic mechanisms of addiction</article-title><source>Nature Reviews Neuroscience</source><volume>12</volume><fpage>623</fpage><lpage>637</lpage><pub-id pub-id-type="doi">10.1038/nrn3111</pub-id><pub-id pub-id-type="pmid">21989194</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubio</surname> <given-names>FJ</given-names></name><name><surname>Liu</surname> <given-names>QR</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Cruz</surname> <given-names>FC</given-names></name><name><surname>Leão</surname> <given-names>RM</given-names></name><name><surname>Warren</surname> <given-names>BL</given-names></name><name><surname>Kambhampati</surname> <given-names>S</given-names></name><name><surname>Babin</surname> <given-names>KR</given-names></name><name><surname>McPherson</surname> <given-names>KB</given-names></name><name><surname>Cimbro</surname> <given-names>R</given-names></name><name><surname>Bossert</surname> <given-names>JM</given-names></name><name><surname>Shaham</surname> <given-names>Y</given-names></name><name><surname>Hope</surname> <given-names>BT</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Context-induced reinstatement of methamphetamine seeking is associated with unique molecular alterations in Fos-expressing dorsolateral striatum neurons</article-title><source>Journal of Neuroscience</source><volume>35</volume><fpage>5625</fpage><lpage>5639</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4997-14.2015</pub-id><pub-id pub-id-type="pmid">25855177</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russo</surname> <given-names>SJ</given-names></name><name><surname>Nestler</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The brain reward circuitry in mood disorders</article-title><source>Nature Reviews Neuroscience</source><volume>14</volume><fpage>609</fpage><lpage>625</lpage><pub-id pub-id-type="doi">10.1038/nrn3381</pub-id><pub-id pub-id-type="pmid">23942470</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saint-Preux</surname> <given-names>F</given-names></name><name><surname>Bores</surname> <given-names>LR</given-names></name><name><surname>Tulloch</surname> <given-names>I</given-names></name><name><surname>Ladenheim</surname> <given-names>B</given-names></name><name><surname>Kim</surname> <given-names>R</given-names></name><name><surname>Thanos</surname> <given-names>PK</given-names></name><name><surname>Volkow</surname> <given-names>ND</given-names></name><name><surname>Cadet</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Chronic co-administration of nicotine and methamphetamine causes differential expression of immediate early genes in the dorsal striatum and nucleus accumbens of rats</article-title><source>Neuroscience</source><volume>243</volume><fpage>89</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2013.03.052</pub-id><pub-id pub-id-type="pmid">23562942</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salery</surname> <given-names>M</given-names></name><name><surname>Trifilieff</surname> <given-names>P</given-names></name><name><surname>Caboche</surname> <given-names>J</given-names></name><name><surname>Vanhoutte</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>From signaling molecules to circuits and behaviors: cell-type-specific adaptations to psychostimulant exposure in the striatum</article-title><source>Biological Psychiatry</source><volume>87</volume><fpage>944</fpage><lpage>953</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2019.11.001</pub-id><pub-id pub-id-type="pmid">31928716</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savell</surname> <given-names>KE</given-names></name><name><surname>Tuscher</surname> <given-names>JJ</given-names></name><name><surname>Zipperly</surname> <given-names>ME</given-names></name><name><surname>Duke</surname> <given-names>CG</given-names></name><name><surname>Phillips</surname> <given-names>RA</given-names></name><name><surname>Bauman</surname> <given-names>AJ</given-names></name><name><surname>Thukral</surname> <given-names>S</given-names></name><name><surname>Sultan</surname> <given-names>FA</given-names></name><name><surname>Goska</surname> <given-names>NA</given-names></name><name><surname>Ianov</surname> <given-names>L</given-names></name><name><surname>Day</surname> <given-names>JJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A dopamine-induced gene expression signature regulates neuronal function and cocaine response</article-title><source>Science Advances</source><volume>6</volume><elocation-id>eaba4221</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.aba4221</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlussman</surname> <given-names>SD</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Kane</surname> <given-names>S</given-names></name><name><surname>Stewart</surname> <given-names>CL</given-names></name><name><surname>Ho</surname> <given-names>A</given-names></name><name><surname>Kreek</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Locomotion, Stereotypy, and dopamine D1 receptors after chronic &quot;binge&quot; cocaine in C57BL/6J and 129/J mice</article-title><source>Pharmacology Biochemistry and Behavior</source><volume>75</volume><fpage>123</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1016/S0091-3057(03)00067-4</pub-id><pub-id pub-id-type="pmid">12759120</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaham</surname> <given-names>Y</given-names></name><name><surname>Shalev</surname> <given-names>U</given-names></name><name><surname>Lu</surname> <given-names>L</given-names></name><name><surname>de Wit</surname> <given-names>H</given-names></name><name><surname>Stewart</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The reinstatement model of drug relapse: history, methodology and major findings</article-title><source>Psychopharmacology</source><volume>168</volume><fpage>3</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1007/s00213-002-1224-x</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinha</surname> <given-names>S</given-names></name><name><surname>Jones</surname> <given-names>BM</given-names></name><name><surname>Traniello</surname> <given-names>IM</given-names></name><name><surname>Bukhari</surname> <given-names>SA</given-names></name><name><surname>Halfon</surname> <given-names>MS</given-names></name><name><surname>Hofmann</surname> <given-names>HA</given-names></name><name><surname>Huang</surname> <given-names>S</given-names></name><name><surname>Katz</surname> <given-names>PS</given-names></name><name><surname>Keagy</surname> <given-names>J</given-names></name><name><surname>Lynch</surname> <given-names>VJ</given-names></name><name><surname>Sokolowski</surname> <given-names>MB</given-names></name><name><surname>Stubbs</surname> <given-names>LJ</given-names></name><name><surname>Tabe-Bordbar</surname> <given-names>S</given-names></name><name><surname>Wolfner</surname> <given-names>MF</given-names></name><name><surname>Robinson</surname> <given-names>GE</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Behavior-related gene regulatory networks: a new level of organization in the brain</article-title><source>PNAS</source><volume>117</volume><fpage>23270</fpage><lpage>23279</lpage><pub-id pub-id-type="doi">10.1073/pnas.1921625117</pub-id><pub-id pub-id-type="pmid">32661177</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Steiner</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><chapter-title>Psychostimulant-Induced Gene Regulation in Striatal Circuits</chapter-title><person-group person-group-type="editor"><name><surname>Steiner</surname> <given-names>H</given-names></name><name><surname>Tseng</surname> <given-names>K. Y</given-names></name></person-group><source>Handbook of Behavioral Neuroscience</source><publisher-name>Elsevier</publisher-name><fpage>639</fpage><lpage>672</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-802206-1.00031-3</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steiner</surname> <given-names>H</given-names></name><name><surname>Gerfen</surname> <given-names>CR</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum</article-title><source>The Journal of Neuroscience</source><volume>13</volume><fpage>5066</fpage><lpage>5081</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.13-12-05066.1993</pub-id><pub-id pub-id-type="pmid">7504719</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steiner</surname> <given-names>H</given-names></name><name><surname>Van Waes</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Addiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulants</article-title><source>Progress in Neurobiology</source><volume>100</volume><fpage>60</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.pneurobio.2012.10.001</pub-id><pub-id pub-id-type="pmid">23085425</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Svaren</surname> <given-names>J</given-names></name><name><surname>Meijer</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The molecular machinery of myelin gene transcription in schwann cells</article-title><source>Glia</source><volume>56</volume><fpage>1541</fpage><lpage>1551</lpage><pub-id pub-id-type="doi">10.1002/glia.20767</pub-id><pub-id pub-id-type="pmid">18803322</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terem</surname> <given-names>A</given-names></name><name><surname>Gonzales</surname> <given-names>BJ</given-names></name><name><surname>Peretz-Rivlin</surname> <given-names>N</given-names></name><name><surname>Ashwal-Fluss</surname> <given-names>R</given-names></name><name><surname>Bleistein</surname> <given-names>N</given-names></name><name><surname>Del Mar Reus-Garcia</surname> <given-names>M</given-names></name><name><surname>Mukherjee</surname> <given-names>D</given-names></name><name><surname>Groysman</surname> <given-names>M</given-names></name><name><surname>Citri</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Claustral neurons projecting to frontal cortex mediate contextual association of reward</article-title><source>Current Biology</source><volume>30</volume><fpage>3522</fpage><lpage>3532</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2020.06.064</pub-id><pub-id pub-id-type="pmid">32707061</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Topilko</surname> <given-names>P</given-names></name><name><surname>Schneider-Maunoury</surname> <given-names>S</given-names></name><name><surname>Levi</surname> <given-names>G</given-names></name><name><surname>Baron-Van Evercooren</surname> <given-names>A</given-names></name><name><surname>Chennoufi</surname> <given-names>AB</given-names></name><name><surname>Seitanidou</surname> <given-names>T</given-names></name><name><surname>Babinet</surname> <given-names>C</given-names></name><name><surname>Charnay</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Krox-20 controls myelination in the peripheral nervous system</article-title><source>Nature</source><volume>371</volume><fpage>796</fpage><lpage>799</lpage><pub-id pub-id-type="doi">10.1038/371796a0</pub-id><pub-id pub-id-type="pmid">7935840</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turm</surname> <given-names>H</given-names></name><name><surname>Mukherjee</surname> <given-names>D</given-names></name><name><surname>Haritan</surname> <given-names>D</given-names></name><name><surname>Tahor</surname> <given-names>M</given-names></name><name><surname>Citri</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Comprehensive analysis of transcription dynamics from brain samples following behavioral experience</article-title><source>Journal of Visualized Experiments</source><volume>90</volume><elocation-id>51642</elocation-id><pub-id pub-id-type="doi">10.3791/51642</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyssowski</surname> <given-names>KM</given-names></name><name><surname>DeStefino</surname> <given-names>NR</given-names></name><name><surname>Cho</surname> <given-names>JH</given-names></name><name><surname>Dunn</surname> <given-names>CJ</given-names></name><name><surname>Poston</surname> <given-names>RG</given-names></name><name><surname>Carty</surname> <given-names>CE</given-names></name><name><surname>Jones</surname> <given-names>RD</given-names></name><name><surname>Chang</surname> <given-names>SM</given-names></name><name><surname>Romeo</surname> <given-names>P</given-names></name><name><surname>Wurzelmann</surname> <given-names>MK</given-names></name><name><surname>Ward</surname> <given-names>JM</given-names></name><name><surname>Andermann</surname> <given-names>ML</given-names></name><name><surname>Saha</surname> <given-names>RN</given-names></name><name><surname>Dudek</surname> <given-names>SM</given-names></name><name><surname>Gray</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Different neuronal activity patterns induce different gene expression programs</article-title><source>Neuron</source><volume>98</volume><fpage>530</fpage><lpage>546</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2018.04.001</pub-id><pub-id pub-id-type="pmid">29681534</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyssowski</surname> <given-names>KM</given-names></name><name><surname>Gray</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The neuronal stimulation-transcription coupling map</article-title><source>Current Opinion in Neurobiology</source><volume>59</volume><fpage>87</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2019.05.001</pub-id><pub-id pub-id-type="pmid">31163285</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valjent</surname> <given-names>E</given-names></name><name><surname>Aubier</surname> <given-names>B</given-names></name><name><surname>Corbillé</surname> <given-names>AG</given-names></name><name><surname>Brami-Cherrier</surname> <given-names>K</given-names></name><name><surname>Caboche</surname> <given-names>J</given-names></name><name><surname>Topilko</surname> <given-names>P</given-names></name><name><surname>Girault</surname> <given-names>JA</given-names></name><name><surname>Hervé</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Plasticity-associated gene Krox24/Zif268 is required for long-lasting behavioral effects of cocaine</article-title><source>Journal of Neuroscience</source><volume>26</volume><fpage>4956</fpage><lpage>4960</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4601-05.2006</pub-id><pub-id pub-id-type="pmid">16672671</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voiculescu</surname> <given-names>O</given-names></name><name><surname>Charnay</surname> <given-names>P</given-names></name><name><surname>Schneider-Maunoury</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Expression pattern of a Krox-20/Cre knock-in allele in the developing hindbrain, bones, and peripheral nervous system</article-title><source>Genesis</source><volume>26</volume><fpage>123</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1526-968X(200002)26:2&lt;123::AID-GENE7&gt;3.0.CO;2-O</pub-id><pub-id pub-id-type="pmid">10686605</pub-id></element-citation></ref><ref id="bib120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volkow</surname> <given-names>ND</given-names></name><name><surname>Wang</surname> <given-names>GJ</given-names></name><name><surname>Telang</surname> <given-names>F</given-names></name><name><surname>Fowler</surname> <given-names>JS</given-names></name><name><surname>Logan</surname> <given-names>J</given-names></name><name><surname>Childress</surname> <given-names>AR</given-names></name><name><surname>Jayne</surname> <given-names>M</given-names></name><name><surname>Ma</surname> <given-names>Y</given-names></name><name><surname>Wong</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction</article-title><source>Journal of Neuroscience</source><volume>26</volume><fpage>6583</fpage><lpage>6588</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1544-06.2006</pub-id><pub-id pub-id-type="pmid">16775146</pub-id></element-citation></ref><ref id="bib121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volkow</surname> <given-names>ND</given-names></name><name><surname>Morales</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The brain on drugs: from reward to addiction</article-title><source>Cell</source><volume>162</volume><fpage>712</fpage><lpage>725</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.07.046</pub-id><pub-id pub-id-type="pmid">26276628</pub-id></element-citation></ref><ref id="bib122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname> <given-names>DM</given-names></name><name><surname>Cates</surname> <given-names>HM</given-names></name><name><surname>Loh</surname> <given-names>YE</given-names></name><name><surname>Purushothaman</surname> <given-names>I</given-names></name><name><surname>Ramakrishnan</surname> <given-names>A</given-names></name><name><surname>Cahill</surname> <given-names>KM</given-names></name><name><surname>Lardner</surname> <given-names>CK</given-names></name><name><surname>Godino</surname> <given-names>A</given-names></name><name><surname>Kronman</surname> <given-names>HG</given-names></name><name><surname>Rabkin</surname> <given-names>J</given-names></name><name><surname>Lorsch</surname> <given-names>ZS</given-names></name><name><surname>Mews</surname> <given-names>P</given-names></name><name><surname>Doyle</surname> <given-names>MA</given-names></name><name><surname>Feng</surname> <given-names>J</given-names></name><name><surname>Labonté</surname> <given-names>B</given-names></name><name><surname>Koo</surname> <given-names>JW</given-names></name><name><surname>Bagot</surname> <given-names>RC</given-names></name><name><surname>Logan</surname> <given-names>RW</given-names></name><name><surname>Seney</surname> <given-names>ML</given-names></name><name><surname>Calipari</surname> <given-names>ES</given-names></name><name><surname>Shen</surname> <given-names>L</given-names></name><name><surname>Nestler</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Cocaine Self-administration alters Transcriptome-wide responses in the brain's Reward Circuitry</article-title><source>Biological Psychiatry</source><volume>84</volume><fpage>867</fpage><lpage>880</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2018.04.009</pub-id><pub-id pub-id-type="pmid">29861096</pub-id></element-citation></ref><ref id="bib123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warner</surname> <given-names>LE</given-names></name><name><surname>Mancias</surname> <given-names>P</given-names></name><name><surname>Butler</surname> <given-names>IJ</given-names></name><name><surname>McDonald</surname> <given-names>CM</given-names></name><name><surname>Keppen</surname> <given-names>L</given-names></name><name><surname>Koob</surname> <given-names>KG</given-names></name><name><surname>Lupski</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies</article-title><source>Nature Genetics</source><volume>18</volume><fpage>382</fpage><lpage>384</lpage><pub-id pub-id-type="doi">10.1038/ng0498-382</pub-id><pub-id pub-id-type="pmid">9537424</pub-id></element-citation></ref><ref id="bib124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warner</surname> <given-names>LE</given-names></name><name><surname>Svaren</surname> <given-names>J</given-names></name><name><surname>Milbrandt</surname> <given-names>J</given-names></name><name><surname>Lupski</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Functional consequences of mutations in the early growth response 2 gene (EGR2) correlate with severity of human myelinopathies</article-title><source>Human Molecular Genetics</source><volume>8</volume><fpage>1245</fpage><lpage>1251</lpage><pub-id pub-id-type="doi">10.1093/hmg/8.7.1245</pub-id><pub-id pub-id-type="pmid">10369870</pub-id></element-citation></ref><ref id="bib125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname> <given-names>IM</given-names></name><name><surname>Doubles</surname> <given-names>L</given-names></name><name><surname>Rebec</surname> <given-names>GV</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Cocaine-induced activation of striatal neurons during focused stereotypy in rats</article-title><source>Brain Research</source><volume>810</volume><fpage>146</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1016/S0006-8993(98)00905-6</pub-id><pub-id pub-id-type="pmid">9813293</pub-id></element-citation></ref><ref id="bib126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkinson</surname> <given-names>DG</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Genetic control of segmentation in the vertebrate hindbrain</article-title><source>Perspectives on Developmental Neurobiology</source><volume>3</volume><fpage>29</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">8542253</pub-id></element-citation></ref><ref id="bib127"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname> <given-names>ME</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Synaptic mechanisms underlying persistent cocaine craving</article-title><source>Nature Reviews Neuroscience</source><volume>17</volume><fpage>351</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.1038/nrn.2016.39</pub-id><pub-id pub-id-type="pmid">27150400</pub-id></element-citation></ref><ref id="bib128"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Worley</surname> <given-names>PF</given-names></name><name><surname>Bhat</surname> <given-names>RV</given-names></name><name><surname>Baraban</surname> <given-names>JM</given-names></name><name><surname>Erickson</surname> <given-names>CA</given-names></name><name><surname>McNaughton</surname> <given-names>BL</given-names></name><name><surname>Barnes</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Thresholds for synaptic activation of transcription factors in Hippocampus: correlation with long-term enhancement</article-title><source>The Journal of Neuroscience</source><volume>13</volume><fpage>4776</fpage><lpage>4786</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.13-11-04776.1993</pub-id></element-citation></ref><ref id="bib129"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname> <given-names>K</given-names></name><name><surname>Gerber</surname> <given-names>DJ</given-names></name><name><surname>Iwayama</surname> <given-names>Y</given-names></name><name><surname>Ohnishi</surname> <given-names>T</given-names></name><name><surname>Ohba</surname> <given-names>H</given-names></name><name><surname>Toyota</surname> <given-names>T</given-names></name><name><surname>Aruga</surname> <given-names>J</given-names></name><name><surname>Minabe</surname> <given-names>Y</given-names></name><name><surname>Tonegawa</surname> <given-names>S</given-names></name><name><surname>Yoshikawa</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Genetic analysis of the calcineurin pathway identifies members of the EGR gene family, specifically EGR3, as potential susceptibility candidates in schizophrenia</article-title><source>PNAS</source><volume>104</volume><fpage>2815</fpage><lpage>2820</lpage><pub-id pub-id-type="doi">10.1073/pnas.0610765104</pub-id><pub-id pub-id-type="pmid">17360599</pub-id></element-citation></ref><ref id="bib130"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yap</surname> <given-names>EL</given-names></name><name><surname>Greenberg</surname> <given-names>ME</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Activity-Regulated transcription: bridging the gap between neural activity and behavior</article-title><source>Neuron</source><volume>100</volume><fpage>330</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2018.10.013</pub-id><pub-id pub-id-type="pmid">30359600</pub-id></element-citation></ref><ref id="bib131"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname> <given-names>HH</given-names></name><name><surname>Knowlton</surname> <given-names>BJ</given-names></name><name><surname>Balleine</surname> <given-names>BW</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Lesions of dorsolateral striatum preserve outcome expectancy but disrupt habit formation in instrumental learning</article-title><source>European Journal of Neuroscience</source><volume>19</volume><fpage>181</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1111/j.1460-9568.2004.03095.x</pub-id></element-citation></ref><ref id="bib132"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zahm</surname> <given-names>DS</given-names></name><name><surname>Becker</surname> <given-names>ML</given-names></name><name><surname>Freiman</surname> <given-names>AJ</given-names></name><name><surname>Strauch</surname> <given-names>S</given-names></name><name><surname>Degarmo</surname> <given-names>B</given-names></name><name><surname>Geisler</surname> <given-names>S</given-names></name><name><surname>Meredith</surname> <given-names>GE</given-names></name><name><surname>Marinelli</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Fos after single and repeated self-administration of cocaine and saline in the rat: emphasis on the basal forebrain and recalibration of expression</article-title><source>Neuropsychopharmacology</source><volume>35</volume><fpage>445</fpage><lpage>463</lpage><pub-id pub-id-type="doi">10.1038/npp.2009.149</pub-id><pub-id pub-id-type="pmid">19794406</pub-id></element-citation></ref><ref id="bib133"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zapata</surname> <given-names>A</given-names></name><name><surname>Minney</surname> <given-names>VL</given-names></name><name><surname>Shippenberg</surname> <given-names>TS</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Shift from goal-directed to habitual cocaine seeking after prolonged experience in rats</article-title><source>Journal of Neuroscience</source><volume>30</volume><fpage>15457</fpage><lpage>15463</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4072-10.2010</pub-id><pub-id pub-id-type="pmid">21084602</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.65228.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Day</surname><given-names>Jeremy J</given-names></name><role>Reviewing Editor</role><aff><institution>University of Alabama at Birmingham</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>Drugs of abuse like cocaine alter gene expression patterns in brain reward circuits, and this transcriptional response is essential for drug-induced cellular and behavioral plasticity. Supported by careful transcriptional profiling, single-molecule RNA analyses, and genetic perturbations, this manuscript identifies Egr2 as a top marker of cocaine-activated neuronal ensembles in the dorsal striatum and establishes a role for this gene in cocaine response. This work will be of broad interest to researchers studying programmed gene responses, and also to the addiction neuroscience community.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Egr2 induction in Drd1<sup>+</sup> ensembles of the ventrolateral striatum supports the development of cocaine reward&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Kate Wassum as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed the reviews with one another, and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>As the editors have judged that your manuscript is of interest, but as described below that additional experiments are required before it is published, we would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). First, because many researchers have temporarily lost access to the labs, we will give authors as much time as they need to submit revised manuscripts. We are also offering, if you choose, to post the manuscript to bioRxiv (if it is not already there) along with this decision letter and a formal designation that the manuscript is &quot;in revision at <italic>eLife</italic>&quot;. Please let us know if you would like to pursue this option.</p><p>Summary:</p><p>Drugs of abuse like cocaine alter gene expression patterns in brain reward circuits, and this transcriptional response is essential for drug-induced cellular and behavioral plasticity. In this manuscript, the authors use careful transcriptional profiling, single-molecule RNA analyses, and genetic perturbations to further define the cellular populations and transcriptional response programs that contribute to cocaine response. Together, the results of this manuscript establish that cocaine activates an Egr2<sup>+</sup> neuronal ensemble in the ventrolateral striatum and reveal a role for Egr2 in cocaine-related behavioral responses. Overall, the results of the manuscript are compellingly presented, and validation of the role for Egr2<sup>+</sup> ensembles with distinct approaches supports the conclusions of the manuscript. A limitation of this work is that it does not define the potential gene targets of Egr2 and does not address how Egr2-regulated gene programs contribute to VLS function and physiology. Further, it does not demonstrate the sufficiency of Egr2 for cocaine-related behavioral plasticity. However, this is a solid manuscript that makes an important and detailed contribution to our understanding of addiction-relevant transcriptional regulatory mechanisms. This work will be of broad interest to researchers studying programmed gene responses, and also to the addiction neuroscience community.</p><p>Essential revisions:</p><p>1) The results presented in Figure 1I are intriguing and suggest that inhibition of Egr2<sup>+</sup> neurons in the dorsal striatum blocks development of cocaine locomotor sensitization. However, this result is based on a small sample size (n=3 per group), and is missing some key controls (most notably, delivery of DIO-Kir2.1 to Cre- animals). Further, the authors do not show any validation that this approach resulted in silencing of Egr2<sup>+</sup> DS neurons. At the very least, repeating the Kir2.1 overexpression experiment and validating the approach would significantly strengthen the author's conclusions.</p><p>2) The authors should provide the scoring or stereotypies that usually developed following repeated exposure (20 mg/kg) to cocaine. This is important because it could be simply that mice biased their behavioral responses towards stereotypies. This issue should be clarified. Similarly, in the discussion the authors mention that VLS receives strong inputs from cortical areas conveying information arising from limbs and mouth, which are both highly impacted following repeated exposure to cocaine (stereotypies). The authors had therefore a unique opportunity to directly test whether neuronal ensembles within this striatal domain could be involved in the development of motor stereotypies induced by psychostimulants. The authors should seriously consider this option.</p><p>3) Part of the data of this study has already been used in a recent publication of the lab in Current Biology (Gonzales et al., 2020). While this is not a problem as there are different cocaine programs in this study, this point should be clearly mentioned. Similarly, Figure 1B, acute of this manuscript contains the same images as Figure 1C of the current biology: these images should be either changed, or “from Gonzales et al., 2020” should be in the legend of the Figure. The same applies to Figure 3A, Drd1, acute. The overlap of the data of Figure 1A-C in Mukherjee et al., 2018 and this study should also be clarified in the text and figures.</p><p>4) Figure 3 panel E and G: In contrast to what they state, these experiments do not support direct evidence that Egr2 in VLS D1 neurons contribute to the rewarding properties induced by cocaine. Single values from panel E clearly show that only 1 out of 6 mice do not display CPP following DREADD activation. The decreased CPP therefore relies only on this point. Repeating this experiment would strengthen the claims that the authors make. Moreover, the dose of CNO used is particularly high. The experiments should be performed with a lower dose of CNO and include validation showing that Egr2 neurons expressing hM4Di are indeed inactivated.</p><p>5) Similarly, in their last experiment, the authors provide elegant loss of function experiments by using an inhibitory DREADD (hM4Di) and an Egr2 mutant which does not bind to DNA, to demonstrate the implication of the Egr2 pathway in the induction of cocaine CPP. However, the authors mention it is necessary for cocaine CPP, while all hM4Di mice except one, and all DNEgr2 except 2, still exhibited CPP after the manipulation. The authors need to temper their conclusion to reflect the data and say they demonstrated an implication of Egr2 in the VLS in cocaine CPP. Necessity would be reflected by an absence of CPP. In the future, the authors might consider bilateral injections to obtain stronger behavioral effects.</p><p>6) Please ensure full statistical reporting in the main manuscript (e.g., test statistic, degrees of freedom, in addition to p value).</p><p>[Editors' note: further revisions were suggested prior to acceptance, as described below.]</p><p>Thank you for resubmitting your work entitled &quot;Egr2 induction in Drd1<sup>+</sup> SPNs of the ventrolateral striatum supports cocaine place preference in mice&quot; for further consideration by <italic>eLife</italic>. Your revised article has been evaluated by Kate Wassum (Senior Editor) and a Reviewing Editor.</p><p>Summary:</p><p>Drugs of abuse like cocaine alter gene expression patterns in brain reward circuits, and this transcriptional response is essential for drug-induced cellular and behavioral plasticity. Supported by careful transcriptional profiling, single-molecule RNA analyses, and genetic perturbations, this manuscript identifies Egr2 as a top marker of cocaine-activated neuronal ensembles in the dorsal striatum and establishes a role for this gene in cocaine response. This work will be of broad interest to researchers studying programmed gene responses, and also to the addiction neuroscience community.</p><p>The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:</p><p>1) Please adjust the title to more accurately reflect the finding of the manuscript. Specifically, we suggest replacing &quot;supports&quot; with &quot;contributes&quot;, to make it more clear that Egr2 neuron silencing in SPNs of the VLS is not abolishing cocaine CPP, but rather dampening it. Moreover, it may not be accurate to mention Drd1<sup>+</sup> SPNs, as a significant proportion of Egr2<sup>+</sup> neurons are Drd2<sup>+</sup> (about 41.6% if including Egr2<sup>+</sup>Drd2<sup>+</sup> and Egr2<sup>+</sup>Drd1<sup>+</sup>Drd2<sup>+</sup>). While there are more Drd1<sup>+</sup> (about 73.6% if including Egr2<sup>+</sup>Drd1<sup>+</sup> and Egr2<sup>+</sup>Drd1<sup>+</sup>Drd2<sup>+</sup>), this is still less than twice more. We suggest the following title: &quot;Egr2 induction in SPNs of the ventrolateral striatum contributes to cocaine place preference in mice&quot;.</p><p>2) The new results included in Figure 3—figure supplement 3 supports the role of Egr2 neurons in the context of cocaine CPP and uses a lower dose of CNO. This experiment addresses several major concerns raised in the prior round of review and is as or more convincing than the current Figure 3F. We suggest including the data from Figure 3—figure supplement 3 in the main part of the paper and not as a supplemental figure.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.65228.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) The results presented in Figure 1I are intriguing and suggest that inhibition of Egr2<sup>+</sup> neurons in the dorsal striatum blocks development of cocaine locomotor sensitization. However, this result is based on a small sample size (n=3 per group), and is missing some key controls (most notably, delivery of DIO-Kir2.1 to Cre- animals). Further, the authors do not show any validation that this approach resulted in silencing of Egr2<sup>+</sup> DS neurons. At the very least, repeating the Kir2.1 overexpression experiment and validating the approach would significantly strengthen the author's conclusions.</p></disp-quote><p>We accept the reviewers’ critique of this experiment. Currently we are limited in our capacity to develop additional experiments. We believe that the results of this experiment are valid and have applied a similar approach (of Kir2.1 inhibition of Egr2<sup>+</sup>-expressing neurons) in previous studies (Atlan et al., 2018; Terem et al., 2020), in which we characterized the physiological impact of Kir2.1 expression (Atlan et al., 2018; Figure S2B). However, we accept the reviewers’ concern of the number of mice in the study is small. As this experiment is not a crucial building block of this manuscript, we have simply removed it from the revised version, so as not to cause an unwarranted delay in publication.</p><disp-quote content-type="editor-comment"><p>2) The authors should provide the scoring or stereotypies that usually developed following repeated exposure (20 mg/kg) to cocaine. This is important because it could be simply that mice biased their behavioral responses towards stereotypies. This issue should be clarified. Similarly, in the discussion the authors mention that VLS receives strong inputs from cortical areas conveying information arising from limbs and mouth, which are both highly impacted following repeated exposure to cocaine (stereotypies). The authors had therefore a unique opportunity to directly test whether neuronal ensembles within this striatal domain could be involved in the development of motor stereotypies induced by psychostimulants. The authors should seriously consider this option.</p></disp-quote><p>This is truly a fascinating notion and is the basis of work we are currently developing in the lab, addressing the role of VLS neurons in cocaine stereotypy. Since the focus of the experiments described in the current manuscript were on locomotor sensitization and place preference, the paradigm and behavior tracking protocol were tailored to address these questions, rather than address the development of stereotypies. Our understanding, based on the literature and our cumulative experience, is that the behavioral output induced by cocaine depends on the concentration of the drug applied and the context (size of the arena) in which the drug is administered. Therefore, we applied 10 mg/kg for CPP experiments and 20 mg/kg for locomotor sensitization. Orofacial stereotypies are reputed to emerge as the major behavioral output at higher concentrations of cocaine (30 mg/kg) under conditions in which the path of the mice is restricted, by placing them in smaller arenas (Xu et al., 1994; Blanchard, 2000; Caster and Kuhn, 2009; Giros et al., 1996).</p><p>In any case, we are not able to quantify stereotypies in the experiments included in the manuscript, as these experiments were documented solely with a top-view camera with the objective of quantifying locomotion.</p><disp-quote content-type="editor-comment"><p>3) Part of the data of this study has already been used in a recent publication of the lab in PNAS (Gonzales et al., 2020). While this is not a problem as there are different cocaine programs in this study, this point should be clearly mentioned. Similarly, Figure 1B, acute of this manuscript contains the same images as Figure 1C of the current biology: these images should be either changed, or 'from Gonzales et al. 2020' should be in the legend of the Figure. The same applies to Figure 3A, Drd1, acute. The overlap of the data of Figure 1A-C in Mukherjee et al., 2018 and this study should also be clarified in the text and figures.</p></disp-quote><p>We acknowledged the reuse of data in the original submission and following the reviewer’s suggestions have added a subsection “Re-used data”. This section details all overlap with data used in other manuscripts:</p><p>Regarding specific comments made by the reviewer – the panel in Figure 1B is a summary of the behavior of all mice included in the current study (partially overlapping with mice included in previous studies, as defined in the Materials and methods), and has not been previously published. With regard to the request to relate in the figure legends to panels that appeared in previous publications, we have a reference, as requested, in the legend of Figure 2 and Figure 3: “Images relating to acute cocaine (in panels B, C and D) were replicated from Gonzales et al., 2020, PNAS, with permission).”</p><disp-quote content-type="editor-comment"><p>4) Figure 3 panel E and G: In contrast to what they state, these experiments do not support direct evidence that Egr2 in VLS D1 neurons contribute to the rewarding properties induced by cocaine. Single values from panel E clearly show that only 1 out of 6 mice do not display CPP following DREADD activation. The decreased CPP therefore relies only on this point. Repeating this experiment would strengthen the claims that the authors make. Moreover, the dose of CNO used is particularly high. The experiments should be performed with a lower dose of CNO and include validation showing that Egr2 neurons expressing hM4Di are indeed inactivated.</p></disp-quote><p>We thank the reviewers for this comment. We have indeed, in the past, performed this experiment in additional iterations, providing confidence in the validity of our observations. We have now included an additional experiment as Figure 3—figure supplement 3. This experiment was based on a slightly different CPP paradigm, in which the preference of mice was tested repeatedly, interleaved between each of 3 conditioning sessions, in contrast to the experiment included in Figure 3E-F, in which we tested the preference of mice only once, following 3 consecutive conditioning days. The interleaved protocol supports analysis of behavior during the induction of <italic>Egr2</italic> &amp; <italic>CRE</italic> expression (following the first cocaine exposure), gradually leading up to hM4Di recombination and behavioral impact. Furthermore, in this experiment, controls were hM4Di expressing mice which were exposed to saline, while in the experiment included in Figure 3E-F, control mice (expressing mCherry) were exposed to CNO, similar to experimental mice (expressing hM4Di). Finally, in the experiment included in Figure 3—figure supplement 3, CNO was administered at 5 mg/kg.</p><p>The relevant section of text in the manuscript currently reads: “The selective enrichment of Egr2 induction within VLS Drd1<sup>+</sup> neurons suggests a causal role for this neuronal population in supporting cocaine-conditioned behaviors. […] We therefore conclude that VLS Egr2<sup>+</sup>-expressing neurons contribute to the development of cocaine-seeking behavior, with no obvious impact on locomotor aspects of cocaine-driven behavior.”</p><p>With regard to further validation of the action of CNO on hM4Di DREADDs, we have previously performed an electrophysiological evaluation of the impact of CNO-hM4Di on excitability of Egr2<sup>+</sup> neurons (albeit claustrum Egr2<sup>+</sup> neurons; Atlan et al., 2018).</p><fig id="sa2fig1"><label>Author response image 1.</label><caption><title>Efficacy and efficiency of transduction of hM4Di infection of CL<sub>Egr2+</sub> neurons.</title><p>(A) Representative traces of whole-cell current clamp recordings from CL<sub>Egr2+</sub> neurons expressing the hM4Di DREADD, in the presence or absence of CNO (clozapine-N-oxide; 1 μM). 50-250 pA current injections (right) demonstrate the reduction of excitability in cells expressing hM4Di before(middle) and after (right) application of CNO. (B) Summary graph of the impact of CNO on the excitability of neurons expressing hM4Di.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65228-resp-fig1-v2.tif"/></fig><p>While we do not have a direct measurement in VLS Egr2<sup>+</sup> neurons and are limited in our capacity to perform these experiments currently, we have observed, in unpublished immunostaining experiments, that exposure to CNO inhibited the expression of Fos in hM4Di-expressing Egr2<sup>+</sup> neurons in the claustrum (see <xref ref-type="fig" rid="sa2fig2">Author response image 2</xref>). As we are utilizing the same reagents (mice, viruses and CNO) in the current study, we assume the effect to be similar.</p><fig id="sa2fig2"><label>Author response image 2.</label><caption><title>hM4Di-CNO inhibits cocaine-induced Fos induction in Egr2<sup>+</sup> claustral neurons.</title><p>The claustrum of Egr2-CRE mice was transduced with AAV viruses conditionally expressing hM4Di. 3 weeks later, following habituation to ip saline injections, mice were injected (i.p. 10mg/kg) with CNO, and 30 minutes later with cocaine (20mg/kg), sacrificed 1.5 hrs later. Sections were submitted to immunostaining for Fos (magenta). The representative overview image (left) and merged image (right) demonstrate the absence of co-localization of Fos staining in cells expressing the hM4Di DREADD.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65228-resp-fig2-v2.tif"/></fig><p>Furthermore, a similar experiment (CNO action on hM4Di prior to cocaine), performed in the VLS of Drd1-Cre mice (in a separate study) provided essentially the same results, increasing our confidence that ligation of hM4Di by CNO acts to inhibit VLS neurons (see <xref ref-type="fig" rid="sa2fig3">Author response image 3</xref>).</p><fig id="sa2fig3"><label>Author response image 3.</label><caption><title>hM4Di-CNO inhibits cocaine-induced Fos induction in VLS Drd1<sup>+</sup>-neurons.</title><p>The VLS of Drd1<sup>+</sup>-CRE mice was transduced with AAV viruses conditionally expressing hM4Di (red). Following habituation to ip saline injections, mice were injected with CNO (i.p. 10 mg/kg), and 30 minutes later with cocaine, sacrificed 1.5 hrs later. Sections were immunostained for Fos (green). A representative image from a mouse injected with saline before cocaine (left) demonstrates co-localization of green+red cells (white arrows), which are not observed in the representative image (right) from the mouse exposed to CNO prior to cocaine.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65228-resp-fig3-v2.tif"/></fig><disp-quote content-type="editor-comment"><p>5) Similarly, in their last experiment, the authors provide elegant loss of function experiments by using an inhibitory DREADD (hM4Di) and an Egr2 mutant which does not bind to DNA, to demonstrate the implication of the Egr2 pathway in the induction of cocaine CPP. However, the authors mention it is necessary for cocaine CPP, while all hM4Di mice except one, and all DNEgr2 except 2, still exhibited CPP after the manipulation. The authors need to temper their conclusion to reflect the data and say they demonstrated an implication of Egr2 in the VLS in cocaine CPP. Necessity would be reflected by an absence of CPP. In the future, the authors might consider bilateral injections to obtain stronger behavioral effects.</p></disp-quote><p>We hope the additional experiment, now included in Figure 3—figure supplement 3 appeases the reviewers’ concerns regarding the reliability of the effect of hM4Di DREADD inhibition of VLS Egr2<sup>+</sup> neurons. All experiments were performed with bilateral injections, which we now state more clearly in the text (single hemispheres are shown in the figure only for illustration). Following the reviewers’ suggestion, we have tempered the description of the results and conclusions in the text, and the title of this section has also been revised to read “Implication of VLS Egr2 transcriptional activity in the development of cocaine-seeking behavior”.</p><disp-quote content-type="editor-comment"><p>6) Please ensure full statistical reporting in the main manuscript (e.g., test statistic, degrees of freedom, in addition to p value).</p></disp-quote><p>We have made sure to add full statistical reporting to the main manuscript, in addition to the Supplementary file 6, which provides a comprehensive description of the statistical methods and results.</p><p>[Editors' note: further revisions were suggested prior to acceptance, as described below.]</p><disp-quote content-type="editor-comment"><p>The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:</p><p>1) Please adjust the title to more accurately reflect the finding of the manuscript. Specifically, we suggest replacing &quot;supports&quot; with &quot;contributes&quot;, to make it more clear that Egr2 neuron silencing in SPNs of the VLS is not abolishing cocaine CPP, but rather dampening it. Moreover, it may not be accurate to mention Drd1<sup>+</sup> SPNs, as a significant proportion of Egr2<sup>+</sup> neurons are Drd2<sup>+</sup> (about 41.6% if including Egr2<sup>+</sup>Drd2<sup>+</sup> and Egr2<sup>+</sup>Drd1<sup>+</sup>Drd2<sup>+</sup>). While there are more Drd1<sup>+</sup> (about 73.6% if including Egr2<sup>+</sup>Drd1<sup>+</sup> and Egr2<sup>+</sup>Drd1<sup>+</sup>Drd2<sup>+</sup>), this is still less than twice more. We suggest the following title: &quot;Egr2 induction in SPNs of the ventrolateral striatum contributes to cocaine place preference in mice&quot;.</p></disp-quote><p>As requested, we have revised the title of the manuscript, which now reads: “Egr2 induction in spiny projection neurons of the ventrolateral striatum contributes to cocaine place preference in mice”.</p><disp-quote content-type="editor-comment"><p>2) The new results included in Figure 3—figure supplement 3 supports the role of Egr2 neurons in the context of cocaine CPP and uses a lower dose of CNO. This experiment addresses several major concerns raised in the prior round of review and is as or more convincing than the current Figure 3F. We suggest including the data from Figure 3—figure supplement 3 in the main part of the paper and not as a supplemental figure.</p></disp-quote><p>As further requested, we have transferred the experiment included in Figure 3—figure supplement 3 into the main figure, and it now comprises panels D, E of Figure 3.</p></body></sub-article></article>